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The thesis is divided into two sections.
Section I describes the development of a technique
for separating and estimating the catecholamines and
their metabolites in a single sample of brain tissue.
This section is divided into two sub-sections. In
sub-section 1 a method is described in which the amines
are separated, prior to estimation, by paper chromato¬
graphy using phenol s hydrochloric acid. Thus method
proved to be unsuitable for several reasons when
applied to brain extracts. A much more satisfactory
procedure was developed in which the amines are
separated and estimated in the form of their acetylated
derivatives. This latter technique and its application
to the analysis of extracts from rat brain are described
in sub-section 2.
Section II is concerned with an investigation
into the effects of chlorpromasine on the metabolism
of catecholamines in discrete areas of dog brain, using
the analytical techniques described in Section I,
Sub-section 2.
SECTION I
Methods for the Estimation of
Catecholamines and their
Metabolites in Brain Tissue
INTRODUCTION
The first estimations of brain catecholamines were
carried out with biological methods and were of necessity
limited to the estimation of adrenaline and noradrena¬
line. Using these methods, the distribution of
adrenaline and noradrenaline in brain and the effects of
drugs on the amine levels were studied (Vogt, 1954-,).
It was impossible to tell from these experiments if a
change in amine concentration following administration
of a drug resulted from an effect of the drug on storage,
synthesis or metabolism of the amine. Localisation
of the sites of drug action only became feasible after
the introduction of fluorimetric methods whereby not
only adrenaline and noradrenaline but also their
precursors and metabolites, could be assayed.
Development of methods for estimating the amines
and their metabolites stimulated a search for methods
of sepax'ating the amines previous to their measurement.
Separation techniques have tended to lag behind estima¬
tion techniques with the result that the number of amines
and their metabolites which can be estimated in one
sample has been limited. Deficiencies in separation
have to some extent been made good by development of
assay methods which are sufficiently specific to allow
one compound to be estimated in the presence of another
2
and sufficiently sensitive to allow division of the
sample into as many aliquots as there are compounds to
be measured. Thus most of the reports to date on
brain amines and their metabolites have been restricted
to the estimation of only two or three of these compounds
from one brain sample (Baird and Lewis, 1964; Juorio
and Vogt, 196$; Bertler and Hosengren, 1959) or have
covered a wider range of compounds by pooling brains
from several animals and taking aliquots for the estima¬
tion of individual compounds or groups of confounds
(Wiegand. and Perry, 1961; Oarlsson and Lindquist, 196$),
Estimation of an amine or an amine metabolite in the
presence of other related substances is not, however,
always satisfactory if the concentration of the substance
being measured is low relative to the concentrations
of other compounds present in the assay solution.
This situation is liable to occur in bi4ain extracts,
particularly after treatment of the animal with a
drug causing a preferential rise in the concentration
of certain of the amines or their metabolites in brain
tissue.
Statement of the Problem
A method capable of separating and assaying
the catecholamines, their precursors and metabolites
in the one brain sample would avoid the dangers and
limitations attendant upon estimating one compound in
the presence of another or others. The least amount
3
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of amine or metabolite detectable in a sample would
at the same time be decreased because division of tbb
sample into several portions would no longer be necessary.
This section of the thesis describes the development of
such a method., which is applicable to brain tissue add
can therefore be used in studies on the metabolism of
the catecholamines in brain and the effects of drugs
thereon.
The possible catecholamines, their precursors and
metabolites present in brain are shown in Figure 1 .
They can be sub-divided into (i) the catecholamines -
adrenaline, noradrenaline and dopamine, (ii) the amino
acid precursors - tyrosine and dihydroxyphenylalanine
(dopa), (iii) the methoxy derivatives of the catechol¬
amines - inetanephrine, normetanephrine and methoxy-
dopamine;$0the acids - dihydroxymandelic acid and di-
hydroxyphenylacetic acid with their respective methoxy
derivatives - vanillinmandelic acid and homovanillic
acid and (v) the alcohols (not shown in Figure 1 ) which
represent an alternative pathway following the action
of monoamine oxidase on each of the amines (Rutledge and
Jonason, 1967).
This section describes a technique for the separa¬
tion of (i), (ii), (iii) and (iv) and for the assay of
the components of (i), (ii) and (iii) in the same
brain sample, with the exclusion of an assay method
for tyrosine. Description of the separation and aspay
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of the acids will be brief, since this work was done,
concurrently with work on the amines, by a colleague,
Dr Guldberg. In order to limit this study, the alco¬
hols were not investigated.
■#,
Historical Introduction
The literature survey is divided into three parts,
corresponding to the three stages involved in determin¬
ing several catechol derivatives in a tissue. These
are:
(1) extraction of the compounds from the tissue,
(2) separation of the compounds, one from another,
(3) estimation of the separated compounds by fluorescence
techniques.
These stages are inter-dependent in that selection of
a particular technique fax* any stage has to be made
with due consideration of the techniques used for the
other two stages. For maximum sensitivity, the most
sensitive method of fluorescence assay should be chosen
and extraction and separation procedures evolved, to
allow for the application of this method.
Extraction of the Amines and their hetabolites from
Tissues
Since the catechols are more stable in an acidic
environment, initial homogenisation of the tissue is
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always done in acid solution, usually in 0,011? hydro-
chloric acid or G.4N perchloric acid. Soft tissues
such as brain adrenal medulla can be readily broken
down by homogenisation in a glass hosogeniser. The
amines and their metabolites may be extracted from the
acid homogenate into an organic solvent or the protein
may be removed by precipitation and centrifugation to
give an aqueous acidic supernatant which contains the
amines and their metabolites. Shore and Olin (1958)
found that adrenaline and noradrenaline could be
extracted into n-butanol from a salt saturated tissue
homogenate prepared in 0.G1N hydrochloric acid. The
amines were back-extracted into acid by shaking the
butanol layer with acid and heptane. This technique
is not advised for tissues, such as brain, which have
a low amine content, since only 65% of the adrenaline
and noradrenaline and none of the dopamine (Cass and
Spriggs, 1961) is extracted. The alternative method,
entailing clarification of the acid homogenate by
precipitation of the protein is therefore more usually
employed.
Various protein precipitants have been used.
Occasionally tissues homogenised in Q.1N sulphuric acid
(Laverty and Sherman, 1965) show adequate protein
precipitation but usually addition of a protein preci¬
pitant such as methanol (Montagu, 1957)» ethanol
(Crawford and Outschoorn, 1951)♦ equal parts of methanol
7
and acetone (Hagopian, Dorfman and Gut, 1961), trichloro¬
acetic acid (Bourkes and Drujan, 1957) 03? perchloric
acid (Bertler, Jarlsson and Rosengren, 1956) to the
acid homogenate, is required. Choice of protein
precipitant depends largely on the next step in the
procedure. If the extracted material is to be applied
to a paper chromatogram, 0.01H hydrochloric acid plus
ethanol is useful since it can be readily evaporated
in vacuo. The acid precipitants are best removed
before any evaporation, since on concentration they
give rise to concentrations of hydrogen ion which
could destroy small amounts of the amines. In addi¬
tion, perchloric acid is an oxidising agent and in
increased concentration could oxidise the amines
(Anton and Sayre, 1962). Perchloric acid can be
removed as its relatively insoluble potassium salt
(Bertler et al., 1956). trichloroacetic acid can be
extracted into ether but losses of the amines may
occur during this procedure (Bertler et al., 1956).
Extracts applied to ion exchange or alumina columns
must be free of organic solvents to avoid emulsification
of lipids extracted into the solvent, by the aqueous
phase in the columns. Acid ethanol is therefore not
a suitable preliminary to ion exchange or alumina
chromatography (Bertler et al,, 1956). Perchloric
acid extracts are the most widely used for application
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to both ion exchange columns and paper chroraatograms.
Perchloric acid has an advantage over ethanol in that
it does not extract lipids (Callingham and Cass, 1963,
p, 21). The initial homogenisation in Q.01N hydro¬
chloric acid can be omitted and the tissue homogenised
directly in perchloric acid (Bertler et al., 1958).
No quantitative studies comparing methods of
amine extraction from tissues could be found in the
literature. There are, however, reports on conditions
conducive to optimal extraction and stability of the
amines. These are:
(i) Extraction of the tissue: The tissue should be
extracted immediately after removal from the animal
(Vogt, 195*0 or immediately frozen solid. Graborits,
Chessick and Lai (1966) found there was no loss of
noradrenaline from brain after four hours in the deep¬
freeze, providing the brain was homogenised without
thawing.
(ii) Temperature of extraction; The tissue and
extracting fluid should be kept thoroughly chilled
(H&ggendal, 1966; Anton and Sayre, 1962). Precipi¬
tation of proteins and clarification of extracts are
aided by a low temperature and most workers recommend
centrifuging extracts at 4-° - 10°G (Bertler et al.t
1958).
(15,1) Number of extractions necessary to remove the
amines from the tissue: Bertler et al. (1958)
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investigated the efficiency of catecholamine extraction
from brain and heart by repeated extraction with three
volumes 0.4-N perchloric acid per g tissue. They found
on average 98% removal in the first two combined
extractions, 2% in the third and zero in the fourth.
They also found that the amines distributed themselves
between the supernatant fluid and the precipitate as
though their concentrations in the supernatant and
in the water phase of the precipitate were the same.
Anton and Sayre (1982) and Gunne (1963) have used
this finding to correct for amine loss in the preci-
tate after extraction of the brain tissue with 6 to
10 volumes of 0.4N perchloric acid. The correction
factor with such large volumes of extracting fluid is
small and most workers have ignored it without any
consideration of the error involved.
(iv) Addition of anti-oxidants: Catecholamines are
readily oxidised in dilute solution (von liuler, 1936,
p. 11). Reducing agents such as ascorbic acid or
sodium metabisulphite are often added during the
extraction process. This is possibly an unnecessary
precaution, since brain extracts have themselves a
stabilising effect on the amines (Vogt, 195^» Shore
and 01in, 1938,•
(v) Addition of chelating agents: Ethylenediamine
tetra-acetic acid (EDTA) is often added during
10
extraction to protect the amines against attack by metal
ions (von Euler and Eloding, 1956). In acid solution,
heavy metals such as copper (Hfiggendal, 1963) catalyse
oxidation of the catecholamines. The necessity of
the addition of EDTA probably depends on the purity
of the water supply. Distilled deionised water should
not contain any metal ions, but these might originate
from materials used during the extraction or separation
processes, particularly from alumina (Anton and Sayre,
1962; 196*).
(vi) Effect of pH on the stability of catecholamines
in tissue extracts prepared with 0.4-N perchloric acid:
The pH of these extracts is about 0.5 - 1*0 and under
these conditions noradrenaline is stable for one week
at 0°C (Bertler et al., 1958). Stability can be
prolonged to three months by adjusting the pH to about
3.8 and storing in a deep-freeze (Gunne, 1963).
The acid metabolites of the catechol- arid
methoxyamines are extracted from tissues by the same
procedures and with the same precautions as are
employed to extract their parent amines. Carlsson
and Billarp (1962) have used G.*N perchloric acid to
extract dihydroxyphenylacetic acid and homovanillic
acid from rabbit brain and Hagopian et al. (1961)
used hydrochloric acid followed by acetone-methanol
to extract both acids and amines from bovine hypothalamus.
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The acid metabolites in the extract can be separated
from the amines and the amino acids by extraction
into ethyl acetate (Oarlsson and Hillarp, 1962),
Sharman (196$) reported that saturation of the aqueous
phase with sodium chloride was essential for quantitativ
transfer of homovanillic acid into the organic layer.
In the few reported, experiments on amine and acid
levels in the same sample of tissue (Laverty and
Sharman, 196$*) Juorio and Vogt, 1965), separate ali-
quots have usually been taken for assay of the amines
and the acids, respectively. The effect of the ethyl
acetate extraction on the estimation of the amines
remaining in the aqueous has not been determined.
Methods of Reparation of the Amines
There are three techniques for separating the
catecholamines namely, (i) adsorption onto alumina,
(ii) ion exchange chromatography and (iii) paper
chromatography.
(i) d.sorption onto alumina. Alumina was intro¬
duced as the first specific adsorbent for the catechol¬
amines by Shaw (193S). Unlike ion exchange and paper
chromatography, it does not separate the amines one
from another. Adsorption onto alumina is specific
to the catechol nucleus (Lund, 1949b; von Euler and
Orwen, 1955), so that the catecholamines, their catechol
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Precursor dopa and catechol metabolites dihydroxyphenyl-
^cetic acid and dihydroxymandelic acid are all adsorbed.
These compounds are eluted simultaneously and may be
Estimated in the presence of one another by selection
°f specific methods of assay. Alumina adsorption is,
however, more frequently employed as a preliminary
Purification technique for tissue extracts before
separation of the individual catechols by ion exchange
or paper chromatography (Whitby, Axelrod and Weil-
^alherbe, 1961} Glowinski, Iversen and Axelrod, 1966).
(ii) Ion exchange chromatography. Previous to
the introduction of ion exchange resins, von Euler,
Hamberg and Hellner (1951) used partition on a starch
column to separate adrenaline, noradrenaline and
dopamine. eparation by this technique was very slow,
since it depended entirely upon non-ionic differences
between the partition characteristics of the amines.
V^ith ion exchange columns ionic as well as non-ionic
differences are operative and separation becomes
possible with a much shorter time for elution. Catechol¬
amines are usually adsorbed as their cations, since
they are unstable at the alkaline pH necessary for
their ionisation as anions. ('The pKa for adrenaline
ionised as an anion is 10.2 and as cation, 8.7)•
The first ion exchangers used for separation of
15
the catecholamines were the weak cationic resins.
(These have the disadvantage that they only function at
a pH greater than 6, at which pH the catechols are not
very stable. Hetanephrine and normetanephrine, which
are more stable at pH 6 - 6.5 than their parent catechols,
were isolated using a weak cationic resin by Pisano
(I960) and Smith and Weil-Malherbe (1962).
Strong cationic exchangers have two main
advantages over their weak counterparts,
(1) they adsorb cations very readily at almost any pH,
so that the amines may be applied in acid solution,
in which they are more stable and
(2) it is possible to elute the adsorbed amines
preferentially with different concentrations of acid
and thus obtain separation of at least some of the
amines without lengthening the column disproportionately.
Ellm&n (1956) first used a strong cationic resin
to adsorb catecholamines at pH 2 from an extract of
adrenal medulla. H&ggendal (1962a) found that complete
separation of adrenaline, noradrenaline, dopamine,
metanephrine, normetanephrine and methoxydopamine was
possible using IN hydrochloric acid as the eluting
fluid only if the cationic resin column was 105 cm
long. Varying degrees of separation were achieved
with shorter columns. Elution from long columns took
several hours during which time there was considerable
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amine loss, which could partly he avoided by the
addition of ascorbic acid and EDTA. Large amounts of
acid were required to develop these long columns and
as a result the separated amines were obtained in large
volumes of eluant which considerably reduced the sensi¬
tivity of amine assay. Despite thorough washing,
these columns released a material during acid elution
which, upon treatment with potassium ferricyanide, gave
rise to a fluorescence similar to that derived from the
catecholamines, thus further reducing the sensitivity
of amine assay. For these reasons, Mggendal's method
for separating all the amines at once has not been
generally adopted. Using much shorter columns of a
strong cationic resin which therefore required much
less ©luting fluid, Bertler et al. (1958) obtained
almost quantitative separation of adrenaline and nor¬
adrenaline from dopamine by eluting the former two
amines in IN hydrochloric acid followed by the latter
amine in 2N hydrochloric acid. Although there is
little published evidence, it seems likely that this
is the limit of amine separation possible with short
columns. Glowinski, Iversen and Axelrod (1966) and
Ivereen, Glowinski and Axelrod (1966) have used such
columns in conjunction with alumina adsorption, to
separate radio-active dopa, noradrenaline, dopamine
and the methoxyamines. The methoxyamines were not
15
separated from one another using this technique.
Wright (1958) and Takahashi and Fitzpatrick (1964)
have used anionic resins to remove catecholamines and
dopa from urine. Oxidation at the alkaline pH necessary
for amine adsorption onto the anionic resin was prevent¬
ed by complexing the catechols with borate before
applying them to the column. Recoveries of adrenaline
and noradrenaline were poor. Strong cationic resins
remain the exchangers of choice.
(iii) Paper chromatography. James (1948) first
demonstrated that adrenaline and noradrenaline could
be separated on a paper chromatogram using phenol.
The only other solvent systems known to separate
the amines are n-butanol:acetic acidswater (4:1:5) or
n-butanol equilibrated with N hydrochloric acid
(Shepherd and West, 1953} McGeer and Clark, 1964).
Phenol gives the better separation and has been
preferred for the chromatographic separation of
adrenaline and noradrenaline from tissue extracts.
Vogt (1959) showed dopamine and dopa had almost the
same Rfs in phenol containing (v/w) 0»1N hydrochloric
acid as adrenaline and noradrenaline, respectively.
When biological methods of assay were used (Holton,
1949} Crawford, 1951} Crawford and Outschoorn, 1951)
these compounds did not contribute to the adrenaline
and noradrenaline estimates. They could, however,
16
contribute to estimates obtained by chemical assay.
One disadvantage of phenol chromatography is that
phenol is leached out of the chromatogram into the
paper eluates from which it must be removed since it
interferes with both biological and chemical methods
of assay. for quantitative recovery, suitable
precautions such as development of the chromatogram
in an atmosphere of an inert gas and the use of freshly
distilled phenol must be taken to guard against amine
oxidation during chromatography.
"Weiss and Rossi (1962) separated adrenaline,
noradrenaline, dopamine and dopa using descending
chromatography in phenol:hydrochloric acid, drying the
chromatogram and then developing it, in the opposite
direction, in n-butanol saturated with IN hydrochloric
acid. Their technique was tested only qualitatively
but it represents one of the few attempts to improve
the resolution of the separation of the amines in
phenolJhydrochloric acid.
fluorescence Methods of Assay
Catecholamines fluoresce in their native form.
The fluorescence is, however, weak and since it is due
to their phenolic structure, not specific (Udenfriend,
1962, p. 140). There are two methods currently
17
available for producing highly fluorescent derivatives
from the catecholamines. The older and more specific
is the 'trihydroxyindole' method; the other more recent
and less specific method involves coupling with
ethylenediamine. The sensitivities of the amine assays
by these two methods are approximately the same.
(i) The trihydroxvlndole method. Loew (1918)
first observed that the oxidation products of adrenaline
fluoresced in alkaline solution. Gaddum and Schild
(1934-) and Hueber (194-0) used this yellow-green fluor¬
escence to assay adrenaline but commented on its
evanescence. Stabilisation of the fluorescence by
addition of ascorbic acid along with the alkali (Ehrlen,
194-8; Lund, 194-9b) allowed the reaction to be used for
routine adrenaline assays. The chemical constitution
of adrenolutine, the adrenaline fluorophor, is not
known with certainty, but is most likely to be a tri-
hydroxyindole, specifically the l-methyl-5»6-dihydroxy
derivative of indoxyl which itself possesses a strong
yellow fluorescence (Lund, 194-9a). In a following
paper, Lund (1950) reported formation of a similar
fluorophor from noradrenaline if oxidation was carried
out at pH 6*5i the pH is much less critical for
oxidation of adrenaline. In order to achieve
consistent quantitative production of fluorescence,
oxidation must be allowed to proceed for a controlled
18
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period/time (Lund, 1949b). Various modifications to
Lund's original method have been introduced, in
particular the use of potassium ferricyanide (von
Euler and Floding, 1956) or iodine (Drujan, Sourkes,
Layne and Murphy, 1959) as the oxidising agent instead
of manganese dioxide, which was used by Lund. The
mechanism of the reaction has been explained by Lund
(1949a) and Barley-Mason (1950) as follows; The
amine is oxidised in acid solution for a period of time
sufficient to allow the chrome, but not the oxidation
product from the chrome (melanin), to form. The
chrome is then re-arranged to the fluorescent lutlne
derivative by alkali in the presence of a reducing
agent to prevent oxidation of the lutine (figure 2. ).
Formation of the dopamine fluorophor occurs much
less readily than that of the adrenaline or noradrena¬
line fluorophors. A strong oxidising agent such as
periodate (Anton and Sayre, 1964) or iodine is required
and the slow development of the fluorophor (Bischoff
and Torres, 1962) can be speeded up by TJ-V irradiation
(Garlsson and Waldeck, 1958) or heating (Udenfriend,
1962, p. 157). The fluorescence derived from
dopamine is intensified and its excitation and
fluorescence maxima changed from those of the fluoro¬
phors from adrenaline and noradrenaline if the solution
is acidified. Bu'lock (I960) suggested that although
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the alkaline fluorescence might be due to the dihydroxy-
indole derivative of dopamine, the acid fluorescence
was more likely to originate from the tetrahydroxy-di
indole derivative. Methoxydopamine gives rise to a
fluorescence which has the same characteristics as
the dopamine fluorescence but is ten times less intense
(Carlsson and Waldeck, 1964),
Metanephrine and normetanephrine are resistant to
oxidation by potassium ferricyanide, unless zinc
sulphate is present as a catalyst (Brunjes, Wybenga
and Johns, 1964). Alternatively, as in the case of
dopamine and methoxydopamine, a stronger oxidising agent
such as periodate (Taniguchi, K&kimoto and Armstrong,
1964) or iodine (Bertler et al., 1959b) may be used.
Since the fluorophors from normetanephrine and nor¬
adrenaline fluoresce maximally at about 400/500 mp and
those from metanephrine aid adrenaline at about
410/520 mp, it would appear that the fluorophors and
presumably their mechanism of formation, are the same
in each case. Due to their identical fluorescence
characteristics, it is not possible to estimate
a catecholamine and its methoxy derivative in a single
portion of the sample. Estimation can only be achieved
by dividing the sample into two and estimating in one
portion the catecholamine plus the methoxyamine and
in the other portion the catecholamine alone. In order
.
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to avoid dividing the sample with concomitant loss of
sensitivity, a point of particular importance having
regard to the low amounts of methoxyamines present
in brain tissue (Garlsson and Lindquist, 1962;
Carlsson and Wal&eck, 1964), it is necessary to
separate each of the catechols from their methoxy
derivatives previous to assay.
Adrenaline and noradrenaline have been estimated
in the same sample, either by utilising the slight
difference in the wavelengths for maximal excitation
and fluorescence of their fluorophors (Price and Price,
1957; Vendsalu, I960) or by utilising the fact that
whereas both amines are oxidised at pH 6.5* only
adrenaline and 5 - ?;•• of the noradrenaline, is oxidised
at pH 5,5 (Lund, 1950; de Schaepdryver, 1958).
Dopa can be assayed in the same way as adrenaline
and noradrenaline (Bertler et al., 1958).
With the exception of the methoxyamine s, all the
discussed compounds have the structure considered
essential for the trihydroxyindole reaction, namely,
a catechol nucleus with a two carbon side chain ending
in an amino nitrogen and at least one hydrogen atom
attached to each of the side chain carbon atoms
(Lund, 1949b).
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(li) The ethylenediamine condensation method*
Hatelson, Lugovoy and Pincus (194-9) first described
the reaction of ethylenediamine with adrenaline to form
a fluorophor which was stable and extractable into
aliphatic alcohols. Weil-Malherbe and Bone investi¬
gated the reactions of catechols with ethylenediamine
in more detail and described application of this
reaction to the estimation of adrenaline (1992) and
noradrenaline and dopamine (1957)• Weil-Malherbe and
Bone (1952) heated adrenaline at 5 ° for 20 minutes
with an aqueous mixture (pH about 10) of ethylenediamine
and ethylenediamine dihydrochloi*ide and extracted the
fluorophor into isobutanol. Apart from the use of
hydrochloric acid (Laverty and Sharman, 1965) or
ammonium chloride (K&gi, Burger and Giger, 1957)
instead of ethylenediamine dihydrochloride, there have
been no worthwhile amendments to this technique.
Unlike the trihydroxyindole method, this one set of
reaction conditions produces fluorophors from all
compounds capable of coupling with ethylenediamine.
Natelson et al. (194-9) and Weil-Kalherbe (1952)
described the reaction with adrenaline as involving
oxidation, in alkaline solution, to the quinone,
adrenochrome, and subsequent coupling with ethylene-
diamine. The reaction is not limited to the catechol¬
amines but is given by all compounds having a catechol
23
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nueleus. The fluorophors from dihydroxymandelic
acid, adrenaline, noradrenaline and dopamine are
extractable from the reaction solution into isobutanol
but those from dopa and dihydroxyphenylaeetic acid are
only extracted to a slight extent, suggesting they retain
their carboxyl groups after condensation (Weil-Halherbe,
1959)# Adrenaline is considered to produce only one
fluorophor, dihydro-3-hydroxy-l-methylpyrrolo-(4-:5-g)-
quinoxaline, by coupling of one molecule of ethylene-
diamine onto the quinonoid oxygens of adrenochrome
(Harley-Fiason and Laird, 1958)• Noradrenaline gives
a mixture of fluorophors. The main fluorophor is
believed to be 1,2,3*4~tetrahydro-l,4-,5|8^tetra-aza-
anthracene, which is also obtained from condensation of
catechol with ethylenediamlne (Weil-Ma'lherbe, I960)
(Figure 3 ). The structure of the dopamine fluorophor
has not been worked out apart from the fact that the
side chain is not eliminated during the reaction of
ethylenediamine with dopamine (Weil-Kalherbe, 1959).
Certain of these fluorophors, particularly those
from noradrenaline, are light sensitive. Aronow and
Howard (1955) suggested working in a red-illumined room
to protect the light sensitive fluorescence. However,
loss of the light sensitive component leaves a fluor¬
escence which is stable and perfectly adequate for
assay purposes. Weil-Malherbe (1959) and Goldfien
(1961) concluded that greater uniformity was achieved
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by allowing the light sensitive fluorescence to fade
completely than by attempting with varying success to
preserve it.
Fluorescence and its Measurement
Fluorescence occurs when a molecule, after
absorbing light at a particular wavelength, emits light
of a different wavelength. The wavelengths of maximum
absorption, or excitation and of maximum emission, or
fluorescence, are characteristic of a given compound
and may be used as an aid to its identification.
Fluorescence can only be used for quantitative purposes
in very dilute solution, in which there is a linear
relationship between fluorescence and concentration,
if the wavelength and intensity of the exciting light is
kept constant.
Instrumentation
Spectrophotofluorimeters (SPFs) are instruments
specially designed for the detection and measurement
of fluorescence. The basic components of these
instruments are (i) a light source, (il) two light
filtering systems and (iii) a light detection apparatus.
Two SPFs, namely the •Farrand* and the 'Aminco-Bowman•
were used in the studies reported in this thesis.
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(i) The light source is usually a Xenon arc lamp
which is capable of delivering high intensity mono¬
chromatic light throughout the U-V and visible spectrum,
(ii) The grating monochromators are used to select
the excitation wavelength and to select fluorescent
light of a particular wavelength coming from the
sample. The excitation spectrum or scan of a compound
can be obtained by setting the fluorescence monochroma-
tor at a wavelength close to that of maximum fluor¬
escence of the compound and recording the relative
fluorescence intensity while exciting the solution
containing the compound with light of shorter wavelengths
starting at 200 mp. The instruments are designed so
that this can be done automatically. In a similar
manner it is possible to obtain the fluorescence spectrum,
by setting the excitation monochrometor at the wave¬
length for maximal excitation of the fluorescence and
continuously changing the wavelength of the light trans¬
mitted through the analysing monochrome.tor to the detect¬
or. The band widths of the light activating the solution
and of the light reaching the detector can be varied
by the insertion of slits of different widths between
the monochromators and the sample. Reducing the band
width of the existing and/or fluorescent light increases
resolution at the cost of diminished fluorescence due
to decreased light intensity. Wide band widths were
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used in the assays described in this thesis, in order
to obtain maximum excitation and hence maximum fluor¬
escence, from the very small amounts of material, often
less than 50 mug/ml, present in the solution in the
cuvette. Excitation (x) and fluorescence (y) wave¬
lengths used in any procedure in this thesis are
uncorrected for instrumental variation and are written
thus: x/y mix.
(iii) The emitted fluorescent light is detected by means
of a photomultiplier tube. In the following investi¬
gations IP 28 tubes, which are more sensitive to U-V
light than IP 21 tubes, were used in both instruments.
Renevral of a worn-out tube may result in altered and
possibly reduced readings for the fluorescence of
standard solutions because the sensitivity of individual
tubes can vary widely (Aminco-Bowman catalogue, 1965*
p. 18).
Practical considerations for the preparation of
fluorescent solutions. Great care is necessary when
measuring catecholamines by fluorimetry due to the
susceptibility - which is much increased at concentra¬
tions as low as those encountered in the work
described in this thesis - of the amines and their
fluorophors to pH (Williams, 1959)* temperature
(Udenfriend, 1962, p. 106), various ions (Anton and
S&yre, 1966) and other, often unknown, factors.
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Fluorescence assays are notoriously fickle and can be
influenced by light and in particular by substances,
often unidentified (Laverty and Sharman, 1965) present
in the water supply used to make up the reagents#.
We found distilled water passed through a mixed-bed ion
exchange resin was satisfactory. All-glass apparatus,
cleaned in chromic acid, was used. Thorough rinsing
in tap water, followed by distilled water, was necessary
to remove the chromic acid, which itself has a fluor¬
escence (Udenfriend, 1962, p. 99)• Polythene
apparatus is not advised as it may adsorb traces of the
amines and/or their fluorophors.
In order to obtain maximum specificity and sensi¬
tivity in any assay, the fluorescence of the reagents
must be as low as possible. Analytical grade chemi¬
cals and deionised distilled water were used to this
end. The light scatter peak was minimised by using
absolutely clear reagent solutions. Reagents should
be renewed frequently, especially buffer solutions,
which tend to form fine deposits on standing.
Scattered light reveals itself on the fluorescence
spectrum (p. 26) by an emission peak, distinguishable
from a fluorescence peak by the fact that its wave¬
length of maximum emission is identical with the
excitation wavelength. If the wavelengths of maximum
excitation and fluorescence of a compound are close
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together, the light scatter peak may not be completely
separated from the fluorescence peak and may contribute
to the sample reading, which is usually taken at the
wavelengths of maximum excitation and emission of the
compound being estimated.
Preparation of Blanks
In any assay method it is necessary to determine
the contribution made to the measurement, by substances
present other than that being measured so that this
contribution by the 'blank' may be allowed for in the
estimation. In pure solution, the fluorescence of
the blank consists of the fluorescence resulting from
admixture of all the reagents used during the assay.
This blank is referred to as the 'reagent* blank.
When a substance is estimated in the presence of a
tissue extract, its blank must also include the
fluorescence originating from components of the extract
or from the reaction of these components with any of the
assay reagents. Such a blank is called a'tissue'or
'extract* blank. Preparation of a representative
tissue blank is a ma^jor problem in the use of fluori-
metry for the assay of substances in tissues. In
the trihydroxyindole method for the assay of catechol-
amines, 'faded* blanks, in which the catecholamine
fluorophor is allowed to decompose before adding the
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stabilising, reducing agent, are frequently used as
tissue blanks. Other methods of forming tissue blanks
include omission of a reagent vital to the production
of the flucrophor or addition of the reagents in an
order different from that required for fluorophor
formation. All these techniques have their own
disadvantages and the method of determining the blank
value must be tailored to suit each individual assay.
■Standards
Known amounts of the substance being assayed
should always be included with each batch of samples,
since the fluorescence intensity derived from the same
amount of substance can vary on different occasions.
The amount of fluorescence derived fi'om a standard in
the presence of a tissue extract may be different
from that produced from the same standard in pure
solution. This is because materials j>resent in an
extract can sometimes influence the fluorescence,
usually reducing or 'quenching' it. Measurement of
such interference is achieved by processing an aliquot
of the tissue extract to which the standard has been
added, in parallel with the sample. The standard
added to the tissue extract is referred to as the
'internal standard*. Comparison of the fluorescence
from this internal standard with that from the same
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standard in pure solution (the Aqueous* standard)
gives a measure of the extent of interference caused
by the tissue extract and the sample estimates can then
be corrected accordingly.
sensitivity of an Assay
The sensitivity of an assay i.e. the smallest
amount of substance that can be measured depends upon
(i) the fluorescence yield from the substance, (ii) the
size of the blank and (iii) the degree of quenching,
if any. In this thesis, the sensitivity of an assay
is assessed, arbitrarily, as that amount of substance
which produces a fluorescence reading equal in size
to that produced by the appropriate blank at the same
wavelengths of excitation and emission. It is,
however, possible to measure, albeit with diminished
accuracy, amounts of a substance giving rise to a
fluorescence relatively less than this. The lowest
limit of estimation of a substance with any degree of
confidence has been taken as that amount of substance
giving rise to a fluorescence intensity equal to half
that of the blank. In subsequent discussions this
limit has been referred to as the "level of detection'.
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REAGE'ST3
Unless otherwise stated in the text, all reagents
used were of analytical grade.
Distilled de-ionised water (p. 28 ) was used for
all procedures described in this thesis and for
preparing all solutions.
Hydrochloric acid: BDH Micro-analytical reagent.
Ethylenediamine: 1:2 diaminoethane (BDH,
Laboratory Reagent), was distilled three times, only
the middle one third fraction being collected from each
distillation. The re-distilled ethylenediamine was
stored in a brown-glass bottle and was used for not
more than 2 weeks#
Potassium ferricyanide: Analar, recrystallised
from water.
Ethyl acetate: following on Ferrand's (1966)
studies on the adverse effect of ethyl acetate which
had been exposed to light and air for periods of
2-48 hr., on the determination of vanillin-mandelic
acid, ethyl acetate (Analar) was obtained in 500 ml
brown-glass bottles. These bottles were stored in a
dark cupboard and a fresh bottle used for extractions
in each experiment.
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Dichloromethane: Dichloromethane (BDH, Laboratory
Reagent) was distilled and that fraction boiling at
4-0° C used for extractions.
Methanol: Methanol (Analar) was distilled once
before use.
Isobutanol: iso-Butyl Alcohol FT, 'for the
fluorimetric determination of vitamin ' (BDH,
Laboratory Reagent) was used. It was purchased in
500 ml bottles and the contents used within two weeks
of opening a bottle.
Toluene: Toluene (Analar) was distilled once
before use.
Ethanol; Ethanol was refluxed for 2 hr. with
20 g sodium hydroxide per 400 ml ethanol and then
distilled twice.
Starch Glycerin ante; 20 g starch and 70 g glycer¬
in was heated until it was liquid and ^ust started to
thicken. It was then removed from the heat and
stirred continuously until thick.
Drug^s
Adrenaline: (-)-Adrenaline bitartrate, Burroughs
Wellcome•
Noradrenaline: (-)-Noradrenaline bitartrate, Bayer Ltd.,
Dopamine; 3-Hydroxytyramine hydrochloride, Koch-Light
Lab. •
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iiopg: DIr-3,4—Dihydroxyphenylalanine, Koch-Light Lab..






Tyraraine: Tyramine hydrochloride, BDH Laboratory
Chemicals.
Hydroxytryptamine; Serotonin creatinine sulphate,
Koch-Light Lab..
Octopamine: (-f)-Octopamine hydrochloride, K. and K.
Lab, Inc..
Stock solutions of 10 mg base/ml of the amines and
1 mg/ml of dopa in C.01H hydrochloric acid were stored
at ~4°0 and renewed every 6 weeks. Dilutions of
1-10 pg/ml in 0.01N hydrochloric acid were prepared
fresh from these stock solutions.
SUB-SECTION 1
Estimation of noradrenaline, adrenaline, dopamine,
normetanephrine, rnetanephrine and dopa in rat brain.
Determination after extraction and subsequent separation
by paper chromatography using a phenol : hydrochloric
acid solvent system.
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Investigations in this department had indicated
that metanephrine, normetanephrine and methoxydopamine,
in addition to adrenaline, noradrenaline and dopamine
as reported by James (1948) and Crawford (1951)
(p» )» could be separated by paper chromatography
using phenol containing hydrochloric acid.
In i960, Sharman, in thi3 department, found that
tryptophan, tryptamine and 5-hydroxytryptamine, which
in large concentration might interfere in the catechol¬
amine assays, could be separated from the catechols by
ascending paper chromatography in 0.1N hydrochloric
acid saturated with sodium chloride. Since we
intended to study the effect of tryptophan loading on
the catechol pathway, this initial separation of the
catechol from the indole group was thought advisable
before separation of the individual catechols.
A method for the estimation of dopa, noradrenaline,
adrenaline, dopamine, normetanephrine and metanephrine
in rat brain, which was based on these techniques, is
described in this sub-section. Methoxydopamine was
excluded because at the time of this investigation there
was no way of assaying it.
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METHODS
Extraction and Separation of Amines and Dopa
from Rat Brain
Three or four rats v/ere killed by decapitation
and their brains rapidly removed and pooled (minus
cerebellums) to give a total weight of 4 - 6 g brain
tissue. The brains v/ere homogenised in an all-glass
homogeniser for 4 min. in 3 vol. G.4N perchloric acid
at 4°C. The homogenate, contained, in a measuring
cylinder, was placed in the deep-freeze (-20°G) for
30 - 60 min.. The homogenate was then allowed to thaw
and mixed by carefully inverting the measuring cylinder
3 or 4 times. Using a 5 ml safety pipette, six
portions of 3«0 to 4.0 ml each were transferred into
separate centrifuge tubes. Known amounts of the
amines and dopa, contained in 0.10 ml 0.01N hydro¬
chloric acid, were added to two of these portions to
determine the recoveries of the amines and dopa through
the procedure; these portions will be referred to as
procedure recoveries. The six samples of homogenate
were centrifuged and the supernatants removed. The
pll of each supernatant was adjusted to about 4, using
bromophenol blue paper as external indicator and
adding dropwise 5N potassium carbonate followed by IN
when the end-point was near. The mixtures were kept
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kept at -2G°C for 30 min. (or left overnight at -2G°C
if more convenient), then thawed and centrifuged for
10 min. at 3020 £ at 4°G» The precipitates were
washed with 0,5 ice-cold water and re-centrifuged.
The bulked superaatants were evaporated under reduced
pressure at 4-5 - 50°0 (external temperature) to
approximately 0,5 ml and remaining traces of potassium
perehlorate removed by adding 5 ml ethanol, ehillir
and centrifuging. The potassium perchlorate precipi¬
tates were washed with 1 ml ethanol and the ethancl
supematants combined and evaporated under reduced
pressure at 45 ~ 50 G to damp dryness. 100 pg
adrenaline, noradrenaline, dopamine, dopa, 5-hydroxy-
tryptamine, tryptaraine and tryptophan and 200 pg
metanephrine and normetanephrine were added, in 0.10 ml
G.C1N hydrochloric acid, to two of the four samples.
These samples will be referred to as -he tissue markers
and they were used to determine the Rf of each amine
and dopa on the chromatograms in the presence of the
tissue extract. They contained amounts of the amines
and amino acids sufficiently great to be visualised
as coloured bands when streaked across 5 cm wide
sodium chloride impregnated filter xoaper and treated
with certain reagents (p. l+i )•
The extracts were taken up in 0.1 to 0.2 ml
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Figure 4-


























Q0% (v/v) methanol containing 25 mg % (w/v) ascorbic
acid. They were applied across 5 cm wide strips of
Whatman no. 1 chromatography paper which had been
washed by descending chromatography for 24 hr. in
0.G1N hydrochloric acid and dried in air several hours
before use. Care was -taken to ensure that the extract
did not diffuse more than 0.5 cm from either side of the
line of application. A stream of nitrogen was
projected on to the paper at the site of application of
the solution in order to speed up the evaporation of
the solvent and to decrease the possibility of losses
by oxidation. About 20 |xg adrenaline, noradrenaline,
dopamine and dopa and about 40 pg metanephrine and
norinetanephrine were applied as discrete spots of not
more than 0.3 cm diameter, across a seventh 5 cm wide
paper strip and IOC pg tryptophan streaked over these
spots, once they had dried. After chromatography and
treatment with the appropriate reagents the positions
of the spots on this strip, known as the aqueous
marker, served to identify the separated compounds,
visible as coloured bands on the tissue marker strips.
The seven chromatogram strips required in one experi¬
ment, together with the two 4 cm wide cross-pieces of
paper holding the strips together, were cut out of one
piece of filter paper (Figure If ). The chromatograms
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ffigure 5
Ohromatogram of the Catecholamines, Me thoxyamines, Dopa
and the Indoles run for 2 hr. in an ascending
solution of 0.Q25N hydrochloric acid saturated with
sodium chloride.
Catechols and methoxyamines visualised with alkaline ferricyanide.
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were developed in an atmosphere of nitrogen at
18 - 20 0 in an ascending saturated solution of sodium
chloride containing Q.025N hydrochloric acid, for 2 hr.,
during which time the solvent front reached 15 - 16 cm
from the origin. The concentration of hydrochloric
acid was not critical; all that was required was a
sufficiently acid medium to prevent oxidation of the
catechols. The chromatograms were then dried in a
glass tank through which a brisk stream of nitrogen
was passed. One of the two marker chromatograms was
cut out and divided longitudinally to give two narrow
strips. On one strip the catechols were visualised
as pink spots showing a yellow-green fluorescence
in U-V light when the strip was sprayed with a
solution of 0.5 g potassium ferrlcyanide in 100 ml
O.IK disodium hydrogen phosphate. On the other strip
the indoles were visualised as purplish blue areas
on treatment of the strip with Ehrlich's reagent
(0.5 g dimethylaminobenzaldehyde dissolved in a mixture
of 42 ml acetone and 5 ml conc. hydrochloric acid).
A typical chromatogram of catechols and indoles run
under these conditions is shown in Figure 5"
Extracts of rat brain did not affect the catechol-indole
separation. The indole-bearing regions of the other
chromatograms were removed as determined from the
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6 cm. wide piece of filter paper
2 glass strips (exactly superimposed), 16 cm. x 3 cm.
Chromatography trough
43
marker ch.romatogram. Since there was only a 1 - 2 cm
separation of the catechols from the indoles, there
remained an insufficient depth of amine-free paper
to dip into the phenol solvent for further development
of the chroaatograms. Therefore an additional 6 cm
piece of Whatman no. 1 paper was attached to the foot
of the chromatograms. At the junctures with the
chromatograms there was an overlap of 0.5 cm* contact
being maintained by sandwiching the papers between two
3 cm deep strips of glass held together at their
extreme ends and between the chromatograms, by perspex
clips (Figure & ). After positioning the chromato¬
grams and their attachments in the chromatography
tank, the intermediate clips ( in Figure 6 )
were removed to allow for easier flow of the solvent.
The chromatogram was developed in an ascending solution
of phenol containing 13% (v/w) 0.025$ hydrochloric
it\ cuvi c^irMospheife of
acid overnight (about 20 hr.),Abetween two filter paper
curtains saturated with phenol solvent. Fresh
phenol redistilled from zinc dust was used for each
run (Crawford and Outschoom, 1951)• The temperature
during both chromatographic separations was controlled
at 18 - 20°C by keeping the chromatography tanks inside
a hot-box heated by two electric lamps. Temperatures
of over 20 G tended to give poor separations of the
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Figure 7
Chromatogram of Catecholamines, ftethoxyamines, Dopa and Indoles
run for 2 hr. in 0.025N hydrochloric acid saturated with sodium
chloride, followed by Chromatography of Catecholamines, Methoxy-
amines and Dopa, after Indoles had been cut off, for 20 hr. in
phenol: hydrochloric acid.
Temp, of run - 15.5 - 18.5°C
Catechols and methoxyamines visualised with alkaline
ferricyanide.
Indoles visualised with dimethylaminobenzaldehyde.
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indoles from the catechol derivatives and the raethoxy-
amines and of dopamine from noradrenaline. Temper¬
atures below 18°C necessitated increasing the duration
of chromatography to more than 20 hr. to achieve the
same distance of solvent flow and the same amine
separation that was achieved by chromatography at 20°C
for 20 hr..
Each chromatogram strip was washed thoroughly
in two fresh portions of benzene to remove as much
phenol as possible (Crawford and Gutschoora, 19: 1;.
The benzene remaining on the paper was removed by
hanging the paper strip in a tank through which flowed
a brisk stream of nitrogen. The chromatograms carry¬
ing the marker amounts of the amines and dopa were
sprayed with the alkaline ferricyanide reagent (p. 4-/ )•
Dopa and the catechol amines were satisfactorily
visual!; oy this treatment (p. 4-/ ) but additional
treatment with alkali (spraying with 5M sodium carbon¬
ate) was necessary to visualise the methoxyamines by
their deep blue fluorescence in U-Y light. Sometimes
their positions were visible in normal lighting, as
uncoloured regions against the pale green background
produced by the ferricyanide reagent. Figure 7
is a copy of a typical chromatogram of a mixture of
catechols and indoles run .in 0.025N hydrochloric acid:
4-6
sodium chloride for 2 hr. followed, after cutting off
the indole strip, by phenol:hydrockloric acid for 20 hr.
at 15.5 - 16.5 G. Methoxydopamine was also included
in this chromatogram. Marker amounts of the catechols
(100 - 200 fig) when put through the extraction procedure
or when applied to the chromatogram origin together
with an extract prepared from an amount of rat brain
equal to that being assayed, were, at most, only
slightly retarded. On occasion, the upper and lower
boundaries of the bands of visualised markers, in
particular adrenaline and dopamine, were rather wavy.
This was probably due to the difficulty in getting
rid of all traces of potassium perehlorate before
chromatography and the ensuing difficulty of applying
a salt-ladened extract evenly to the origin of the
chromatogram.
hlution of Separated Amines for Estimation
From the sample and procedure recovery chromato-
grams, the sections bearing the separated amines, as
located in the marker chromatogram, were cut out and
each was eluted by immersion in 6.0 ml Q.C1N hydro-
chloric acid in glass stoppered test-tubes, for 60 min.
at 4°G. fhe piece of paper was then carefully removed
by means of a glass x'od. Since noradrenaline and dopa
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were not completely separated on the ehroraatograms
they were eluted together. Under favourable conditions
adrenaline and dopamine were completely separated and
could be eluted independently but more often they had
to be eluted together. Metanephrine and norraetanephrin
were eluted separately, although the separation of
normetanephrine from adrenaline was not always very
satisfactory.
The paper eluates were stored for up to ten days
in the deep-freeze before assay. The amines were
assayed as described below.
ffluorimetric Estimation of the Amines and bopa
The methodology was examined using solutions of
the appropriate amines in 0.G1N hydrochloric acid
containing 1>.. (w/v) phenol. This was because it was
planned to elute the amines from the phenol chromato-
gram in 0• 01N hydrochloric acid and l'/o was an estimate,
which later investigations indicated to be rather high,
of the amount of phenol liable to be present in such
eluates. Only when a method had been shown to give a
linear and reproducible relationship between fluoresc¬
ence intensity and amine concentration in the presence
of this amount of phenol, was it used to analyse
chromatogram eluates.
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All assays were carried out using a test-tube
rack designed to protect the samples from light during
fluorophor development. This rack consisted of a
solid oblong piece of wood having several cylindrical
holes bored into it, each hole sufficiently wide
and deep to accommodate a 15 ml test-tube so that only
the top 2 cm of the tube protruded from the hole.
This precaution was taken in view of Sherman's report
(Sherman, I960, p. 29) that light lowered the intensity
of the adrenaline and noradrenaline fluorophors.
Noradrenaline and Dopa
Two methods were used to assay these compounds,
one being a modification of H&ggendal's (1962)
technique and the other a modification of a method of
Bertler et al. (1956).
(i) H&ggendal's method for the estimation of nor¬
adrenaline ana dopa. 1.50 ml of a chromatogram eluate
or of a standard solution of noradrenaline or dopa in
C.01N hydrochloric acid wan adjusted to pH 6.5 by
adding 1.0 ml of a mixture of equal volumes of 1M
pH 6,3 sodium phosphate buffer and 0.6M pH 6.5 sodium
citrate buffer. At zero time, 0.20 ml C.02M iodine
solution was added to reagent blanks and aqueous
standards and 1.00 ml G.04M iodine solution to
chromatogram elu&tes. After 3 min., 1.00 ml 3% (w/v)
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sodium sulphite containing 2$ (w/v) disodium edetate was
added, followed "by 1.00 ml 5N sodium hydroxide 30 sec,
later. 8^ min. after addition of the iodine, 1.00 ml
ION acetic acid was added. The 1.00 ml 0.0hM iodine
was found to give a persistent iodine colour to eluates
from the phenol chromatogram in addition to precipitating
traces of phenol. The triiodophenol precipitate did
not affect the sensitivity of the asBay and could be
satisfactorily removed by centrifugation before reading
the supernatant in the spectrophotofluorimeter.
Removal of phenol by warming the chromatogram clu tea
at hO°C in an atmosphere of nitrogen (Crawford and
Outschoorn, 1951) or by extraction into ether, carbon
tetrachloride, benzene and petroleum ether (Crawford,
personal communication), resulted in amine loss.
Reagent blanks and mixed standards of 100 mpg
noradrenaline plus 100 mpg dopa in 1.50 ml 0.01M
hydrochloric acid, together with internal standards of
100 ffljig noradrenaline plus 100 mpg dopa added to 1.50 ml
of each chromatogram eluate, were processed in parallel
with each batch of samples. Mixed standards were
satisfactory since, under tne conditions of the nor¬
adrenaline assay, 100 u\ig dopa contributed no
fluorescence and under the conditions of the dopa assay
100 mjxg noradrenaline contributed no fluorescence.
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1.50 ml of each chromatogram eluate was used as a
tissue faded blank by adding the sodium sulphite-
EDTA solution 10 min. after the sodium hydroxide.
The fluorescence intensities of the samples were
measured, between 50 and 60 min. after production of
the fluorophor, at the excitation and emission wave¬
lengths for maximal fluorescence of the noradrenaline
derivative [580/490 K(j. on the Parr&nd 3PF and 400/490 mp
on the Amineo-Bowman SPI']. After 60 min. the nor¬
adrenaline fluorophor slowly declined in intensity,
while the reading for the faded blank slowly rose.
Excitation and emission spectra were recorded for all
samples to check that their excitation and fluorescence
peaks corresponded with those from authentic noradrena¬
line.
After measuring the fluorescence due to the
noradrenaline fluorophor, the samples were heated for
50 min. at 60°J and then left overnight at room
temperature, before measuring the fluorescence
intensities at 550/580 the wavelengths for maximum
fluorescence of the dopa derivative. A primary filter,
Coming no. 9865, was inserted between the excitation,
monochromator and the sample, before taking readings
at 550/580 mp on the Farrand SPF. This was necessary
to prevent visible light, passed when the excitation
diffraction grating on this instrument was set to
wavelengths of 4-00 mp or less, from reaching the sample
(Sherman, I960, p. 83). The heat treatment resulted
in the formation of the dopa fluorophor while simult¬
aneously reducing the amount of noradrenaline fluoro¬
phor to levels which did not interfere with the dopa
assay. Irradiation with U-V light (Garlsson and
Waldeck, 1958) could be used to form the dopa fluorophor
but heating was just as effective. Leaving overnight
was necessary, to allow the readings to stabilise and
reduce 'between duplicate' variation. A linear
relationship was obtained between the relative
fluorescence measurements and concentration over the
range of 56 to 200 mpg for noradrenaline and for
dopa. The intensities of fluorescence derived from
noradrenaline and dopa and the size of the blanks
were unaffected by the presence of phenol during
development of the fluorescence.
(ii) Adaptation of the method of Bertler et al.
(1536) for the assay of noradrenaline axiu. dopa. 1.0 ml
0.1M pH 6.5 phosphate buffer and 0.10 ml 0.25% (w/v)
zinc sulphate (ZaSO^./HgG) were added to 1.00 ml
chromatogram eluate or 1.00 ml of a standard solution
of noradrenaline or dopa in 0.01N hydrochloric acid.
At zero time, there was added 0.10 ml 0.25% (w/v)
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potassium ferricyanide; at 2 rain.,0.10mlfreshly
prepared 2% (w/v) ascorbic acid and at 2i min.» 0.9 ml
5N sodium hydroxide, with thorough mixing after each
addition. Tissue blanks were prepared as followst
zero time, 0.10 ml 2% ascorbic acid; 2 rain. 0.9 ml 5N
sodium hydroxide and 2k rain., 0.10 ml 0.25% potassium
ferricyanide. Faded blanks, analogous to those used
in H&ggendal's method (p.SO) in which the reducing
agent (in this case, ascorbic acid) was added 10 min.
after the sodium hydroxide, were abandoned becaiise they
gave anomalously high readings with 1,0 ml 0.01H
hydrochloric acid containing 1% (w/v) phenol and lhOpg
ascorbic acid. Ascorbic acid had the same Rf as
noradrenaline on chromatograms developed in phenol:
hydrochloric acid. 11+0 pg ascorbic acid was the
greatest amount that could be expected in a 1,0 ml
aliquot of a *noradrenaline-dopa* eluate from a
chromatogram, assuming all the added ascorbic acid
(p. 3<j ) finished up in this eluate.
Each eluate was divided into four 1.0 ml aliquots
for sample, tissue blank, internal standard of 100 mpg
noradrenaline and internal standard of 100 mpg dopa
respectively. Reagent blanks and separate aqueous
standards of 100 rapg amounts of noradrenaline and
dopa were run in parallel with each batch of samples.
The samples were centrifuged to get rid of any
filter paper particles originating from the
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chromatogram eluates. Within 30 rain, of developing
the fluorophors, the fluorescence Intensities of the
samples were read, at 360/480 rap and 400/520 mp which
are excitation/fluorescence maxima for the dopa and
noradrenaline derivatives respectively. Both the
Amineo-Bowman SFF and the Farrand SPF were used in these
assays. The amounts of noradrenaline and dopa in a
sample were calculated as follows:~
If: Maao = relative fluoreseence intensity from
100 mpg noradrenaline at 360/480 mp
H^oo = relative fluorescence intensity from
100 mpg noradrenaline at UOO/520 mp
1>3®o = relative fluorescence intensity from
100 mpg dopa at 36O/I4.8O mp
IU00 = relative fluorescence intensity from
100 mpg dopa at I4.OO/52O mp
S3so » relative fluorescence intensity of the
sample aliquot (after subtraction of the
blank) at 360/480 mp
S4.00 = relative fluorescence intensity of the
sample aliquot (after subtraction of the
blank) at 400/520 mp
Then:
n (Ma©© j ^ (Dsso)
100 100
= S36 0
n ^40°) + d (Pj&£,£l) « S400
100 100
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Solution of these equations gave the value for n
(noradrenaline in m pgin sample aliquot) and for d
(dopa in mpg in sample aliquot).
In this method phenol was not removed before
fluorophor development and produced a fluorescence
peak of its own at 530/460 mp, the intensity of which
was proportional to the amount of phenol present.
This peak was presumably due to oxidation of phenol by
potassium ferricyanide since it did not occur
if the latter was omitted. A fluorescence peak at
characteristic wavelengths was obtained from as little
as 25 mpg noradrenaline despite the presence of Ik
(w/v) phenol, because the phenol peak at 330/460 m p ,
was sufficiently distant from the noradrenaline
fluorophor peak at 400/520 mp. ho fluorescence peak
at the wavelength characteristic of the dopa fluorophor
could be detected from amounts of dopa less than 200 mpg
since it was submerged in the phenol fluorescence
spectrum because the dopa fluorophor had almost exactly
the same fluorescence characteristics as the fluoresc¬
ence derived from phenol. Nevertheless although 1%
(w/v) phenol increased the blank in the dopa assay, thus
reducing the sensitivity of the dopa assay, it did not
increase the blank in the noradrenaline assay and did
not affect the linearity or intensity of fluoi*escence
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Figure 8
Calibration Curves for Noradrenaline, Dopa, Normetanepbrlne,
and Metanephrine•








































derivable from either noradrenaline or dopa (figures $
and 8 ). The following results were obtained on
assaying two mixtures of noradrenaline (200 mpg\ and
dopa (20 mpg, in 1.0 ml 0.011? hydrochloric acid
containing 10 (w/v) phenol and 140 pg ascorbic acid:-
Noradrenalina Dopa
recovered recovered
Mixture 1: 202 m pg 19 21 pg
Mixture 2: 207 ® pg 20 m pg
Estimation of mixtures containing less dopa was not
Zo-
attempted because 30 mpg was considered to be the
limit of detection of dopa in a chromatogram eluate
(Table / and p. 80 ).
Adrenaline, but not dopamine, normetanephrine or
metanephrine, could also be estimated using this method
of fluorophor production.
Adrenaline and Dopamine
Occasionally there was a sufficient separation
of adrenaline from dopamine on the chromatogram for
these two amines to be eluted and assayed separately,
but more often they had to be eluted and assayed
together. They were estimated in chromatogram eluates
in exactly the same way as method (i) (p. 4$ ) for
noradrenaline and dopa. Mixed standards could
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Figure 9
Calibration Curve for Dopamine by Haggendal's Method
m/ig Dopamine
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be used because 100 mpg adrenaline did not contribute
to the dopamine assay nor 100 m pg dopamine to the
adrenaline assay. leak adrenaline fluorescence was at
4-10/510 mfi on the Farrand SP9 and 4-25/510 m |i on the
Aminco-Bowraan SPF. Peak dopamine fluorescence was at
550/380 mp, on both instruments. As in the dopa
assay (p. 5"o ), a primary filter, Corning no. 9863,
was used when reading at 330/380 znp on the Parrand
SPF.
A linear relationship was obtained between the
relative fluorescence measurements and concentration,
from 50 mpg to 500 mpg for adrenaline and for dopamine
(Figure <7 ). Figure f also demonstrates that leaving
the samples for 19 hr. after heating stabilised, and
increased the precision of, the dopamine readings, as
it did the dopa readings (p. 5! ). The intensities
of fluorescence derived from adrenaline and dopamine
and the si2e of the blanks were unaffected by the
presence of phenol during development of the fluoresc¬
ence. Various unsuccessful attempts were made to
improve upon the sensitivity, which was only Bp m<ftg,
of this dopamine assay. Oxidation with potassium
ferricyanide (Carlsson and Wal&eck, 1964-) produced a
derivative the fluorescence of which was-less intense
than that produced by iodine (p. /7 ).
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Metanephrine and Normetanephrine
These two amines were ©Tuted separately from
the chromatograro and assayed (i) using a modification
of Brunges' et al. (1964) method or (ii) using a
modification of H&ggendal's method, described on p. 48
(1) Modification of Brun.les* method for the assay
of metanephrine and normetanephrine« 0.50 ml 0.5%
(w/v) zinc sulphate (Zn 80^*7SU0) in 0.02N hydrochloric
acid was added to 1,00 ml or 1.50 ml sample or standard
metanephrine or normetanephrine in 0.Q1N hydrochloric
acid. At zero time, 0.50 ml 0.075% (w/v) potassium
ferricyanide (a freshly prepared dilution of a 0.25%
(w/v) stock solution which was stored in a dark bottle
in a refrigerator) was added and, at 4 rain., 0#50 ml
acetate buffer pH 5*6 (2.22 ml 1011 acetic acid + 4 ml
5N sodium hydroxide to 100 ml) was added. At 8 min.,
0.50 ml of a freshly prepared tautomerising solution
made by mixing 1.00 ml freshly prepared 2% (w/v)
ascorbic acid with 0.30 ml redistilled ethylenediamine
and 8.7 ml 5N sodium hydroxide, was added.
The fluorescence from metanephrine and normeta¬
nephrine was reduced by 11% if the samples were exposed
to light during the assay, instead of being protected
from light by enclosing the tubes in the solid wooden
test-tube rack (p. ) used routinely for the assays.
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Three 1.50 ml aliquots of the paper eluates were used
for sample, internal standard and blank. Sample
blanks were faded blanks, that is, at 8 min. only
0.4-4- ml 5N sodium hydroxide was added, and, after a
further 10 min., 0.06 ml of a mixture of 1.C0 ml 2%
(w/v) ascorbic acid and 0.3 ml ethylenediamine was
added. The samples were centrifuged to remove filter
paper particles (p. SZ ), and the fluorescence read
on the Aminco-Bowman SPF or the Farrand SPP between
20 to 40 niin. after addition of the ferricyanide. On
both instruments the fluorescence of the metanephrine
fluorophor was maximal at 410/520 mp . The fluoresc¬
ence from normetanephrine was maximal at 400/505 m|J.
on the Aminco SPF and at 390/500 mp, on the Farrand SPF.
As in method (ii) for the assay of noradrenaline
and dopa (p.SI ) phenol was not removed by precipi¬
tation and gave rise to a fluorescence peak at
330/460 m p. The peak from 1% (w/v) phenol completely
masked that, at 400/505 from the fluorojfaor derived
from amounts of normetanephrine of 200 mpg and less.
Sine© the metanephrine peak, at 410/520 up. , was rather
further away from the phenol peak, it was possible to
obtain a fluorescence peak from as little as 100 mpg
metanephrine in the presence of 1% (xv/v) phenol.
The assay sensitivities for metanephrine and normeta¬
nephrine were reduced by about 10% by 1% (w/v) phenol.
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Linear relationships were obtained between the
relative fluorescence intensity and concentration for
h0 mjj,g to 200 mpg amounts of the amines in the absence
or presence of 1% (w/v) phenol (Figure 2 ).
Adrenaline and noradrenaline, but not dopamine,
could be assayed by this method.
(U) Modification of Hftggendal's method for the
assay of metanenhrlne and normetaneohrine. Hhggendal 's
method (p. ) could be used to assay metanephrine
and normetanephrine in chromatogram eluates if bromine
water was used to precipitate the phenol previous to
iodine oxidation. No fluorophor was produced from
metanephrine and normetanephrine if excess iodine was
used to precipitate the phenol. Bi^omine v?ater was
added, drop by drop, with continuous tapping of the tube
to ensure thorough mixing, until a faint persistent
yellow colour was obtained. The yellow colour was
discharged with the minimum amount of % (w/v) sodium
sulphite containing 2% sodium edetate (w/v) added drop-
wise. The faintly yellow flocculent precipitate was
removed by filtration through a small pledget of cotton^
wool in the stem of a small filter funnel because it
did not pack down well on centrifugation. An aliquot
of the filtrate was then subjected to the assay procedure
described on p. U9 . The disadvantages of this
technique were its awkwardness and the reduction of
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sensitivity by 50$ due to retention of half the sample
by the cotton-wool filter. Failure to remove the
precipitate of tribromophenol prior to assay resulted
in formation of a flocculent precipitate in the final
stages of the assay and in no fluorophor foliation,
faking into account the 50'p loss caused by filtration,
the relative fluorescence intensities of the fluoro-
phors derived from metanephrine and normetanexjhrine
were not diminished by the bromine water procedure and,
in the case of normetanephrine the intensity was
slightly increased. On the Farrand SPF, the fluorophor
from inetanephrine peaked at 4-10/510 mp and the
fluorophor from norraetanephrine at 580/51^- mp.
raBIfiJL

















































Lowest detectable concentrations of amines and dope in rat brain















The sensitivities of assay of the amines and dopa
both in 0*011? hydrochloric acid solution and in
eluates from chromatograms of extracts of rat brain, by
all the methods which have been described, are given
in Table 1 . The sensitivities of assay in chromato-
gram eluates did not differ greatly from that in pure
solution because, for the most part, the blanks from
the eluates were about the same as the reagent blanks
and quenching of fluorescence (as indicated by
% 3in Table ) by the eluates
Aqueous standard
was not marked.
It was considered that the least amount of amine
and dopa detectable in any assay was that amount
giving rise to a fluorescence intensity equal to half
its appropriate blank. The lowest concentration
detectable of each amine and dopa in whole rat brain
was calculated on this basig (Table 2 ).
Recovery of Amines and Dopa through the
Chromatographic Procedure
A mixture containing 500 mp;; of noradrenaline,
dopamine and normetanephrine and 500 mjug of dopa,
adrenaline and metanephrine was applied in 0.15 nil
60^ (v/'v) methanol containing 23 mg % (w/v) ascorbic
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Amines and Dopa (ng/g) in Rat Brain
Estimates uncorrected for procedure recoveries
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acid, to a chromatogram i\?hieh was developed as
described on p. 37 . Hormetaneprhine and metanephrine
were assayed by Brunjes' method and the other amines
and dopa by E&ggendal's method. The experiment was
carried out in duplicate. The recoveries of each
amine are given in Table 3 . The eluted amines
showed the same fluorescence characteristics as their
respective standards.
Estimation of Amines and Dopa in Rat Brain
The results of three experiments are given in
Table 1+ . To determine the recoveries of the amines
and dopa through the procedure f 730 mpg each of
noradrenaline, dopamine and normetanephrine and pQO mpg
each of adrenaline, dopa and metanephrine were added to
two portions of rat brain homogenate in each experiment,
as described on p. 3 6. Additions of metanephrine and
normetanephrine and of adrenaline and dopamine were
omitted in experiments (1) and (2), respectively, in
order to limit the number of samples for estimation.
The concentrations of the amines and of dopa are
expressed as pg/g wet tissue and calculated on the basis
of the appropriate internal standards. They are
uncorrected for procedure recoveries. Some nor¬
adrenaline and dopa samples were estimated by
HSggendal's method (p. 4$ ) &nd some by Bertler's method
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(p. 57 )• Metanephrine and normetanephrine were
assayed "by Brunjes* method (p. ), which was used
in preference to H&ggendal's method because it was
simpler and more sensitive (Table 1 )•
noradrenaline and Dona
The 'noradrenaline* brain samples and procedure
recoveries assayed by H&ggendal's or Bertler's method
showed maximal fluorescence at the same wavelengths as
the noradrenaline aqueous and internal standards.
These wavelengths were different from the wavelengths of
maximal fluorescence of the blanks which were 1*10/500 mg
for the sample faded blank in H&ggendal's method on the
Farrand SPF and 1*00-44.20/1*60 mg for the sample faded
blank in Bertler's method on the Amineo-Bowman SPF.
The values for brain noradrenaline whether assayed by
H&ggendal's or Bertler's methods were reasonably
consistent, despite the fact that the procedure recov¬
eries ranged from 1*0 to 89^. Since dopa has never been
detected in normal rat brain (Bertler, B'alck and
Rosengren, 1963} Anton and Sayre, 1961+), its concentra¬
tion in this tissue must be zero or very low; Anton and
Sayre (1961*) quote a concentration of less than
0.05 gg/g. H&ggendal's method, however, gave values
for rat brain dopa of 3.0, 3.1*8 and 5«9 V&/s in three
separate samples (Table 4- ). These high figures
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were attributed to a substance which fluoresced, like
dopa, at 530/380 mp. This substance was not ascorbic
acid, which was known to raitoabout the same place as
noradrenaline on the phenol chromatogram and could
therefore be present in the noradrenaline-dopa eluates.
Since this high fluorescencewas not obtained from
chromatograms of pure solutions (Table 3 ), it must
originate from the brain itself. An alternative
'unprecipitated blank', in v.hich phenol was not precipi¬
tated, was tried, in the hope that it might include
this interfering substance. 5% (w/v) sodium sulphite
containing 2% (w/v) sodium edetate (p. 47) was added
first, followed by iodine and the other reagents in
their usual order. However, this blank gave the same
reading as the faded blank and peaked, like both
faded and reagent blanks, at 330/3SC np. The inter¬
fering substance did not appear to fluoresce when
Bertler's method was used to estimate noradrenaline
and dopa. Much more reasonable figures were obtained
for rat brain dopa using this method, and the procedure
recoveries v/ere satisfactory. Ascorbic acid, if
present in these eluates, was very much less than the
estimated 14< jug (p. SZ ),
The fluorescence peak due to the phenol in a
1.5 ml aliquot of a chromatogram eluate was very much
less than that produced from 1.5 ml Q.01N hydrochloric
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acid containing 1% (w/v) phenol, inferring that 1$ was
an over-estimate of the amount of phenol present in the
chromatogram eluates. If, as in experiment (3), the
developed chromatograms were washed with four instead
of two portions of benzene, this peak was very small.
Peak fluorescence from the procedure recoveries, since
they contained 2.5 times as much noradrenaline as
dopa, occurred at the wavelengths of maximum fluorescence
from noradrenaline (i.e. 400/520 mp). These samples
gave, at most, only slight indication of a peak with
the wavelength character*!sties (360/480 mp) of dopa.
Adrenaline and .Dopamine
No adrenaline could be detected in rat brain.
The fluorescence irom the procedure recoveries of
adrenaline, which varied from 46$ to 74$, like that
from the internal adrenaline standards, was maximal
at 425/510 mp. On the Parrand SPP, the sample faded
blank gave a small excitation peak at 410 mp, i.e. at
the wavelength for maximum excitation of the adrenaline
fluorophor but it showed no fluorescence peak at 510 mp,
when excited at 410 mp. The adrenaline fluorophor
could thus be distinguished from the blank by the fact
that, unlike the blank, it showed a fluorescence peak
at 510 mp. The dopamine fluorophor, however, could
not be distinguished from its blank because fluorophor
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WW 5
Dopamine (mpg) in eluates from dopamine and adrenaline
positions of chromatograms of rat brain extracts
Dopamine Dopamine Total
Experiment Sample in in dopamine
dopamine adrenaline
position position
Duplicate 1 1510 233 1743
(1) Samples
2 1470 262 1732
Implicate 3 1330 1040 1570
Recoveries 4 1080 350 • 1630
Duplicate 1 151 497 648
(2)
Samples 2 228 286 514
802Duplicate 3 90 892
Recoveries 4 197 553 750
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and blank had both excitation and fluorescence maxima
at the same wavelengths viz. 330 rap and 380 rap,
respectively. values for rat brain dopamine
in experiments (1) and (3) are respectively about
3 times and 1.5 times those quoted in the literature
(Bertier and Rosengren, 1959; Anton and Sayre, 1964)
inferring that there might be present in the dopamine
eluates a material originating from brain which was
similar, though less in amount, to that found in the
dopa eluates. The 'unprecipitated' blank: from the
dopamine eluates was the 3ame as the faded blank,
suggesting that any interfering substance in the
dopamine eluates behaved similarly, under the
conditions of blank formation, to that present in the
dopa eluates. The procedure recoveries for dopamine
varied from 42% to 156%.
some.
InAexperi®ents (1) and ( 7 adrenaline and dopamine
were eluted separately. Despite apparently adequate
separation on the marker ciiromatograras, some dopamine
or dopamine-like substance was found in eluates from
the adrenaline position of all chromatograms of brain
extracts (Table 5") and in two out of four procedure
recoveries adrenaline was recovered from the dopamine
position instead of the adrenaline position.
Metanephrine and Rormetanephrine
The values obtained for rat brain normetanephrine
were rather suspect because the normetanephrine samples,
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unlike the 'recovery' sampieS| did not give a fluore¬
scence peak at 400/500 mp, waVelength of maximal
fluorescence of the aormetanephrine fluorophor. Both
samples ana blanks produced a fluorescence peak at
550/420 mp, which was due to phenol leached from the
chromatogram. This peak wa3 considerably less than
that produced by 1% (w./v) phenol, corroborating the
evidence obtained from assays of noradrenaline-contain-
ing eluates by Bertler's method (p. 7/ ), that the
amount of phenol present in the chromatogram eluates
was less than 1#. As little as 100 mpg normetanephrine
could be detected, as a fluorescence peak at 400/500 mja,
in these phenol-containing eluates. A major
disadvantage of this technique for assaying norraeta-
nephrine was the rather poor chromatographic separation
of normetanephrine from adrenaline (figure 7 )•
Any adrenaline present in the normetanex>hrine eluate
would be assayed as normetanephrine (p« 6/ ) and thus
give rise to falsely high normetanephrine values.
No metanephrine could be detected in rat brain.
The fluorescence peaks obtained from samples and blanks
were the same and had the wavelength characteristics
(250/420 mp) of the phenol fluorophor. 20 mpg to
5Gmpg metanephrine should give rise to a fluorescence
peak at 410/520 mp in the presence of chromatogram
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eluates containing; phenol. Metanephrlne was well
separated on the chromatogram from all other amines.
Effect of Different Methods of Extraction
on the Estimation of Amines and Dopa in Rat Brain
Several methods of extraction, different from that
described on p. 36 were investigated. Method (i) was
used by Ashcroft, Eccleston and Crawford (1965) for
the estimation of the 5-hydroxyindoles in rat brain.
It was originally hoped that, by pooling a sufficient
number of rat brains, it would be possible to use part
of such an extract for the estimation of the 5-hydroxy-
indoles and part for the estimation of the catechol
derivatives. Such a technique would allow indole-
allcylamine and catecholamine metabolic pathways to be
followed simultaneously from the same brains. Method
(ii) was an attempt to remove the substance interfering
in the dopa and dopamine assay* (p. 73 ) by extraction
of this substance into isoamyl alcohol or ethyl
acetate.
(i) Protein Precipitation with Acetic Acid and Acetone
compared with Perchloric Acid
Rat brains were homogenised In acetic acid, protein
precipitated with acetone and lipids removed by
extraction into petroleum ether, as described by
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Ashcroft et al. (1965). The ensuing extract, reported
to give a good separation of 5-hydroxyindoles on paper
chromatography using butanol:acetic acid as the
developing solvent (Ashcroft et el., 1965), when applied
to a chromatograia was found to form a yellow greasy
layer impermeable to the aqueous hydrochloric acid:
sodium chloride solvent. The material responsible
for this deposit could be removed by adding sufficient
4N perchloric acid to the extract, after it had been
shaken with petroleum ether, to produce a 0.1N perchloric
acid extract solution. On processing this solution
as on p. 36 , an extract was obtained which was easily
applied to chromatography paper and did not affect the
Rfs of marker amounts of the amines end dopa in
hydrochloric acid:sodium chloride and phenol:hydrochloric
acid. Recoveries of adrenaline, noradrenaline, dopa
and dopamine added to rat brain and taken through this
procedure were very poor and the brain noradrenaline
values very low, probably due to the lengthiness
of the procedure. This extraction method was
therefore rejected in favour of the shorter method
of homogenising the brain directly in perchloric acid
(p.36 ), which gave better recoveries and values for
noradrenaline in rat brain similar to those reported
in the literature (Pletscher, Bartholin!, Bruderer,
Burkard and Gey, 1964} Anton and Sayre, 1964).
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(ii) Pf Percli^pilQ. iv.glff
M<?im:L/Aoqtiol m$, athyl, Aget,at$
In one experiment ((k) in Table 6 ), the perchloric
acid supernatants from the brain homogenate were
shaken with 10 volumes washed Isoamyl alcohol for 3 min.,
centrifuged, and the alcohol removed by suction. The
pH of the aqueous phase was then adjusted to k and the
samples processed as on p. 37• Isoamyl alcohol
was used because Axelrod, Inscoe, Senoh and Wltkop
(1958) found it removed substances interfering in the
estimation of urinary metanephrine and nonietanephrine.
In a second experiment ((5) in Table 6 ) the
perchloric acid supernatants were saturated with sodium
chloride and extracted 3 times with an equal volume of
ethyl acetate before adjusting the pH to k and process¬
ing as on p. "?7 • The effect of extraction with ethyl
acetate was investigated because in the future it was
hoped to separate the acid metabolites of the amines
from the amines by extraction of the acids into
ethyl acetate.
Footnote: Washed isoamyl alcohol : 500 ml isoamyl
alcohol was washed with 100 ml IN sodium
hydroxide, 100 ml IN hydrochloric acid
and with 2 x 100 ml distilled water. The
water washes were removed after centrifugation,
Table6
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(h) Extract¬ edwith isoaxayl alcohol































(5) Extract¬ edwith ethyl acetate





































The results of these two experiments are given
in Table 6 . Comparison of the results in Table
with those in Table 4- (p• 6 7 ) shows that extraction
with isoamyl alcohol lowered the dopa figures while
extraction with ethyl acetate abolished them altogether.
The material responsible for these high dopa estimates
was presumably partially extracted into isoamyl alcohol
and wholly extracted into ethyl acetate. Neither
solvent extraction had any marked effect on the dopamine




The relative fluorescence obtained from a constant
amount of amine or dopa varied from run to run, possibly
due to fluctuations in the light intensity of the
xenon lamp and to variation in the intensity of light
incident upon the samples during fluorophor development.
Despite taking the precautions listed on p.2% , the
blanks obtained on different occasions from all assays,
whether phenol was present or not, could vary by
about + 50% of the mean value. Sometimes, on sub¬
sequent investigation, the blame for an increased blank
could be traced to a particular reagent. Since the
sensitivity of an assay depended on the relative
fluorescence obtained from a constant amount of the
substance and from the blank (p.3/ ) and since these
two factors varied independently, a marked variation
in sensitivities was obtained (Table 1 ).
The limits of detection of the amines and dopa
in rat brain (Table 2, , p, &t+ ) are not as low as might
be expected from the sensitivities of assay of each
compound (Table / , p. because the actual amount
quantitated in the SPF was only a fraction (about one
fifth) of the total present in the original sample of
tissue taken for analysis. This was because aliquots
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were taken after homogenisation (p.3£ ) and again after
elution (p.^2) when the eluate was divided into three
portions for the estimation of sample, faded blank and
internal standard.
The recoveries of two mixtures of the amines plus
dopa in pure solution, taken through the chromatography
and assay procedures (Table 3 , p.^6 ) were, with the
exception of adrenaline and possibly dopamine, satis¬
factory, showing that reasonably consistent results can
be obtained using this technique. Adrenaline, being
the least stable, is the most likely to be lost during
processing. The recovery of noradrenaline was 10% and
the recoveries of the other amines and dopa were Op when,
starting from pure solution, they were put through the
tissue extraction procedure before chromatography.
These poor recoveries were almost certainly due to the
difficulty of adjusting the pH of unbuffered solutions.
The recoveries were all much improved in the presence
of brain tissue, extracts of which contain substances
which can act as buffers and thus make more easy the
adjustment of the pH. The reason for the variation
in recoveries of noradrenaline, adrenaline and dopamine
from tissue extracts (Table 4 , p. 47) was not investi¬
gated at this stage but will be discussed in Section II
of this thesis. Since these recoveries were much
better through the chromatography alone, the variable
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loss is roost probably occurring at the extraction stage.
In calculating the recoveries it was assumed that thq
added amines and dopa behaved like the endogenous
. i
amines and dopa in that they were evenly distributed
between the supernatant and the water content of the
tissue precipitate, estimated by Bertler et al. (1958)
at 75^ (v/w) of the tissue weight.
Acid acetone, like acid ethanol (Bertler et al.,
i
1958) and unlike perchloric acid, was found to Extract
a large amount of lipid. Vogt (1999) reported that
acid ethanolic brain extracts, which presumably
contained lipid, did not affect the Rfs of the catechol-*
*
amines when chromatographed in the phenol:hydrochloric
acid solvent but this lipid was found (p. 76 ) to
»
prevent the flow of an aqueous chromatographic solvent.
1
Using the procedure of extraction with perchloric acid
i
described on p. 36 extracts were obtained which were
easily applied to the chromatogram and produced only a
faint yellowish deposit on the paper. The degree of
clarity of the supernatant obtained, from the acid
homogenate and the amount of the deposit visible at
the origin of the chromatogram after application of the
f
extracts varied slightly from experiment to experiment
but there appeared to be no correlation between these
factors and the final amine levels.










































hxcept in experiment (1) (Table h- » p. 67 ),
quenching of fluorescence by paper eluates was found not
to be marked, but it was variable. This variability
made difficult the comparison of the degree of quenching
of fluorescence by eluates obtained from pure solution
chromatograms with that caused by eluates obtained from
brain chromatograms. It did, however, appear that, in
general, the cluates from chromatograms of brain tissue
produced no more quenching of catecholamine, methoxy-
amine or dopa fluorescence than did those from pure
solution chromatograms.
The estimates for rat brain noradrenaline obtained
in these experiments varied from 0.26 to 0.36 ng/g
(Table 4- , p. ^7) with a mean of 0.29 fig/g. The
values for rat brain reported in the literature vary
from 0.15 to 0.58 jug/g with a mean of 0.38 jog/g
(Table 7 ). Significantly lower noradrenaline
estimates were obtained if the acid extracts of brain
were extracted with isoamyl alcohol or ethyl acetate
(Table 6 , p. 7%), It would appear therefore that
there was some loss af noradrenaline into these solvents
This will be discussed in more detail in the second
part of this section, in which an ethyl acetate
extraction was incorporated into the general technique
in order to separate the carboxylic acid metabolic
derivatives of the catechlamines from those still
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retaining an amino group. The procedure recoveries
for noradrenaline varied from 4-0$ to 87%» The
sample estimates did not show such a wide variation,
suggesting that the recovery of noradrenaline added to
the perchloric acid homogenates might not accurately
represent the recovery of the endogenous noradrenaline
extracted from the brain. This important point will
be discussed more fully in Section I, Sub-section 2
and in Section II.
Dopa has never been detected in normal, untreated
brains (Anton and Sayre, 1964) and provided Bertler's
method was used none was found in these experiments.
Since maximum fluorescence from noradrenaline occurred
at wavelengths close to those of maximum fluorescence
from dopa (p. 5"3 ),discrete fluorescence peaks from
these two amines could only be obtained when the concent
ration of each was about the same. When, as in the
procedure recoveries (p.^& ) the concentration of one
was as much as 2% times the concentration of the other,
only one peak, at the wavelengths of maximum fluoresc¬
ence of that compound present in the higher concentra¬
tion, was demonstrable. In experiments in which a
dopa estimate would be required, as for instance after
dopa administration to the animals when the concentra¬
tion of dopa might be considerably in excess of that
of noradrenaline, only a dopa peal: would be detectable.
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A substance, present in the dopa and possibly also
in the dopamine, eluates from brain chromatograms,
reacted similarly to dopa in Hflggendal's but not in
Bertler's, method of estimation. It would appear
therefore that the method of Bertler is the one of
choice for the assay of dopa. No other information on
the nature of this interfering substance is available
apart from the fact that it appears to be extractable
into polar solvents.
Rat brain has been reported to contain about
0.05 fig/g adrenaline (Table 7 , p. 23). This amount
was too small to be detected by the method of assay
reported in this section.
Rat brain dopamine estimates by other workers
vary fro# 0.53 to 0.89 pg/g, with a mean of 0.65 pg/g
(Table 7, p. &3). The dopamine estimates obtained
using Mggendal's method were all equal to or greater
than the upper limit of this range, possibly due to
contamination with some of the 'interfering substance'
already referred to. Dopamine was found in both
'dopamine' and 'adrenaline' eluates from two brain
phenol chromatograms but only in the 'dopamine' eluate
of a pure solution chromatogram. There was no indica¬
tion that the dopamine estimate in either the 'dopamine'
or the 'adrenaline' eluates was due entirely to the
'interfering substance'. A possible explanation for
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the presence of dopamine in the adrenaline eluates is
that extraction of dopamine with perchloric acid by the
procedure on p. ?(> gave rise to two forms of dopamine
with different Rf values, analogous to the double spots
found by Shepherd and West (1952) on chromatographic
trichloroacetic acid solutions of adrenaline and
dopamine, in butanol:acetic acid;water. This hypo¬
thesis was reconsidered on finding (p./^"5) that the
spread of acetyl-dopamine along a chromatogram was
apparently greater than that indicated by its visualised
marker. Assuming dopamine behaves similarly, it is
possible that the "adrenaline' chromatogram eluates
would contain some dopamine which had spread from the
immediately adjacent 'dopamine' position even though,
judging by the markers, there was an apparent clear-cut
separation of adrenaline from dopamine. The amount
of dopamine on the pure solution chromatogram (500 m/ug)
was less than the amounts of dopamine on the brain
extract chromatograms (Table V, p.^7) and, because of
the greater distance travelled by the solvent, the
separation of adrenaline from dopamine was much better
on the pure solution than on the brain extract,
chromatograms. These facts could explain why no
dopamine was found in the adrenaline eluates from the
pure solution chromatograms.
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The figures obtained for rat brain normetanephrine
are considerably higher than that of 0.03 jug/g repoi'ted
by Garlsson and Lindquist (1962), It is unlikely
that adrenaline, which was not well separated on the
chromatogram from normetanephrine, would contribute
to these high figures, because there is so little
adrenaline present in x*at brain (Table 7 )• Three
out of the four normetanex>hrine recoveries were, unlike
the recoveries for noradrenaline, adrenaline and
dopamine, both satisfactory and consistent. This
may be a reflection of the greater stability of nor-
metanephrine compared with the catecholamines.
No metanephrine was detected in rat brain although
Milhaud and Glowinski (,1963) found radioac lively
labelled metanephrine in rat brain after intra-ventri-
1 lL
cular injection of ) pg G -dopamine, suggesting that
metanephrine can be synthesised by the brain. No
estimates of brain metanephrine could be found in the
literature. The low metanephrine recoveries may have
been due in part to inaccurate localisation on the
chromatogram strip. This is possible because the
positions of 'marker' metanephrine and normetanephrine
were not always very distinctly visualised. In cases
of doubt, nonaetanephrine could be safely assumed to lie
just above the adrenaline position, but there was no
such additional check on the position of metanephrine.
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Attempts to improve the visualisation of metanephrine
and normetanephrine by using iodine, which is a
stronger oxidising agent than ferrlcyanide, to oxidise
the amines before treating them with alkali, produced
no increase in the intensity of the blue fluorescence
seen under U-V light (p. 40* The choice of reagents
to visualise catecholamines on phenol impregnated
chromatograms is limited since reagents capable of
detecting phenolic groups are valueless..
Methoxydopamine, the o-methylated metabolite from
dopamine, is present in brain tissue (Carlsson and
Waldeck, 1964), At the time of these experiments,
there was no reported method for estimating methoxy-
dopaaine. Given such a method, estimation of methoxy-
dopamine in the same sample as the other amines would
be possible because it was satisfactorily separated
from its nearest neighbours, metanephrine and normeta¬
nephrine, by chromatography in phenolihydrochloric acid.
On reviewing the results obtained for the estimates
of catecholamines, methoxyamines and dopa in rat brain,
it became obvious that the methodology for their
estimation, as described in this section, had severe
limitations. The principal disadvantages were:
(1) The presence of phenol in the chromatogram eluates
complicated the assays. In those assays in which phenol
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was not removed by precipitation, the fluorescence peak
derived from the phenol tended to mask that derived
from the amine.
(2) There was insufficient separation of the amines,
so that adrenaline had to be measured in the presence
of dopamine and noradrenaline in the presence of dopa.
Although methods were developed which would assay
separately the components of these mixtures, such method
are never as satisfactory as methods for assaying the
individual separated compounds. In addition, nor-
raetanephrine was not very i\rell separated from adrena¬
line. These two substances, unlike noradrenaline and
dopa, cannot be assayed in the same eluate sample.
Differential assay could be obtained by measuring the
total amine in one sample and determining the catechol¬
amine, e.g. by the ethylenediamine method (Weil-
Walherbe and Bone, 1954-), in another sample; a
procedure which results in an undesirable increase in
the least amount of each amine which can be detected.
(3) The sensitivity of dopamine assay was so poor that
the amount of dopamine in whole rat brain as v--.ported
in the literature, was not much greater than the limit
of sensitivity of the method. The figures for rat brain
dopamine were suspiciously high, suggesting they
included some other substance.
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These disadvantages stem largely from the use of
phenol as the chromatographic solvent. A method of
separating the amines as their acetylated derivatives,
using a phenol-free solvent system (Goldstein, Friedhoff,
Simmons and Prochoroff, 1959$ was therefore investigated.
This system had the additional advantage over phenol:
hydrochloric acid that adrenaline, noradrenaline and
dopamine v/ere separated from one another and from their
corresponding methoxy derivatives. Application of this
method to the estimation of brain catechol- and methoxy-
amines is described in the next sub-section.
SUB-SECTION 2
Separation of Adrenaline, Noradrenaline, dopamine,
Pletanephrine, Normetanephrine, Fiethoxydopamine,
and Dopa as their Acetylated Derivatives
and their subsequent Estimation in
Extracts of Rat Brain.
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METHODS
The possibility of separating the catecholamines
and their methoxy derivatives from one another in the
form of their acetyl derivatives as a preliminary to
their estimation was suggested by the work of Goldstein,
Friedhoff and Simmons (,1959a) and Goldstein, Friedhoff,
Simmons and Prochoroff (1959b). These workers
separated the acetylated derivatives of the amines by
descending paper chromatography in the organic phase
of toluene:ethyl acetate:methanol:water = 9:1:5*5 or
10:1:5:5* at 57°G (Bush, 1952), and used ethylenediamine
to estimate the separated acetylated catecholamines.
This technique appeared to be a promising alternative
to the phenol:hydrochloric acid method, which, as
already pointed out in the preceding section (p. SW, <?£> ),
had proved rather unsatisfactory. The apparent
advantages of the method involving the acetyl derivatives
were as follows:
(i) the acetylated derivatives of adrenaline,
noradrenaline, dopamine, metanephrine, normetanephrine
and methoxydopamine could be separated from one another
on one paper chromatogram;
(ii) the absence of phenol in the chromatographic
procedure eliminated the difficulties experienced with
the amine assays as a result of the presence of phenol
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in the chromatogram eluates;
(iii) possible losses due to oxidation of the catechol¬
amines during chromatography would be decreased since
they would be in the form of the less readily oxidisable
acetyl derivatives;
(iv) extraction of the acetylated amines into an organic
solvent from the brain extract might be expected to
exclude many substances which contribute to the blank
fluorescence and to the bulk of the extract for chromato¬
graphy, thus reducing the blank and increasing the
ease with which the extract can be applied to the
chromatogram.
With these points in mind, together with the
possibility of estimating the acetylated methoxyamines,
in addition to the acetylated catecholamines (Goldstein
et al., 1959a), it was decided to investigate the
methodology of acetylation. The aim was to develop
a method whereby the amines and their carboxylic acid
metabolites could be measured in the same brain sample.
Initial investigations of this technique were carried
out in pure solution. These were followed by develop¬
ment of the method using whole rat brain, while bearing
in mind its future application to discrete areas of dog
brain (Section II).
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Extraction of Dopa, the Catecholamines and their Amine
and Acid Metabolitest from Hat Brain
The extraction technique was based on that descri¬
bed by Bertler et al. (195&).
Three adult white Wlatar rats, weighing 100 - 190 g
were killed by decapitation. The brains were removed
as quickly as possible and, after discarding the
cerebellum, were wrapped in aluminium foil and quickly
frozen in solid carbon dioxide contained in a vacuum
jar. It was found that they could be stored overnight
in this state without any alteration in the concentra¬
tions of the catecholamines. The brains were weighed
and while still frozen, homogenised in G.4N perchloric
acid at h°C, 4 rol/g brain tissue, in an all-glass
homogeniser. The perchloric acid and the homogeniser
had previously been cooled to 4°0 and the homogenisation
was continued for not more than 3 min. in order to
maintain a low temperature during this procedure.
Disodium edetate, 2 mg/g brain tissue, and in later
experiments, ascorbic acid, 5QQ pg/g brain tissue, were
present during this homogenisation. After the volume
had been noted the homogenate was divided into three
equal portions. Two of these portions served as
duplicate samples for the estimations of the endogenous
amines. To the third portion was added a mixture
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containing a known amount (200 - 800 mjag) of each of
noradrenaline, adrenaline, dopamine, normetanephrine,
metanephrine, methoxydopamine, dopa and homovanillic
acid. The purpose of the addition of these exogenous
substances was to permit the determination of the
recovery of each substance through the analytical
procedure. These three samples from the same brain
homogenate wex*e then processed in parallel. Each
sample was chilled to 40 and centrifuged. for 7 min.
at 4,300 £« The supernatant was removed and the protein
precipitate re-extracted by homogenisation for about
1 min. at 4°C in 0#4N perchloric acid, 3 ml/g of
original brain tissue. The two perchloric acid extracts
from each sample were combined. Bertler et al. (1958)
found that 97% of the catecholamines in brain tissue
were extracted into 0.4N perchloric acid under such
conditions. In agreement with their findings on
the distribution of amines between supernatant and
precipitate (p.7 )» the amine values obtained by taking
the first supernatant and making axx aliquot correction
for amine remaining in the precipitate were the same
as those obtained by re-extracting this precipitate and
combining the two extracts. Re-extraction was necessary
in order to obtain sufficient amounts for estimation
of those amines such as adrenaline and normetanephrine
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which are present in rat brain in very low concentra¬
tions (Anton and Sayre, 1964} Carlsson and Lindquist,
1962).
Perchlorate was precipitated from the extract
as the potassium salt, by the dropwise addition, with
continuous shaking, of 5N potassium carbonate, followed
by IK potassium carbonate when the end-point was neared,
until the solution had a pH of 9 -4. One drop of
0.02$ (w/v) bromophenol blue (B.D.H. Laboratory Heagent)
nerved as internal indicator, the end-point of the
carbonate addition being indicated by the appearance
of a faint grey-blue colour in the solution when viewed
through its depth against a white background. In
later experiments 5^ and IN potassium hydroxide were
used to adjust the pH since they avoided the evolution
of carbon dioxide which proved troublesome on occasions.
The sample \*as stored at -20 0 for at least 50 min. to
allow maximum precipitation of potassium r>erchlorate
and aggregation of any unprecipitated proteinaceous
matter. The sample could be stored overnight at -20°C
without any deleterious effects. After this time, the
sample was thawed by immersion in a beaker of cold
(10°G) water and centrifuged for 7 min. at 4,500 £ at
4-OC. The supernatant (6 - 7 nil) was transferred into
a glass-stoppered test-tube of 55 ml capacity (Quickfit
and Quarts, B24). The precipitate was washed with
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0.5 ml water at 4 0, centrifuged as before and this wash
fluid added to the supernatant.
Removal of carboxylic acid metabolites. In order
to remove the carboxylie acid metabolites of the
catecholamines from the extract, the supernatant was
acidified to a pH between 1 and 2 (Universal Indicator
paper) by the addition of 1 - 2 drops of 2N hydrochloric
acid, saturated with sodium chloride and shaken
vigorously for 4 min. with 1.5 vol. ethyl acetate.
The extraction was repeated once. The ethyl acetate
layers were separated by centrifugation for 3-5 min.
at 980 g. The acids were back-extracted into 4.0 ml
G.1M 2-amino-2-(hydroxy-methyl)-propane-l:3idiol (B.D.H.
Laboratory Reagent) 'trie* buffer pH 8.6. Hoxaovanillic
acid was estimated in the buffer extract by the method
Anden, Roos and Werdinius (1963).
Preparation of sample for acetylation. After
the removal of the acids, the sample was evacuated
at the vacuum pump to remove traces of ethyl acetate.
The pH was brought to about 4 with a few drops of IN
potassium carbonate or potassium hydroxide and the
sample briefly centrifuged to bring down excess salt
(p./OO). At this stage the sample could, if necessary,
be stored at - 20°C overnight. The supernatant was
taken off, using a 5 ml safety pipette and the precipi¬
tate washed briefly with 0.5 ml water at 4°G. If
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there was a large amount of sedimented salt and a
relatively small supernatant volume, the wash volume
was increased to 1»0 - 1.5 ml. This solution (about
6-8 ml), containing the amino acids and the amines
was acetylated as follows.
.cetylation roceduce (Welsh, 1952)
To the solution was added acetic anhydride
(0.05 ml/ml solution) followed immediately by sodium
bicarbonate (0.1 g/ml solution). The solution was
stirred vigorously for 10 min. before repeating the
additions of acetic anhydride and sodium bicarbonate.
The stirring was continued for a further 20 min. by
which time the evolution of carbon dioxide had ceased
and some sodium bicarbonate remained unreached. The
acetylated amines were extracted by shaking the
solution three times for 4 min. each time, with 2 vol.
dichloromethane. Centrifugation for 5-5 min. at
980 g_ was necessary to break the resultant emulsion.
The combined dichloromethane extract was shaken briefly
with one third its volume of O.IK hydrochloric acid
to remove any unacetylated amines and then 4 times with
one third volumes of water to remove the acid. The
dichloromethane extract was dried by adding anhydrous
sodium sulphate until there was some powdery, unhydrated
salt, in addition to the lumpy, hydrated salt, at the
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foot of the test-tube. The extract was usually left
overnight at this stage, at -20°0.
The dichloromethnne extract was decanted into a
100 ml round-bottomed flask. The sodium sulphate
residue was shaken briefly with a further 5 - 10 ml
dichloromethane and the organic liquid, carefully
decanted and combined with the main dichloromethane
extract. The extract was evaporated to about 1 ml
under a ^et of nitrogen at room temperature. The sides
of the flask were then carefully washed down with 2 ml
dichloromethane and the evaporation continued to dryness.
The almost invisible residue containing the acetylated
amines was taken up in 0.5 ml followed by 0.2 ml
methanol by carefully allowing the methanol to run
down the full circumference of the inside of the flask.
This was necessary to dissolve any amines which, despite
washing down with dichloromethane, remained on the wall
of the flask. Swirling of the methanolic extract
around the flask was avoided because such a procedure
tended to redeposit the amines on the flask wall.
Methanol was used because it was found to be an even
better solvent for the acetylated amines than dichloro¬
methane .
Oorament on acetylation procedure. The solution
for acetylation was saturated with sodium chloride
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Diagram of Whatman no. 20 Paper Sheet used for
Chromatography of the Acetylated Amines in Toluene: Ethyl

















remaining from the acid extraction stage (p.97), so
that after addition of sodium bicarbonate during the
acetylation stage, a heavy salt deposit was formed.
If excess sodium chloride was not removed by centri-
fugation as described on p» 77, this salt deposit was
extremely bulky and made removal by pipette, of the
dichloromethane phase, which was at the foot of the
test-tube along with the salt, very difficult.
Acetyl-dona. The aqueous phase remaining from
the acetylation procedure after extraction of the
acetylated amines into dichloromethane, was retained
for the estimation of acetyl-dopa (p.//8 ).
Paper Chromatography of Acetylated Amines
A sheet of Whatman no, 20 paper for chromatography
was cut into eight strips, 4-6 cm long and 2,5 cm wide,
the tops and bottoms of neighbouring strips remaining
joined by cross-pieces of paper (Figure 10 ), A
solution for chromatography was applied to one of the
strips at the point marked 'origin' in Figure ,
by replicate applications from a capillary tube across
the full width of the strip. Evaporation of the
solvent was hastened by projecting a continuous
stream of nitrogen from a manifold onto the paper
strips at the sites of application of the solutions.
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Care was taken that an applied solution formed a band
not exceeding 1 cm in width at any time during
application to the paper.
To each of the origins of strips 1, 3t 5 and 7
was applied a mixture of the acetyl derivatives of
adrenaline, noradrenaline, dopamine, metanephrire and
normetanephrine equivalent to about 20 pg of each amine
and acetyl-methoxy-dopamine equivalent to about 30 jag
unacetylated amine. These amounts could be adequately
visualised on the developed chromatograms, and served
as markers for localisation of the acetylated amines
in the •sample' chromatograms. These marker mixtures
were prepared from solutions in 50$ (v/v) methanol of
each acetylated amine, containing the equivalent of
10 mg/ml of the parent amine (p,1°$ ). To the origins
of strips 2 and 6 were applied the methanolic solutions
containing the acetylated amines from the rat brain
extracts. To the origin of strip 4 was applied the
similar solution from the rat brain extract to which
known amounts of the amines had been added (p. ).
These extracts, equivalent to 1.0 - 1.5 g brain tissue
were easily applied to the paper and produced a barely
detectable deposit on application. Nothing was
applied to the origin position in strip 8. This strip
was used for the preparation of paper blanks required
for the fluorimetric assay of each amine (p. I0G ).
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An all-glass 'Panglass* (Shandon, 30 x 20 x 36 cm)
chromatography tank was lined with 2 thicknesses of
filter paper impregnated with and dipping into, a
layer of the developing solvent in the foot of the
tank. The chromatogram carrying the samples and
markers was suspended between one long side of the
tank and a filter paper curtain saturated with the
aqueous phase. This curtain was held in a trough
containing the aqueous phase, placed across the length
of the top of the tank. Saturation of the tank with
vapour from the aqueous phase was maintained by the
continual descending flow of the aqueous phase, down
the filter-paper curtain, into a receiving trough at
the foot of the tank. The chromatograms were allowed
to equilibrate for at least 6 hr. at 19 - 22°C in a
thermostatically controlled room. At the end of the
equilibration period, 100 ml of the organic phase of a
mixture of toluene:ethyl acetate methanol:water
(10:1:5*5 by vol.) was introduced into the solvent
trough and the descending chromatograms allowed to
develop for 10-J - 11 hr. at 19 - 22°C. In order to
obtain maximum separation of acetyl-noradrenaline from
acetyl-normetanephrine, the time and temperature of
development were adjusted so that acetyl-methoxydopamine,
the acetylated amine with the greatest Rf, was close
to the foot of the paper strips.
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Freshly distilled, solvents were used for the
preparation of the developing solvent system. TanJ.cs
with polythene accessories and plugs were unsatisfactory,
because polythene absorbed the solvent vapours causing
leakage. A tight seal between the lid and walls of
the tank and between the lid and its coverslip was
essential and was achieved using starch-glycerin paste
(p, 33 ), Screw clamps, one at each end of the
tank, \*ere necessary to ensure firm apposition of the
tank-lid on top of the tank walls. The system was
extremely temperature dependent. The tank was kept,
raised off the floor, in a large box made of 2 inch
polystyrene with a 3 inch air-space between tank and
box, in order to protect the contents of the tank
from draughts and ensure an even temperature within
the tank. The slightest temperature gradient across
the length of the tank resulted in differences in
rates of flow of the developing solvent down the
chromatogram strips exposed to the different tempera¬
tures, with consequent differences in the distances
travelled by a given acetylated amine on these. chromato¬
gram strips.
After development, the chromatogram was dried
by hanging it in a chromatography tank through which
was passed a brisk stream of nitrogen. The strips
bearing the marker acetylated amines were cut out and
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the amines were visualised by spraying the strips
with a solution of diazotised p-nitroaniline. After
the paper had dried it was sprayed with 5% sodium
hydroxide in 50% (v/v) methanol. Fresh diassotised
p-nitroaniline was prepared on each occasion by
mixing 20 ml of a solution of 0.5% (w/v) p—nitroaniline
(B.D.H. Laboratory Reagent) in approx. C.8N hydrochloric
acid (8 ml conc. hydrochloric acid in 100 ml water)
with 1.2 ml 5% (w/v) sodium nitrite. The acetylated
amines were eluted from the appropriate parts of the
sample strips and the blank strip (p./02) in 15 ml
glass-stoppered test-tubes by gentle shaking for
50 min. at room temperature in the following solutions;
acetyl-adrenaline, acetyl-noradrenaline and acetyl-
dopamine in 5.00 ml water; acetyl-metanephrine and
acetyl-normetanephrine in 2.00 ml G.4-N hydrochloric
acid and acetyl-methoxydopamine in 2.00 ml 0.1N
hydrochloric acid. After 50 min., the papers were
drawn up the sides of the tubes to drain and the
eluates stored at A°0 until assayed. The acetylated
catecholamines were estimated within 24- hr. and the
acetylated methoxyamines within '+ days, of their
elution.
Blanks
Since there is no obvious way of preparing a
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tissue blank during the method of assay using ethyl-
diamine it is necessary to have an extract blank for
these assays. Two methods of preparing an extract
blank were investigated and compared. In the first
method, rat cerebellum was extracted, acetylated and
chromatographed in parallel with the rat brain samples
(p. JA--I0S"), it was presumed that rat cerebellum
contains negligible amounts of the catecholamines,
since Juorio and Vogt (1965) found no homovanillic
acid in rat cerebellum. In the second method, a
paper strip with nothing applied to it, was included
in the chromatograms (p. 102- ). Blanks were prepared
for each amine by cutting the cerebellum and the blank
chromatogram strips at the same positions as the
sample strip and eluting and assaying as for each
acetylated amine. The paper blanks were fudged to
be satisfactory and superior to the cerebellum blanks,
for the following reasons:
(i) In the case of the 'acetyl-normetanephrine1 assay;
vin which it is possible to prepare a faded blank
(p.//6), the paper blank gave the same reading as the
faded blank and the cerebellum blank a slightly higher
reading.
(ii) Under normal conditions, adrenaline and meta-
nephrine are not detectable in rat brain. As
expected, the fluorescence readings obtained for these
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amines in brain chromatogram eluates were the same as
those obtained from paper chromatogram eluates. The
fluorescence readings from the cerebellum chromatogram
eluates were, however, slightly higher than those from
the brain chromatogram eluates.
(iii) Those parts of a brain chroaatogram not
corresponding to any amine gave the same fluorescence
as their paper blank but again, the fluorescence from
the cerebellum extract was slightly higher.
After these experiments had been carried out,
Glowinski and Iversen (1%6) published an estimate
for noradrenaline in rat cerebellum of 0.17 pg/g.
The presence of noradrenaline in this amount and
possibly of other catecholamines and their amine
metabolites in rat cerebellum, could account for the
cerebellum chromatogram eluates giving rise to a greater
fluorescence than the paper eluotes.
Assays of Acetylated Amines and Dopa
Preparation of Standard Solutions oi' the Acetyl Deriva¬
tives of Adrenaline, noradrenaline, .Dopamine, Meta-
nephrine, Normetanephrine, Methoxydopamine and Dopa
20 pg of the substance contained in 5 ml 0. 005N
hydrochloric acid was acetylated according to the
procedure described on p.f£. The residue from the
evaporated dichloromethane extract (or the ethyl
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acetate extract in the case of dopa (p./'£) was
dissolved in 10 ml de-ionised distilled water. The
solution so obtained, containing the equivalent of
2 ug of the parent substance/ml, was stored in a 15 ml
glass-stoppered test-tube at 4°C. This solution was
used as a standard solution in the course of the
estimation of the parent substances in 'unknown'
solutions of the acetyl derivatives. These standards
were prepared at monthly intervals and a new prepara¬
tion was checked against the previous preparation
before being used as a standard for assays. Standards
prepared at monthly intervals over a period of 5
months gave the same readings when assayed together,
demonstrating the reproducibility of the acetylation
technique and the stability of the standard solutions,
as judged by the fluorescence yield, over a period of
several months when stored at 4°G.
Solutions of the acetylated amines for use as
markers were prepared in the same way except that
15 mg of the substance was acetylated and the residue
taken up in 1.5 nil 50% (v/v) methanol to give a
solution containing the equivalent of 10 mg/ml unacetyl-
ated amine.
Estimation of Acetyl-adrenaline, Acetyl-noradrenaline
and Acetyl-dopamine
These compounds could be assayed by simultaneous
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hydrolysis and coupling with ethylenediamine to form
their respective fluorophors (p.-^). To a 2.00 ml
sample containing the acetylated amine, in a 15 nil
test-tube with ground glass stopper, was added 0*50 ml
of a freshly prepared and cooled mixture of ethyl-
enediamine and 4-M ammonium chloride in the proportions
of 1:1.3 by vol. (R&gi, Burger and Giger, 1957)*
The sample was heated at 50°0 for 20 min. with shaking,
in a covered water-bath and then cooled. It was
saturated with sodium chloride and the fluorophor
extracted into 2.00 ml isobutanol (Weil-Malherbe, 1959)
by shaking for 4- min.. The phases separated in
2-3 min. -The isobutanol layer was then withdrawn
with a safety pipette and the relative fluorescence
measured on the Aminco-dowman SPF at 4-30/500 rep. for
acetyl-noradrenaline and acetyl-adrenaline and at
4-30/520 mp for acetyl-dopamine. The relative
fluorescences of reagent blanks and aqueous standard
solutions of the acetylated amines were determined
concurrently with each batch of samples. Internal
standards proved unnecessary since eluates from brain
chromatograms were found to have no effect on the
fluorophors from the acetylated amine standards.
The isobutanol used in these assays was obtained
from British Drug Houses and was of the grade
•recommended for fluorimetric assay' (p. 33 ). A
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fresh bottle was used every 2 weeks. The blank
obtained from such isobutanol was low and was not
lowered further by distillation. Old stocks of
isobutanol, on the other hand, gave very high blanks,
which could be reduced by 1 - 3 distillations.
Freshly distilled, absolutely colourless, ethylene-
diamine, prepai*ed at 2 week intervals as described on
p. , was essential. Ethylenediamine stored for
longer than 2 weeks tended to produce high blanks,
even though it remained apparently colourless.
Estimation of Acetyl-methoxydopamine
Acetyl-methexydopamine cannot be simultaneously
oxidised to the corresponding quinone and coupled with
ethylenediamine as can acetyl-dopamine, because the
methcxy group is resistant to oxidation by alkali.
It was found however, that the 0-acetyl group of
acetyl-methoxydopamine could be removed by acid
hydrolysis leaving the methyl monoether which, in
accord with Adler and Magnusson's (1959) report, could
be oxidatively demethylated to the free catechol by
treatment with periodate. Fluorop>hor formation from
the liberated catechol by reaction with ethylene-
diamine was then possible.
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A 1.00 ml portion of a solution of acetyl-methoxy-
dopamlne in O.IK hydrochloric acid (standard solution
or chromatogram eluate), contained in a glass-stoppered
15 ml test-tube was heated for 20 rain, in a boiling
water-bath. After cooling to roora temperature,
C*50 ml O.lSfe (w/v) sodium periodate was added to the
solution and the reaction allowed to proceed for
5 rain, under subdued lighting conditions. Ethyl-
enediamine-ammonium chloride mixture (p. 10°I) 0.$0 ml,
was then introduced into the solution and the
fluorophor developed and extracted into isobutanol,
as described for the estimation of the acetylsted
catecholamines (p. '09). Although the maximum fluor¬
escence occurred at 430/520 mp, the relative fluor¬
escence was measured at 440/540 mp. because the blank
contributed proportionally less to the fluorescence
at the latter wavelengths than it did at the former.
Reagent blanks and aqueous acetyl-methoxydopamine
standards were run in parallel with each batch of
samples. Internal standards proved to be unnecessary
since eluates from brain chroraatograms had no effect
on the fluorescence from acetyl-methoxydopaminc.
The O.IK hydrochloric acid paper eluates gave
fluorescence readings 3 to 5 times those from the
reagent blanks. The cause of these high paper blanks
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was some material which was leached out of the paper
by water (acid conditions increased the amount of,
but were not essential for, this leaching effect) and
which reacted with periodate in acid solution to
produce a fluorescence on addition of the alkaline
ethylenediamine mixture. Pre-washing the chromato¬
graphy paper in a $0:50 (by vol.) benzene:methanol
mixture, as advocated by Goldstein* Friedhoff, Simmons
and Prochoroff (I960) did not remove this interfering
material. Pre-washing the chromatography paper in
0.1N hydrochloric acid followed by water was abandoned
because washing the paper free of traces of acid was
difficult and the use of an acidic paper resulted in
some hydrolysis of the acetylated amines to their
partially acetylated derivatives which failed to
racva from the origin during the chromatography.
A reduction of the paper blank to that obtained
from ethylenediamine treated eluates of the acetyl-
catecholamine portions of the chromatogram was
achieved by concentrating the acetyl-methoxydopamine
by ascending chromatography in methanol, into a much
smaller area of the paper segment before elution.
The 'acetyl-methoxydopamine' section of the sample or
blank chromatogram was sandwiched betv/een two microscope
slides with the end proximal to the origin of the
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chromatogram projecting 0.7 cm from the top of the
slides (Figure II ). The bottom of the slides was
inserted into a glass trough containing methanol so
that the lower end of the paper strip was in line with
the surface of the solvent. The solvent flowing up
the paper evaporated from the exposed part of the
strip but eventually reached the upper edge, when the
flow was allowed to continue for a further- 6 min..
The strip was removed and allowed to dry and the top
0.7 cm eluted in 2.00 ml G.1N hydrochloric acid.
No acetyl-methoxydopamine was detected in the remainder
of the strip in a control experiment in which the
acetyl-methoxydopamine section of a chromatogram of
a brain extract to t^hich had been added 400 mpg acetyl-
methoxydopamine was subjected to this concentrating
technique, thus demonstrating its efficiency at the
caps level.
Estimation of Acetyl-normetanephrine
Acetyl-normetanephrine after acid hydrolysis
and treatment with perlodate might be expected to
yield, on coupling with ethylenediamine, a £lu<xqphor
having the same characteristics as that formed from
acetyl-noradrenaline. In fact, the sensitivities of
assay of normetanephrlne and acetyl-normetanepkrine
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by this method were only 200 mpg and $00 mjig,
respectively i.e. considerably less than that of acetyl-
noradrenaline. Sensitivity was greatly increased if
an adaptation of Brunjes' (1964, p. ^cl) trihydroxy-
indole method, involving an essential initial hydrolysis
of the 0-acetyl ester, was used. Hydrolysis in
O.hN hydrochloric acid gave the maximum reading for
the fluorescence; increasing the concentration of
hydrochloric acid above O.hN did not increase the
fluorescence yield.
1.00 ml 0.4-N hydrochloric acid paper eluate in
a 15 ml glass-stoppered test-tube was heated for 20 min.
in a boiling water-bath and cooled thoroughly.
During the subsequent development of the fluorophor,
the sample was kept in the dark by insertion in the
solid wooden test-tube rack used in Section I, Sub¬
section 1 (p. ). This precaution was taken since
the trihydroxyindole fluorophor derivative of normeta-
nephrine was found to be light sensitive (p. ).
To the solution was added 0.50 ml zinc sulphate
(0.5% (w/v) ZnSG^ . 7^0) in 0.02N hydrochloric acid,
followed by G.50 ml 0.075% (w/v) potassium ferricyanide
(freshly prepared from a 0.25% (w/v) stock solution,
stored in a dark bottle at h°G). Exactly 4 min. after
the ferricyanide addition 0.7 ml 1M sodium acetate
solution previously adjusted to pH about 12.9 with 5N
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sodium hydroxide was added to bring the pH of the
solution to 5*5* After a further 4 min. interval,
0*50 ml of a freshly prepared mixture containing 6.70 ml
5R sodium hydroxide, 0.50 ml redistilled ethylene-
diamine and 1.00 ml freshly prepared 2# (w/v) ascorbic
acid, was added. The solution was thoroughly mixed
after each reagent addition. The relative fluorescence
was read in the Aminco-Bowman SPP at 400/500 mp,
20 - 30 min. after addition of the ferricyanide, to
allow time for maximum production of the fluorophor.
Unlike in the ethylenediamine method, it is
possible in the above method, to obtain a faded blank
which can be used as a tissue blank, by adding only
the sodium hydroxide (0.44 ml 5N) at 4 rain, and waiting
a further 10 min. before adding 0.06 ml of a freshly
prepared mixture of ethylenediamine (0.30 ml) and
ascorbic acid (1.00 ml of a 2% solution). This
faded blank gave the same fluorescence reading as the
chromatogram paper blank* The latter blank was used
routinely because it was technically simpler and
because, unlike the faded blank it did not utilise a
portion of the sample cliroraatogram eluate and thus
left all the acetyl-norraetanephrine in the eluate
available for assay. Reagent blanks and aqueous
standards were processed along with each batch of
samples. It was found possible for one person to cope
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with a maximum of 8 samples, including blanks and
standards, in any one run. Internal standards were
not processed routinely, since it was found that they
did not differ significantly from aqueous standards
and because, as was also the case in the other assays
(p .108,1/0), it was essential to conserve the available
acetylated amine for the estimation in view of the
very small amounts present.
estimation of Acetyl-metanephrine
Although the sensitivity of estimation of
metanephrine after treatment with periodate and ethylene
diamine as described for acetyl-normetanephrine
(p. Hip ) was 30 mpg, the sensitivity of assay of
acetyl-metanephrine obtained by this method after
acid hydrolysis, was only loo mpg. Acetyl-mefcanephrine
could be measured with a sensitivity of 10 mjog by
the method used to estimate acetyl-normetanephrine
(p. U5~ ). Addition of sodium acetate was omitted since
oxidation of hydrolysed acetyl-metanephrlne, unlike
oxidation of hydrolysed acetyl-normetanephrine,
proceeded satisfactorily in G#4N hydrochloric acid.
The acetyl-metanephrine fluorophor was more rapidly
produced and broken down than the acetyl-normetanephrine
fluorophor. The fluorescence derived from acetyl-
metanephrine, at 420/520 mp, was therefore measured
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about 15 min. after the addition of the ferricyanide.
Reagent blanks, aqueous standards, faded blanks and
internal standards were as for acetyl-normetanephrine•
Extraction and estimation of Acetyl-dopa
The aqueous phase remaining from the acetylation
procedure after extraction with dichloromethane
(p. /0/ ) would contain acetyl-dopa and any other
acetylated amino acids, such as acetyl-tyrosine.
Acetyl-dopa could be assayed in this aqueous phase but
such a procedure would not be advisable if this
aqueous phase was derived from a tissue extract, in
which tissue substances liable to give rise to high
blanks and/or quenching may be present. Further
purification of the acetyl-dopa-containing solution
before assay is therefore desirable. Purification
was carried out in the following way. The pH of the
solution was adjusted to about 2 (B.D.H. wide range
indicator paper) by the dropwise addition of conc.
hydrochloric acid. It was found that for each ml
acetic anhydride used in the acetylation procedure,
about 1.8 ml conc. hydrochloric acid was required for
this pH adjustment. The solution was still saturated
with sodium chloride from the acid extraction stage
(p. ?7 ) during the subsequent extraction of the
acetyl-dopa into ethyl acetate. Two extractions, with
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2 vol. of the solvent, with shaking for 4 min. each
time, were carried out, separation of the phases
being aided by centrifugation (2-3 min. at 980 g).
The combined ethyl acetate extracts were dried by the
addition of the minimum amount of anhydrous sodium
sulphate for at least 1 hr, at 4°G. The extract was
sometimes stored overnight at this stage, at -20°0,
It was then decanted from the sodium sulphate through
filter paper (Whatman no. 1) and evaporated to dryness
under a jet of nitrogen at room temperature. The
very faint, slightly greasy residue, tinged with
varying amounts of a whitish powder, presumably traces
of sodium sulphate, was dissolved in 3*GC ml water and
assayed for acetyl-dopa as described on p,120.
An alternative procedure of back-extraction of
acetyl-dopa from the ethyl acetate extract into an
alkaline buffer was possible, but not technically
feasible, on account of the relatively high concentra¬
tion, in the ethyl acetate, of acetic acid (about 1 ml
lGFi) liberated by the addition of the conc. hydro¬
chloric acid to the sodium acetate contained in the
solution from the acetylation reaction.
b'stimation of acetyl-dopa. The same technique
used to assay the acetylated catecholamines was
suitable for the assay of acetyl-dopa. The
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acetyl-dopa fluorophor was not extraetable into iso-
butanol, even after acidification of the solution to
pH about 1 t 2, The fluorescence was therefore
measured in the aqueous solution, at 430/540 mp.
Internal standards proved necessary when estimating:
the acetyl-dopa content of extracts from brain since
these were found to produce significant quenching of
the fluorescence.
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INVESTIGATION AND DEVELOPMENT OP METHODS FOR THE ASSAY
OF A MIXTURE OF THE CATECHOL— AND METHOXY-AMINES
AND DOPA
Bach procedure in the preceding 'Methods' section,
with the exception of the perchloric acid extraction,
was separately examined in pure solution with the amines
and dope.. The perchloric acid extraction was not
investigated in pure solution "because of difficulties
experienced in making the several pH adjustments necessarj'
during this procedure, in the absence of the "buffering
action of tissue extracts (p. 8i ), The feasibility of
combining the acetylation, chromatography and assay
stages, 'was then investigated using a mixture of the
amines and dopa in pure solution and any adjustments in
technique necessitated by this combination, made.
Before application of the entire method to the estimation
of the amines and dopa in rat brain, the effect of brain
extracts, prepared by this method, on the dispostion of
several of the acetylated amines on a chromatogram, was
investigated.
Effect <?f xxtwl Acetate aatragUgn on ;.fo-»ppajine,
NoffadfgridliftQ,, Dgpfl
The following experiments were carried out to check
that the catecholamines and dopa were not
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extracted from acid solution into ethyl acetate, along
with their carboxylic acid metabolites (p.??).
Duplicate samples of 200 mjUg adrenaline or of
200 mjug noradrenaline in 4- ml G.1N perchloric acid
were extracted with 3 x 4 ml ethyl acetate and the
amine remaining in the aqueous phase assayed, using
Hfiggendal's method (p. 4-^ ), after removal of perchloric
acid as its potassium salt. 87% and 91% of the
added adrenaline and 86% and c)2% of the added nor¬
adrenaline was recovered in the aqueous phase, showing
that there was no appreciable loss of adrenaline or
noradrenaline into ethyl acetate fi'om an acid aqueous
solution.
Duplicate samples of 2.5 dopa in 3 ml water
at pH about 2 were saturated with sodium chloride
and extracted vdth 2 x 6 ml ethyl acetate. The
bulked ethyl acetate fractions were dried over anhydrous
sodium sulphate, decanted, evaporated to dryness under
nitrogen, taken up in 3 ml water and assayed for dopa,
using ethylenediamine (p. //? )• No dopa could be
detected, indicating that none had been extracted into
ethyl acetate from the acid aqueous solution.
Assays of Acetylated Amines ana Dopa
A linear relationship was found between the amount
of substance present and the fluorescence intensity of
ffireure 12
Calibration Curves for Acetyl—metanephrine





(1) Acetyl-noradrenaline and Noradrenaline
(2) Acetyl-adrenaline and Adrenaline
























x—x Acetyl - noradrenaline












(1) Acetyl-dopamine and dopamine
(2) ace ty1-me thoxydopamin© and Metboxydopamine





























100 200 300 400 500
mpg amine
x
















Unacet. Acet. Unacet. Acetylated
■ ' * Range (n) Mean
+ Dopa E.D. 360/1+70 1+30/51+0 20 30-70 (8) 1+0







1+30/1+90 1+30/1+90 200 300
Noradrenaline O.i+N HCl + T.H.I 1+00/500 1+20/500 20 1+5
x Normetanephrine 0.1+N HC1 + T.H.I hoo/500 1+00/505 20 i+O-65 (6) 1+5







1+30/51+0 1+30/500 20 200
Adrenaline 0 .i+H HCl + T.H.I 1+20/520 1+20/520 1C 10
x Metanephrine 0.1+N HCl * T.H.I 1+20/520 1+20/520 10 5-15(10) 10













335/385 335/385 10c 1+00
•+• and * indicate methods chosen for routine use
'0.1+N HC1' xs heating in 0.1+N HC1 in boiling water-bath for 20 rain.
*0.1N HG1* «s heating in 0.1N HC1 in boiling water-bath for 20 min.
E.D. « ethylenediamine} T.S.I » ^rlhydroxyindole method, using modification of Brunjes1
technique.
Ranges in sensitivity only obtained for those assays used routinely.
Sensitivities calculated as that amount of amine giving the same reading as the reagent blank,
at the wavelengths for maximum excitation and emission of the fluorescence.
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the fluorophor derived from each of the acetylated
amines and dopa when the appropriate assay procedure
was examined using pure solutions containing amounts
ranging from 40 mpg to 200 mpg of the substance.
Linearity was found to persist with acetyl-dopamine
with amounts up to 8.0 p.g in the sample. A linear
relationship was also found between the amount of
substance present and the fluorescence intensity of the
fluorophor from each of the unacetylated amines and
dopa,when the assay for the corresponding acetyl&ted
compound without any hydrolysis was examined in pure
solution with 40 mptg to 200 mpg of the unacetylated
amine or dopa (Figures 12, IU- ).
fable ^ summarises the results of the assay-
investigations and includes assay methods which were
not used because of insensitivity or impracticability.
All the amines, whether acetylated or unacetylated,
yielded fluorescent derivatives on being subjected
to the ethylenediamine assay method or the trihydroxy-
indole assay procedure. Acetyl-adrenaline and acetyl-
noradrenaline could be estimated with approximately
equal sensitivity, using either method. For the
assay of these substances the ethylenediamine procedure
was chosen for routine use because it was technically
simpler and the conditions necessary for production
of the ethylenediamine fluorophors were found to be less
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critical than those required for formation of the
trihydroxyindole fluorophors. Acetyl-metanephrine
and acetyl-normetanephrine, on treatment with the
ethylenediamine reagent, produced fluorophors having
only about 10# the intensity of the fluorophor
produced by treating the same amount of acetyl-adrena-
line with ethylenediamine. Fortunately, the deriva¬
tives obtained by treating acetyl-metanephrine and
acetyl-normctanephrine according to the trihydroxyindole
method had about the same fluorescence intensity as
the trihydroxyindole fluorophor from acetyl-adrenaline.
The fluorophor obtained by putting acetyl-methoxy-
dopamine through the trihydroxyindole method (Garlsson
and Waldeck's method for the estimation of methoxy-
dopamine, 1964 ) after hydrolysis in 0.4N hydrochloric
acid, was only 2.5% the intensity of the trihydroxy¬
indole fluorophor derived from adrenaline. However,
the alternative method of estimation, using ethylene-
diamine, yielded a fluorescent derivative from acetyl-
methoxydopamine having about the same fluorescence
intensity as the ethylenediamine conjugate from acetyl-
adrenaline. No attempt was made to estimate acetyl-
dopamine by the trihydroxyindole method, since it was
very unlikely, in view of the results obtained on
applying this method to the determination of methoxy-
dopamine and its acetylated derivative, that the
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trihydroxyindole method would give a more intense
fluorescence from acetyl-dopamine, than that pi»oduced
by coupling acetyl-dopamine with ethylenediamine*
Unlike the trihydroxyindole method, there is no
of preparing a tissue blank using the ethylenediamine
method. This difficulty was avoided when the ethylene-
diamine method was applied to chromatogram eluates by
using the paper blank (p./os).
The acetylated catecholamines could be assayed
by the methods (marked x in Table 2 ) used to estimate
their methoxy derivatives but the acetylated methoxy-
amines could not be assayed by the methods (marked
+ in Table 8 ) used to estimate the acetylated
catecholamines. Fluorophors with the same wavelength
characteristics were obtained on estimating an
acetylated catecholamine and its respective methoxy
derivative by the method used to estimate the acetylated
methoxyamine.
Acetyl-methoxydopamine hstimations
There was no significant 'between-duplicate *
difference in the fluorescence intensities derived
from duplicate samples of different amounts of acetyl-
methoxydepamine or of acetyl-dopamine processed
concurrently using the'acetyl-methoxydopamine' method.
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However the ratio of the fluorescence intensities
derived from equimolar amounts of acetyl-methoxydopamine
and acetyl-dopamine using the 'acetyl-methoxydopamine'
method of assay, was found to vary from 0.6 to 1.0
on the 12 occasions on which the comparisons were made.
This varying ratio was not accompanied on these
occasions by a similar variability in the ratio of the
fluorescence intensities obtained from acetyl-dopamine
when assayed by the "acetyl-methoxydopamine1 and the
"acetyl-dopamine' methods. This latter ratio varied
only from 0.9 to 1.0, indicating that the preliminary
boiling in O.llf hydrochloric acid followed by treat¬
ment with periodate, had little or no effect on the
fluorescence yield from coupling acetyl-dopamine with
ethylenediamine. The most probable explanation of
the above obsenration would appear to be a variability
in the extent of conversion of the acetyl-methoxy-
dopamine to the catechol derivative, this variation
arising from small uncontrollable differences in
technique on different occasions. The cause of this
variation has not been further investigated, in view
of the fact that the variation was not apparent with
replicate samples processed concurrently.
Effect of Acetylation on the Fluorescence Gharacter-
istics and Intensities of the Eluorophorsderived from
the Amines
Acetylation changed the wavelengths for maximum
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fluorescence from adrenaline and dopa using the
ethylenediamine method of assay but had no marked
effect on the fluorescence characteristics of the
other amines (Table % ). With the exception of
metanephrine assayed by the ethylenediamine method,
acetylation did not affect the sensitivity of assay
of adrenaline and metanephrine. However, the sensi¬
tivity of the assay of noradrenaline and normetanephrine
was decreased and that of dopamine and methoxydopamine
increased, by acetylation. A measure of the fluor¬
escence yields from each unacetylated and acetylated
amine, by the method chosen for the assay of the
acetylated derivative, is afforded by the steepness
of their respective calibration curves (Figures 13, tk-
These curves demonstrate that the increase in the
sensitivity of assay of dopamine and methoxydopamine
by acetylation was due to an increase in the fluorescence
yields from the amines and the decrease in the sensi¬
tivity of assay of noradrenaline after acetylation to
a decrease in the fluorescence yield from noradrenaline.
The sensitivity of assay of an acetylated amine
by a given technique, like the sensitivity of assay
of an unacetylated amine (p. g<5), varied on different
occasions (Table # ), This variation was dtie to
independent variations in the intensity of fluorescence
obtained from a constant amount of amine and in the
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size of the blank. In the case of the ethylene-diamine
assays, any increase in the blank could often be
traced to ethylenediamine which had been in use for
longer than the recommended two weeks (p. ). The
relative contribution of these two factors to the
variation in the sensitivity of the estimation of a
given amine depended on the amine being assayed and
on the method of assay used i.e. whether it was the
ethylenediamine or the trihydroxyindole method.
Comment on the Assay of .icet.yl-noraetanephrine
When first examined in pure solution, the
sensitivity of this assay was 4-5 mpg. Apparently
coincident with a move to a new laboratory,the sensi¬
tivity fell to 100 - 200 mjag, without any significant
alteration in the reagent blank fluorescence. It
seemed possible that this reduction in fluorescence
yield might have resulted from the change in the water
supply used to make up the reagents, the original
supply containing material which catalysed the
fluorophor production. Definitive experiments
however, have not given any evidence of this. It
may be that such a catalyst was present in the reagents
employed originally. Further investigations,
particularly on the effect of copper, which has been
reported (H&ggendnl, 1963) to accelerate the oxidation
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of adrenaline and noradrenaline to their chrome
derivatives, are proceeding.
uantification of the Acet,ylation Procedure
in i-iire Solution
Welsh (1952a) found that 3*3 S of adrenaline could
be quantitatively converted to triacetyl-adrenaline.
Heither he nor Goldstein and co-workers (1959a and
1959b), however, ascertained if acetylation of
adrenaline, noradrenaline, dopamine, metanephrine,
normetanephrine, methoxydopamine and dopa was quantita¬
tive at microgram or millimicrogram levels i.e. at
the amounts liable to be found in extracts of brain
tissue. Two types of experiments were designed to
investigate this question. In the first series of
experiments (i) the degree of acetylation and degree
of extraction of the acetylated compound into an
organic solvent were looked at. In the second
series of experiments (ii) the relative fluorescence
from acetylated amines and dopa which had been acetyl¬
ated in milligram and millimicrogram amounts was
compared with the relative fluorescence obtained after
iacetylation of the same amines and dopa, in microgram
quantities.
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(i) 20 fig amounts of the separate amines and dopa
were acetylated and extracted into dichloromethane
(p. 7? ) or ethyl acetate (p.//2 ). The aqueous solution
remaining after extinction of the acetylated amines
into dichloromethane were acidified to pH about 5.5
with conc. hydrochloric acid. The aqueous solution
remaining after extraction of acetyl-dopa, was adjusted
from pH about 1, to pll about 3*5» using drops of 5$
potassium carbonate.
The aqueous solutions from metanephrine, nor-
metanephrine and methoxydopamine were divided into
4 portions. The acetylated aethoxyamines were estima-
ted in two of these portions and the
unacetylated amines were estimated in the other two
portions, using the same methods as were used to.
measure the acetylated derivatives, but without the
initial hydrolysis step. To one portion from each
pair was added an internal standard, to check for
quenching of the fluorescence by the aqueous solution.
Aliquots of the aqueous solutions remaining from the
aeetylation of adrenaline, noradrenaline, dopamine
and dopa were assayed by the ethylenediamine method
used to estimate their acetylated derivatives (p,10$, Kf)
Both unacetylated and acetylated amines are estimated
by this technique but since the wavelength character¬
istics of the fluorophors from acetyl-adrenaline and
s
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acetyl-dopa are quite different from those of the
fluorophors from adrenaline and dopa it was possible
to determine from the emission spectra, if any
fluorescence from the aqueous solutions was derived
from the acetylated or unacetylated form of adrenaline
and dopa. In the cases of noradrenaline and dopamine,
no such distinction is possible, since the acetylated
forms of these amines, fluoresce maximally at the
same xvavelengths as the unacetylated amines (p./3/ )«
However, the observed fluorescence was no greater than
the fluorescence from the corresponding blank, showing
that no detectable acetylated or unacetylated nor¬
adrenaline or dopamine had been left in the aqueous
phase (Table ? )♦
(ii) 100 rajug to 500 mpg amounts of the amines and dopa
were acetylated and extracted into dichloromethane
(p. ) or ethyl acetate (p.//? ). After evaporating
the solvent extracts to dryness, the residues were
taken up in 3 - 4 ml water and the concentration of
the appropriate acetyl derivative estimated, using
the methods given on p. /<??-//? and standard solutions
prepared as on p. /"/ .
15 mg adrenaline, noradrenaline and dopamine were
acetylated as described for preparation of markers'
(p• ,07 )•> to give a solution containing the equivalent
of 10 mg/ml unacetylated substance in 50^ (v/v)
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T^LE Q
AAcetylation and % Extraction into Dichloroaothane or Ethyl Acetate
of duplicate Amounts of 20 jig of the Amines and Dopa (as judged "by
the amount of uaacetylated or acetylated compound, respectively,
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Metanephrine 100 mpg200 ajxg
148 mpg
238 mpg
Nome tanephrine 500 mpg 393 mpg
Methoxydopamine 250 mpg500 mpg
268 mpg
502 mpg
Dopa 400 mpg kkO rapg
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methanol. This solution was diluted to give the
equivalent of 2 pg/ml unacetylated substance and CJ. ml
and C.05 nil portions assayed for the acetylated amine,
using the appropriate 2 jug/ml acetyl standard (g« /«7 )
prepared by acetylation of 20 fig of the amine.
The results of these experiments are given in
Tables 7 (i) and (ii). Table 7 shows that
there was no detectable unacetylated amine or dopa
left in the aqueous phase after acetylation and extract¬
ion of 20 jag of each amine or dopa. The amines and
dopa must therefore either have been destroyed or
converted to their acetyl derivatives. Detectable
amounts of the acetylsted derivatives were not present
in these same samples, implying total removal of the
acetylated compounds into the organic solvents.
Destruction of the amines or dopa by the acetylation
process, if it occurs, must be negligible, since milli-
mierogram amounts of the amines and dopa could be
quantitatively recovered from the organic phase which
would contain the acetyl derivatives (Table 10 },
It would appear from the results of these control
experiments that the method of acetylation employed
produces quantitative acetylation of the amines and
of dopa no matter whether these are present in milli¬
gram or milliroicrogram amounts in the solution.
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Chromatography of the Acetylated Amines
Sepax'ation of the six acetylated amines using the
maximum distance of travel, i.e. with acetyl-methoxy-
dopamine, the compound vdth the greatest Kf, located
at the foot of a 4-6 cm long chromatogram, was possible
with the slow solvent flow on a Whatman no. 20 paper,
but not with the faster solvent flow on a Whatman no. 1
paper. The band widths obtained with the no. 1 paper
were much greater than with the no. 20. Development
of the chromatogram at 37°0, as recommended by Goldstein
and co-workers (1959b) was not found practicable,
because of the difficulty in maintaining an even temper¬
ature within the chromatography tank. Any temperature
gradients across the tank resulted in differences in
the distances travelled by a given acetylated amine on
chromatogram strips at different positions in the
tank (p./o^O so that the marker strips did not give a-
true indication of the positions of the separated
amines on the sample chromatograms. A trial run in
which a chromatogram was run at 4°G indicated that
there were no problems with temperature gradients
under these conditions but there were possibly poorer
separations of the methoxy- from the catechol-amines.
Experience has shown that, for good separation,
the filter paper curtain carrying the aqueous phase
must be thoroughly wet before introducing the chromatogram.
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The tanks were used once a week for 3 weeks after
preparation and kept well sealed all this time. Organic
and aqueous phases were replenished as required.
Repeated use of the prepared tanks in this way appeared
not to affect adversely the separations. Bush (1952)
who introduced toluene:ethyl acetate:methanol:water *
10:1:5*5 as a solvent system for the separation of
-
steroids, found that replenishment of the solvents as
required, without renewing the whole set-up before
each chromatographic run, gave satisfactory chromatograms.
Even with all these precautions, the extent of separa¬
tion of acetyl-noradrenaline from acetyl-normetanephrine
was not as great as would be desired (Figure /S ). It
is possible to increase this separation by continuing
the chromatography for these two amines after removal
of that portion of the chromatogram carrying the other
four acetylated amines but this modification was not
incorporated into the routine methodology because of the
extra time required for the further re-equilibration
and continued development of the chromatogram.
An amount of extract equivalent to 1.25 g rat
brain applied to the origin of a chromatogram did not
affect the distances of flow of marker amounts of the
acetylated amines added to the brain extract before
application to the chromatogram. In order to check
that acetylation of the much smaller amounts of amine
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Figure 15
Chromatogram of Acetylated Amines after
Development with the Organic Phase of Toluene:
Ethyl Acetate: Methanol: water =10: 1: 5: 5«
Descending chromatography for 11 hrs. at 20 - 21°C.
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present in the brain extract produced acetylated
derivatives with the same Rf as acetylated markers,
chroHistograms were run vdth duplicate portions of rat
brain extract, each equivalent to 1.04- g tissue, after
! extraction and acetylation as on These 56 cm
long ciiromatograms were accommodated in an extra-long
chromatography tank, the use of which was subsequently
abandoned because of difficulties with its sealing and
equilibration. After development, the chromatograms
were cut into 4- cm sections starting at a line 2 cm
from the origin, each section was eluted in 5 ml water
and a 2 ml portion put through the ethylenediamine
assay procedure for the catecholamines ). The
fluorescence profile thus obtained (Figure 16 ) demonstr¬
ates that noradrenaline and dopamine endogenous in rat
brain, after acetylation, showed the same distribution
along a chromatogram as their corresponding aqueous
visualised markers. Aqueous markers were therefore
used routinely (p.toy
A photograph of a typical chromatogram of the
acetylated catechol- and methoxy-amines is shown in
Figure . Also shownin this Figure are the
distances of flow of acetyl-octopamine, acetyl-5-hydroxy
tryptamine and acetyl-tyramine. These acetyl&tcd
amines were prepared in exactly the same way as
the acetylated catecholamines (p. ?2 ). They were
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investigated because all three are possible constituents
of a dichloromethane extract from an acetylated brain
extract. 5-Hydroxytryptamine in high concentration
might interfere with the estimation of noradrenaline
(p. J5*). Such a contingency is avoided by the fact
that by chromatography in toluene:ethyl acetate;methanol:
water « 10:1:5:5, acetyl-5-hydroxytryptamine is separa¬
ted from the acetylated derivatives of the catechol-
and methoxy-amines (Figure IS ). Octopamine and
tyramine have not been detected in normal brain but
have been found in the brains of animals pre-treated
with monoamine oxidase inhibitors (Kakimoto and
Armstrong, 1962). The acetylated derivatives of
homovanillic acid, vanillinmandelic acid, dopa and
tyrosine and the unacetylated amines did not move from
the origin in this system.
The following colours were obtained on visualising
with the alkaline diazotised p-nitroaniline reagent:
acetyl-noradrenaline and acetyl-adrenaline, deep blue;
acetyl-normetanephrine and acetyl-nietanephrine, deep
purple; acetyl-dopamine, acetyl-raethoxydopamine and
acetyl-tyrasine, grey-blue; acetyl-5-hydroxytryptamine,
light orange and acetyl-octopamine, rose-pink.
The Recoveries of Acetylated Amines from the Chromato¬
graphic Procedure
Two experiments were carried out to check
14-5
Figure 17
Distribution of Duplicates of BOOmjutg Acetyl-dopamine
applied directly to Paper and Chromatographed
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quantification of the chromatography, (i) in the
absence of, and (ii) in the presence of,brain tissue,
(i) Duplicate samples of 400 mp.g acetyl-noradrenaline
and 800 mpg acetyl-dopamine were applied directly
to chromatogram strips which were developed (p.'"/ )
along with appropriate marker chromatograms. Each
chromatogram was cut into 2 - $ cm long pieces over
the area corresponding to marker acetyl-noradrenaline
or acetyl-dopamine and each piece was eluted in 3 ml
water. Acetyl-noradrenaline or acetyl-dopamine
(p./*>8) was estimated in the appropriate eluates.
84% and 105% of the applied acetyl-noradrenaline
and 94% and 95% of the applied acetyl-dopamine were
recovered from the chromatograms. Acetyl-noradrenaline
was found only in the acetyl-noradrenaline marker
position; none was found in the neighbouring acetyl-
normetanephrine position. Ho partially acetylated
dopamine was detected in the 10 cm of the acetyl-
dopamine chromatograms including and extending from,
the origin. Acetyl-dopamine appeared to be normally
distributed over a 6 cm wide band corresponding to
the marker position with a 2 cm extension - i.e. part
of the 800 mpg acetyl-dopamine travelled 2 - 5 cm
farther than was indicated by the colour reaction shown
by the marker (Figure 17 ). The acetyl-dopamine found
in this position was 12% and 16% of the total
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acetyl-dopamine recovered in the two samples,
(ii) \pplic tion of this acetylation technique to
the estimation of catecholamines and their metabolites
in discrete areas of dog brain was anticipated.
Since different areas of brain contain differing
proportions of grey and white matter, it was considered
advisable to ascertain if these two types of tissue
differed in their effect on the disposition of the
acetylated amines along the chromatogram. Acetyl-
dopamine was chosen as the test amine because it had a
relatively high Hf value and therefore any influence
of tissue constituents might be expected to be the
more evident.
That part of a dog's brain remaining after removal
of the caudate nuclei, thalami, hypothalamus, midbrain
and globus pallidus was dissected into two portions
corresponding to the grey and the white matter,
respectively. About 2 g of grey and about 2 g of
white matter were extracted and acetylated and each
divided into two aliquots. Acetyl-dopamine (4 jug)
was added to one aliquot of the extract from the
grey matter and acetyl-dopamine (2 fig) to one aliquot
of the extract from the white matter, just before
application to the chromatograms. After development,
the first 6 cm of each chromatogram was divided into
; 4 x 1.5 cm sections which were eluted in 5 ml water.
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Figure 18
DISTRIBUTION OF ACETVL-OOPAMINE FROM GREY AND WHITE DOG BRAIN MATTER
WITH AND WITHOUT ADDED ACETYL-DOPAMINE AFTER CHROMATOGRAPHY
Extract from brain white matter without added a«tyldopamine Wwith 2 jig .. .. o o Wa
without added acetyldopamine x « G
Extract from brain grey matter ... ,' with L jig .. .. x x Ga
metanephrine dopamine methoxydopamine
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These eluates were examined for any partially acetyla-
ted dopamine which, according to Laverty and Sharman
(1965), could be found in this region of the ehromato-
gram. The area of each chromatogram corresponding to
marker acetyl-dopamine, as well as portions in front
of and behind this area, was divided into 1.5 c®
pieces and each piece eluted in 5 ml water. The
eluates were assayed for acetyl-dopamine as described
on p. 10%.
88% of the applied acetyl-dopamine was recovered
from both grey and white brain matter samples. Only
in the recovery sample from the white matter was there
any trace of material producing a fluorophor with the
characteristic maxima, at 450/520 mju, of that derived
from acetyl-dopamine, at or within 6 cm of the origin.
This Acetyl-dopamine' was found at the origin of the
chromatogram and amounted to 4.5/ of the acetyl-dopamine
recovered from the acetyl-dopamine position. The
band spread of bhe marker acetyl-dopamine on a developed
chromatogram shown in Figure /$ is 7 cm and includes
the extremes of the 5 - 4 cm wide bands obtained from
each of the three marker chroaatograms. This slight
difference in the Rf of acetyl-dopamine on different
chromatogram strips may be due to a temperature
gradient across the tank (p./3<?). Acetyl-dopamine
recovered from the sample chromatograms showed an
150
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approximately normal distribution, except Tor a tendency
to 'tail* at the solvent front ends of the distributions
(figure /S )♦ This 'tailing* was proportionately
greater in chromatograms carrying 1 - 2 jig amounts of
the amine ((G;) and (Wa) in Figure /$ ) than in a
chroHistogram carrying 4.8 ug acetyl-dopamine ((Ga) in
/2 ).
The positions of the acetyl-dopamine on the
chromatograms from the white matter sample ((W)) and
from its duplicate containing added acetyl-dopamine
((Wa)) were, with the exception of some 'tailing' in
the case of (Wa), the same as the position of the
marker acetyl-dopamine. The slight difference between
the positions of the acetyl-dopamine distributions
from these two samples could be entirely attributed
to the slight difference, probably caused by a
temperature gradient within the tank, in the Rf of
acetyl-dopamine as determined from marker chromatograms
located at different positions in the tank. There
was thus no evidence that extracts of white matter
affected the disposition of acetyl-dopamine on the
developed chromatograra. The difference between the
positions of acetyl-dopamine from the grey matter
extract ((G)) and from its duplicate containing added
|
acetyl-dopamine ((Ga)), could not be explained entix*ely
by a temperature gradient across the tank and must be
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due in part to a retarding effect of materials present
in the grey matter extract, on exogenous acetyl-
dopamine. This retardation, combined with the large
amount of acetyl-dopamine (4.8 jig) present in (Ga),
resulted in a loss of 1% of the acetyl-dopamine into
the acetyl-metanephrine position."
The band spread of acetyl-dopamine on the
developed chromatograms appeared to be a function of
the amount of acetyl-dopamine present e.g. in sample
(Ga) containing 4.8 jig the band spread was 9 cm,
whereas in sample (W) containing 0.18 pg the band
spread was reduced to 4.5 cm.
Recovery of fixtures of the Amines and Dopa
through the Acetylation and Chromatography
Two experiments, each containing four samples,
were carried out. In the first experiment only the
recoveries of the amines were investigated but in the
second experiment dopa was included. The amine
mixtures were acetylated in 5 ml 0.0G5N hydrochloric
.
acid containing also, in experiment (2), 600 jag ascorbic
acid and 2.2 mg disodium edetate, added to protect
the amines against oxidation and attack by metal ions
(p. i ). In each experiment, two samples had five
times as much noradrenaline as dopamine and two samples
five times as much dopamine as noradrenaline.






























































































Acetyl&tion, chromatography and assay were as described
under 'Methods1.
The results are given in Table / / . All samples
fluoresced maximally at wavelengths characteristic
of the fluorophor from the substance for which they were
being assayed, with the exception of solutions contain¬
ing acetyl-normetanephrine and solutions containing
0.2 ug or less of acetyl-dopa. The results demonstrate
that in pure solution, the components of a mixture of
adrenaline, noradrenaline, dopamine, raetanephrine,
normetanephrine, methoxydopamine and dopa can be
quantitatively separated and estimated as their acetyl
derivatives.
The low recoveries from C in experiment (1)
appeared to result from de-acetylation of the acetylated
amines, possibly by traces of acid from the walls of
the round-bottomed flasks in which the dichloromethane
extracts were evaporated to dryness (p.W )» caused
by insufficient rinsing of the flask after it had
been cleaned in chromic acid. Elution of a 3 cm sectior.
from and including the origin of chromatogram G and
treatment of this eluate with ethylenediamine produced
a fluorescence which corresponded qualitatively and
approximately quantitatively with the acetyl-dopamine
unaccounted for in the acetyl-dopamine eluate from
this chromatogram. Similar treatment of eluates
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from the same position on chromatograms A, B and 0
in experiment (1) yielded fluorescences no greater
than that from the corresponding paper blank. Some
dopamine-like fluorescence (i.e. a fluorescence showing
maximal intensity at 450/520 mju) was also detected in
the eluate from a section of chromatogram G located at
2.0 to 5«5 cm from the origin. This situation was
strongly reminiscent of the retention at the origin of
the paper chromatograra, of breakdown products, presumably
the partially hydrolysed derivatives, on developing the
acetylated amines on acidic chromatography paper
(p. It can be inferred that exposure of the
acetylated amines to acidic conditions before or during
chromatography interferes with their quantitative
recovery from the chromatogram by causing an uncontrolled
partial de-acetylation, followed by separation of the
partially acetylated amines from the fully acetylated
amines, by the chromatographic procedure.
The most probable explanation for the low recover-
les of adrenaline in experiment (1) is a 4-fold error
in the preparation of the adrenaline dilution. The
low recoveries for acetyl-normetanephrine in experiment
(2) can be explained by failure of the assay method,
which even in experiment (1) was not very satisfactory
in that the sensitivity of assay was only 2G0 rapg and
no characteristic fluorescence maxima could be obtained
T,v3LK12











































































































S.D.-standarddeviationc lcul tedfromme nsfdup ica . indopaassaysme nth t,judgingfromeemissionsp ctrum,nodwprese t.v
156
v/ith this amount of standard acetyl-normetanephrine.
The reason for this reduced sensitivity is discussed
on p. 132- .
The sensitivity of assay of acetyl-dopa after
extraction into ethyl acetate (p. Hf ) was 200 mjug i.e. !
five times less than the sensitivity of acetyl-dopa
estimation in pure solution, because of the relatively
high ethyl acetate extract blank and of the slight
(15$) quenching of the fluorescence produced from
100 mug acetyl-dopa by the ethyl acetate extracts.
The high extract blank was found to arise from the
residue from evaporation of 20 - 50 ml ethyl acetate
to dryness (p. .
RESULTS OF ESTIMATIONS OF CATECHOLAMINES,
THEIR AMINE METABOLITES AND DCPA IB RAT BRAIN
The results of five experiments, using homogenates,
each prepared from three pooled rat brains (p.^- ) are
given in Table /%. • Each estimate was obtained from a
chromatogram to which an extract equivalent to 1.1 g
rat brain had been applied.
The estimates for noradrenaline in rat brain
varied from 0.15 to 0,24- pg/g brain tissue with a mean
of 0.17 pg/g and those for dopamine from 0.4-8 to 0.79
Pg/g with a mean of 0.70 jug/g. Adrenaline and meta-
nephrine concentrations were below 0.02 pg/g, the
E'dflp3.?




































limiting concentration for detection of these amines
(Table 13 ). The fluorescences derived from the
acetyl-dopamine and acetyl-noradrenaline fractions
from the brain extracts were maximal at the wavelengths
of maximal fluorescence of the acetyl-dopamine and
acetyl-noradrenaline fluorophors, respectively.
Unfortunately the value of this finding as an indica¬
tion of the specificity of the acetyl-noradrenaline
estimation is reduced by the fact that the fluorescence
derived from the paper blank was maximal at the same
wavelengths as that derived from acetyl-noradrenaline.
Only two estimates were obtained for brain nonneta-
nephrine, both at the limit of detection by the method.
The fluorescence intensity was too low to give rise
to excitation and emission spectra showing the maxima
characteristics of the normetanephrine fluorophor.
Five estimates, varying from 0.05 to 0.10 jag/g
were obtained for methoxydopamine in rat brain. The
fluorescence from which these estimates were calculated,
was maximal at wavelengths characteristic of the
fluorophor derived from authentic acetyl-methoxydopamine^
Eluates from the acetyl-methoxydopamine position of
five other brain chromatograms contained no detectable
acetyl-methoxydopamine, i.e. were derived from samples
containing 0.05 PS methoxydopamine/g brain tissue.
The wavelengths of maximal fluorescence obtained from
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these eluates were the same as those obtained from
their paper blanks and were quite different from the
characteristics of the acetyl-methoxydopamine fluorophor.
Dopa could not, strictly speaking, be estimated
using the method in hand because there was no tissue
blank for the acetyl-dopa assay. However, fudging
from the emission spectrum of the samples, there was
no dopa in rat brain.
As already reported under each assay in the
♦Methods' section, quenching of the fluorescence from
each of the acetylated amines, by eluates from brain
chromatograms, was not significant. The sensitivities
of assay of the amines in the presence of eluates from
rat brain chromatograms were less than the correspond¬
ing sensitivities in pure solution because the paper
blanks were greater than the reagent blanks. Table /3
compares these sensitivities and lists the levels
of detection of each compound per g rat brain tissue
using the methods of analysis described on
The reasonably consistent values for brain amines
were accompanied by extremely variable and poor
recoveries of added amines through the whole procedure.
In the better recoveries each compound showed maximum
fluorescence at the same wavelengths as its aqueous
standard, with the exception of 0.4 jig dopa. Increas¬
ing the amount of dopa to 4- pg gave sufficient
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acetyl-dopa in the recovery sample to produce a
fluorescence peak at the wavelengths characteristic
of acetyl-dopa i.e. at 430/540 mp. The sensitivity
I of the acetyl-dopa assay was only 400 mpg because of
the high extract blank (p./5<> ) and because of the
quenching, by the brain extracts, of the fluor-
escence from 100 - 200 mjug acetyl-dopa added as
internal standard.
Two alternative methods of extraction of the
brains were investigated in attempts to improve the
recoveries. In the first method, the brains were
homogenised in 2 - 3 vol. O.IK hydrochloric acid and
protein precipitated by addition of sufficient 4N
perchloric acid to produce a final concentration of
0.4N perchloric acid. This homogenate was then
divided into 3 portions and known amounts of the
amines and dopa added to one of these portions, as on
p. If to determine the recovery of each substance
through the procedure, which was, from then on, the
same as that described in the 'Methods' section. In
two out of three experiments using this technique
ascorbic acid 500 ug/g brain tissue was present during
the initial C.1N hydrochloric acid homogenisation.
A troublesome frothing occurred during homogenisation
in 0.1N hydrochloric acid although never during
homogenisation in 0.4N perchloric acid.
TABLE14
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In the second method, the brains were homogenised
in 4 vol. O.IK sulphuric acid, the homogenate divided
into 4 portions and known amounts of the amines and
dopa added to 2 of these portions, to serve as
recovery estimates. On centrifugation at 6000 £ for
7 min. these homogenates yielded proteinaceous
supernatants, which cleared somewhat after the next
step, which was saturation with sodium chloride
followed by extraction with ethyl acetate to remove
| the acid metabolites (p.77 )• Addition of drops of
; 2N hydrochloric acid as on p. ?7 , previous to ethyl
acetate extraction was unnecessary since the sulphuric
acid supernatants were sufficiently acid (pH 1.5) to
suppress ionisation of the carboxylic acids. After
this extraction, the procedure was exactly the same
as that described in the 'Methods' section.
The results of three experiments using homogenisa-
tion in 0.1N hydrochloric acid and of one experiment
using homogenisation in 0.1N sulphuric acid are given
in Table . The recoveries were better using an
initial homogenisation in G.1N hydrochloric acid,
especially if ascorbic acid was added but the estimates
for brain amines varied much more widely than when
the tissue was homogenised directly in Q.4N perchloric
acid. Despite the apparent poor protein precipitation
with sulphuric acid, the amine values obtained using
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this technique were quite reasonable, though perhaps
»
rather high but the recoveries were poor.
Since it was the only one of the three tested
methods of extraction which gave consistent figures
for rat brain amines, homogenis&tion directly in
perchloric acid was considered the best extraction
method for studies on brain amines. A disturbing
feature of the experimental results was the variable
and sometimes marked, losses of the exogenous amines
and dopa added to portions of the brain homogenates,
and analysed in parallel with the brain samples.
Investigations into the causes of these losses were
continued, using the method of homogenising in perchloric
acid, in the next series of experiments (Section II).
In this series the recovery investigations were done
at the same time as studies on the levels of eatechol-
and methoxy-amines in discrete areas of brains taken
from control dogs and from dogs which had received
various drugs. It was considered Justifiable to use
the perchloric acid homogenisation method for such
studies, because using this method the estimates for
the amines in rat brain without any correction based
on the recoveries of exogenous amines, were consistent,
desjjite highly variable recoveries.
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DISCUSSION
Acetylation and estimation of the Acet.ylated Amines
If, as according to Welsh (1955)» acetylation
occurs of the phenolic hydroxyls and amino nitrogen,
adrenaline, noradrenaline, dopamine and dopa should
yield tri-acetyl derivatives and metanephrine, nor-
metanephrine and methoxydopamine di-acetyl derivatives.
Evidence in support of the tri-acetyl formula for
acetyl-dopamine was obtained using chromatography
and fluorescence reactions. If acetyl-dopamine was
chromatographed in acid solution, as happened following
the use of acid contaminated glass-ware (p. I5"4" ) or
acid contaminated paper (p,HZ. ), dopamine derivatives
were recovered from three positions on the chromatogram,
namely (i) the origin, (ii) about 1 cm behind the
acetyl-noradrenaline position and (iii) in the usual
acetyl-dopamine position (p./5"4-). The amine at (iii)
was fully acetylated tri-acetyl-dopamine, while (i) and
(ii) were presumably breakdown products resulting from
partial hydrolysis of tri-acetyl-dopamine by acid.
Since phenolic acetates are hydrolysed fairly readily
(Welsh, 1955) it seems likely that (i) was N-acetyl-
dopamine with no phenolic acetyl groups and (ii) was
N-acetyl-dopamine with one phenolic acetyl group.
Since hydrolysis of substituents on the catechol nucleus
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is a necessary preliminary to coupling with ethylene-
. '
diamine (p*&2. ), the phenolic acetyl groups cannot
contribute to the potentiation of fluorescence. This
leaves the N-acetyl group. The foregoing evidence
strongly suggests that the N-acetyl linkage resists
hydrolysis in weak acid or strong alkali and is responsi¬
ble for the potentiation of dopamine fluorescence on
coupling with ethylenediamine.
In order to quantify the chromatography, it is
essential to obtain complete acetylation of dopamine
to its tri-acetyl derivative, since incomplete acetyla¬
tion, like partial de-acetylation (p*'S4)a could give
rise to a mixture of the three acetylated derivatives
which would separate on chromatography. Brief
investigations have indicated, that a similar situation
holds for acetyl-noradrenaline aid acetyl-adrenaline.
Hence precautions, such as thorough mixing (p. 98 ) and
removal of traces of ethyl acetate (p. 97 )» were taken
to ensure complete acetylation of each amine to its di-
or tri- acetyl derivative.
The yield of fluorescence from the interaction of
acetyl-noradrenaline with ethylenediamine, unlike that
from acetyl-dopamine, was found to be less than from
the parent amine. The fluorescence yield from acetyl-
adrenaline was about the Bame as that from adrenaline,
although the fluorescence characteristics differed(Table 8).
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The observed excitation and emission wavelengths for
maximum fluorescence for the fluorophors from acetyl-
dopamine, acetyl-noradrenaline end acetyl-adrenaline were
the same as those reported by Laverty and Sharman
(1965). These workers, however, found that acetyla-
tion increased the fluorescence yield from noradrenaline
and adrenaline as well as from dopamine. Since the
fluorescence yield from adrenaline was found to be
very much higher than that reported by Laverty and
Sharman, this absence of potentiation on acetylation
did not make the sensit:; vity of acetyl-adrenaline assay
any lover than that found by Laverty and Sharman. The
sensitivity of acetyl-noradrenaline assay, however,
was lower and no explanation could be found for this
discrepancy, Jontrol experiments showed that it was
not due to the fact that Laverty and Sharman used 2H
hydrochloric acid to prepare their ethylenediamine
reagent, whereas we used 4-H ammonium chloride.
The characteristics and intensity of the ethylene-
diamine-dopa fluorophor were changed by acetylation
suggesting a different fluorophor which, since it
could not be extracted into isobutanol (p.120), resembled
the dopa fluorophor (p.Z-f) in that it retained its
hydroxy1 group. Acetyl-methoxydopamine, after acid
hydrolysis and periodate to remove the phenolic acetyl
and methyl groups respectively, gave with ethylene-
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diamine a fluorescence which was indistinguishable from
that from acetyl-dopamine. The fluorophor, like that
from acetyl-dopamine (p. /6T) was probably derived from
the condensation of ethylenediamine with K-acetyl-
dopamine.
The fluorescence obtained from acetyl-noradrenaline
and acetyl-normetanephrine following acid hydrolysis
and treatment with potassium ferricyanide had only
half the intensity of the fluorescence from equimolar
amounts of the parent amines. Since the phenolic
acetyl groups must be removed to allow formation of
the quinone necessary for fluorophor production
(p.2.z)y the most likely explanation for this reduced
fluorescence is that the H-acetyl group resists the acid
hydrolysis and that the fluorophor from N-acetyl-nor-
adrenaline has only half the fluorescence intensity of
the fluorophor from noradrenaline, A similar type
of incomplete hydrolysis could explain why acid
hydrolysed acetyl-methoxydoparaine, put through the
trihydroxyindole reaction (p. IZ8) gave a fluorescence
yield only one quarter that from methoxy-dopamine.
Adrenaline, metanephrine, acetyl-adrenaline and acetyl¬
ene tanephrine differed from the foregoing compounds in
that they gave qualitatively and quantitatively
identical fluorescences, suggesting that both 0 and N
acetyl groups were readily removable by hydrolysis and
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that the same fluorophor was involved in each case,
Chrosiatography of the Acetylated Amines
Separation of the acetylated catechol- and methoxy-
amines from one another could be achieved, if the
precautions detailed on p.h>3were taken. The relative
distribution of the acetylated amines on the developed
chromatogram was approximately the same as that reported
by Goldstein et al. (1959a), although direct comparison
is not possible because these workers developed the
chromatogram at 37 C. They make no reference to diffi¬
culties, suchas were encountered in this work, in
controlling the reproducibility of the chromatography.
On some days the acetylated amines travelled farther
than on other days, in spite of the fact that the time
and temperature of development was the same and the
time of equilibration was kept at 8 - 10 hours.
Differing degrees of vapour saturation may account for
these day-to-day variations. These variations however,
did not matter unless the distance travelled by the
amines was so much reduced as to eliminate separations
between the methoxy- and corresponding catechol-amines.
A more serious problem was that in spite of all
precautions taken (p.104-) to prevent temperature
gradients within the tank, marker amines tended to run
at slightly different speeds on chromatograms located
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at different positions in the developing tank. These
differences were only of consequence with the fastest
running amines, namely acetyl-dopamine and acetyl-
methoxydopamine and allowance could be made for these
differences by eluting from sample chromatograms
segments of paper of greater depth than indicated by the
position of the markers; this was possible because
acetyl-dopamine and acetyl-methoxydopamine were well
separated from one another and from their nearest
neighbour, acetyl-metanephrine. .Recent investigations,
which are to be followed up, indicate that chromatography
at 4-°G gives a consistent flow of the markers on
chromatograms located at different positions in the
tank.
Octopamine ad tyramine may occur in measurable
quantities in the brains of animals treated with
monoamine oxidase inhibitors (Kakimoto and Armstrong,
1962). The acetyl derivatives of these amines have
Ef values similar to those of acetyl-noradrenaline and
|acetyl-methoxydopamine, respectively (p./4.-f). Their
presence in chromatogram eluates would not interfere
with the estimation of acetyl-noradrenaline or acetyl-
aethoxydopamine since neither acetyl-octopamine nor
acetyl-tyramine yield fluorophors when subjected to the
assay procedures for acetyl-noradrenaline or acetyl-
methoxydopamine .
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Estimation of Catechol-- and lie thoxy-Amines in Rat Brain
Very few methods have been reported in the litera¬
ture whereby catechol amines and their metabolites may
be estimated in the same tissue sample. Simultaneous
estimations have on the whole been restricted to those
compounds which can be separated by paper or ion
exchange chromatography. A maximum of three amines
can be quantitatively separated usuing ion exchange
columns of reasonable length (.p. [+ ) and various 2 or
3 amine combinations such as noradrenaline and dopamine
(Baird and Lewis, 196*0, noradrenaline, normetanephrine
.
and dopamine (HIggendal, 1962) and noradrenaline,
dopamine aid methoxydopamine (Oarlsson and Waldeek,
1964) have been assayed in brain extracts. Assay of
the acid metabolites has invariably been carried out
on separate aliquots from those used for the amine
estimates. i?or example, no report of the assay of
dopamine and its ma,jor metabolite, horaov&nillic acid,
in the seme aliquot of brain tissue could be found in
the literature. Hagopian, Dorfman and Gut (1961)
described a technique, very similar to the technique
described in this thesis, whereby dopamine could be
separated from homovanillic acid but they did not
estimate the separated compounds. The amino acid
precursor, dopa, which under appropriate pH conditions
may be adsorbed, along with the catecholamines, onto a
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jstrong cationlc resin, can be estimated in the same
sample as its amine derivative out again, owing to the
llimited resolution of this method of separation (p«/4- )J
the number of amines measurable in the same aliquot
as dopa is only one (Wiegand and Perry, 1961) or two
(Glowinski, Iversen and Axelrod, 1966), An advantage
of the technique reported in this thesis is that the
amino acids, the acids and the amines are obtained
in three separate fractions. Interference of the
components of one fraction with estimation of components
of another fraction is thus eliminated. Ho attempts
were made to assay acetyl-tyrosine which would be
present in the same fraction as acetyl-dopa. Tyrosine
could thus be separated from its amine derivative,
tyramine
The only comparable technique of analysis of brain
I
tissue reported in the literature is that described by
jMatsuoka (19C4)., He devised a method for separating
noradrenaline, dopamine, normetanephrine, dihydroxy-
i
roandelic acid and dihydroxyuhenylace tic acid in rabbit
brain by adsorption of the catechols onto alumina,
followed by separation of the components of the eluted
catechol, and of the non-adsorbed non-catechol, groups
.
by ion exchange chromatography. The concentrations of
dihydroxymandelic acid and dihydroxyohenylacetic acid
in normal rabbit brain quoted by him are suspiciously
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high, possibly due to elution of a fluorescence yielding
material from the ion exchange resin, similar to the
material HSggendal (196aj) found could be washed off
Dowex 50 (p. Af- )• From this point of view, paper
chromatography is probably preferable to ion exchange
chromatography, although paper can give rise to high
Iblanks (p.12. and Sharman, 1963). Glowinski, Iversen
and Axelrod (1966) and Glowinski and Iversen (1966 j,
14 3
separated C - or H- labelled dopa, noradrenaline,
dopamine, total methoxyamines, total methoxy deaminated
metabolites and total deaminated metabolites from rat
brain, after administration of c'1- tyrosine or H- dopa,
respectively. These measurements are not affected by
drawbacks, such as elution of fluorescence yielding
material from the ion exchange resin, which are inherent
in the assay of millimicrogram amounts of unlabelled
substances. Since vanillinmandelic acid was not sepa¬
rated from homovanillic acid and normetanephrine was
not separated from methoxydopamine, it is not possible
to distinguish noradrenaline from dopamine metabolism
using this technique.
The estimates for rat brain noradrenaline varied
from 0.13 to 0.22 with a mean of 0.1? + 0.03 (n " 3)
jig/g. Each of these estimates was the average of
duplicate analyses. The standard deviation of the
difference between the duplicates was 0.04 jug/g.
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The figures for rat brain noradrenaline in the literaturfs
may be divided into 2 groups, (i) a group of eight
estimates ranging from 0,32 to 0.58 with a mean of
0.4-6 pg/g and (ii) a group of three estimates of 0.15,
0.19 and 0.22 which mean at 0.20 pg/g (Table 7 , p. 83 )•
This difference may be due to seasonal (Kontagu, 1957)
or strain (Anton and Sayre, 1964) variations in the
rats. Neither of these reasons, however, could account
for the fact that the noradrenaline estimates obtained
using the acetylation technique (Table 12 f p,ISS) were
less than the noradrenaline estimates obtained using
the phenol:hydrochloric acid technique (Table 4 » P* *7)
A possible explanation is that the ethyl acetate extractj-
ion incorporated into the former, but not the latter,
technique was responsible for loss of some of the brain
noradrenaline. Extraction of some brain noradrenaline
into ethyl acetate could be inferred from the results
in sub-section 1 (p. 84-) and was confirmed by further
experiments using discrete areas of dog brain (p.JtZi).
In eight of the ten samples of rat brain analysed
the amount of normetanephrine was below the limit of
detection by the method, which was 0.05 pg/g» The
other two samjjles were estimated to contain 0.05 and
0.04 pg/g. In essential agreement with these findings
are those of Carlsson and Lindquist (1962) who quote
a concentration of 0.03 pg normetanephrine/g rat brain.
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In none of the rat brain samples was the adrena-
line concentration above the limit of detection, which
was 0.02 pg/g. This is less than the reported values,
which range from 0.04 to 0,07 with a mean of 0.05 PS/g
with the exception of one very high estimate of 0.21 jig/
(Table 7 , p. 83 ). It is possible that these figures
are over-estimates, since most of them were obtained
by differential estimation of small amounts of nor¬
adrenaline (p. 2- ). $o raetanephrine has been found
in rat brain, either in these experiments or in the
literature.
The estimates for rat brain dopamine varied from
0.55 to 0.76 with a mean of 0.70 + 0.08 pg (n =» 5).
This agrees closely with the reported figures, which
average at 0.65 Ug/g (Table 7 * p. 83 ). Each of the
present estimates was the mean of duplicate estimates.
The standard deviation of the difference between the
duplicates was 0.1 pg/g.
Estimates for methoxydopamine of 0.05» 0.05 and
0.08 yig/g were obtained in three out of five experiments
No figures for rat brain methoxydopamine with which to
compare these estimates could be found in the literature
The consistency of the estimates of the levels
of the catechol- and methoxy-amines In rat brain
demonstrates that the method is reproducible and that
the poor rid variable recoveries of the amines and
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and dopa added to brain extracts do not reflect the
recoveries of the endogenous amines. The losses
of exogenous amines appeared to be occurring at some
point in the extraction procedure since (i) the amines
and dopa could be quantitatively recovered in pure
solution through the acetylation and chromatographic
procedures (p. J S3 ) and (ii) the presence of a tissue
extract did not interfere with quantitative chromato¬
graphy of acetyl-dopamine (p. further discussion
of these variable recoveries is continued in Section
II.
This technique is unique in that the catechol-
aminos and their metabolites are separated and estimated
in the same brain sample. It is less wasteful of
time and experimental animals , than techniques using
less rigorous separation methods in which pooling of
tissues from several animals is required in order to
obtain measurable quantities of the substance being
estimated, in the aliquots taken for assay of each
substance or group of substances. Since the amines
are separated from one another and from their amino
acid precursors and acid metabolites prior to their
estimation, interference of any of these compounds
in the assay of one amine, is prevented.
This separation method would appear to have
particular application to studies of catecholamine
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metabolism using radioactively labelled precursors,
since it is essential to have complete separation of
the amines and their metabolites before they can be
measured radioactively#
This technique has been applied to a study of the
action of chlorpromazine on catecholamine metabolism
in discrete areas of dog brain (Section II) and to
studies on the interactions of the 5-hydroxyindole and
catecholamine pathways in brain (Moir, 196?)»
SECTION II
Adrenaline, noradrenaline, Dopamine, Metanephrine,
Ilethoxydopamine, Homovanillic Acid and
Dihydroxyphenylacetic Acid in discrete Areas
of Dos Brain and the effect of




The presence of noradrenaline and adrenaline in
brain was first shown by von Buler (194-7). Since
noradrenaline had, at that time, recently been demonstr¬
ated in extracts of peripheral sympathetic nerves
(von Euler, 194-7 and 194-9) the noradrenaline found
in brain was assumed to be related to the sympathetic
vasomotor fibres. Vogt (1994-) showed that this was
not so and that areas of dog brain associated with the
central representation of the sympathetic nervous
system viz. the hypothalamus, midbrain, medial thalamic
nuclei and floor of the fourth ventricle, contained
five to ten times more noradrenaline than other areas.
The conclusion drawn from these results, namely that
noradrenaline may function as a neurotransmitter in
the central nervous system has received support from
recent microscopic and histochemical studies (Hillarp,
Fuxe and DahlstrSm, 1966). flatjnert, Levi and de
Lorenzo (1964-) isolated, by gradient density centri-
fugation of rat brain homogenates, a fraction containing
'nerve-ending particles' which liberated, on ultra¬
sonic rupture, vesicles containing 23% of the total
brain noradrenaline. These vesicles were similar
morphologically to vesicles seen at synaptic functions
in rat brain cortex by electron microscopy (de Robertis,
de Lores Arnaiz and de Iraldi, 1962). Thus, although
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the ultimate criterion for a neurotransmitter, that
it should be liberated from the nerve ending by stimu¬
lation of the nerve axon, has not as yet been satisfied
for noradrenaline in the brain, noradrenaline would
appear to be morphologically disposed in the brain for
such a liberation to be possible.
Synthesis of noradrenaline in the central
nervous system most probably occurs along the same
pathway as in the adrenal medulla (Figure / , p. 3 )•
The ability of the brain to synthesise dopamine and nor¬
adrenaline jji vivo has been demonstrated by the isola¬
tion of C'4-dopamine and C14-noradrenaline in guinea
pig brain after intraperitoneal infection of C14-
tyrosine (Udenfriend and Zaltzman-Hirenberg, 1963)
and by the isolation of H3 -dopamine and H3-noradrenaline
in rat brain after intra-ventricular administration of
H3-dopa (Glowinski and Iversen, 1966). Both tyrosine
and dopa pass readily from the bloodstream into the
brain (Chirigos, Greengard and Udenfriend, I960;
Rosell, Sedvall and Ullberg, 1963). The following
enzymes, necessary for the synthesis of noradrenaline
from tyrosine, have been demonstrated in brain tissue:
tyrosine hydroxylase, which forms dopa from tyrosine
(Nagatsu, Levitt and Udenfriend, 19&U)} dopa decarboxy¬
lase, which forms dopamine from dopa (Holtz, 1959) and
dopaiaine-p-oxidase, which forms noradrenaline from
dopamine (Udenfriend and Creveling, 1959)*
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The intermediate compounds in the synthesis of
noradrenaline from tyrosine are dopa and dopamine
(Figure I , p. 3 ). Dopa has never been detected
in normal brains (Anton and Sayre, 1964) probably
because it is very readily decarboxylated to dopamine
(Bertler and Rosengren, 1959a). In 1959 Bertler and
Rosengren showed the presence of dopamine, in concentra¬
tions similar to those of noradrenaline, in brains from
several species. They also studied the distribution
of dopamine in dog, cow, cat and sheep brain.
Contrary to what might be expected if dopamine was
present solely as a precursor of noradrenaline, the
concentrations of dopamine in the caudate nucleus and
lentiform nucleus of these four species were found to
be about fifty and twenty times, respectively* the
concentration of noradrenaline in these same areas of
brain. Other basal ganglia in other species, such
as monkey putamen (Poirier and Sourkes, 1965), human
putamen (von Bernheimer and Hornykiewicz, 1965) and
human substantia nigra (Homykiewicz, 1963) also
contain very much more dopamine than noradrenaline.
Damage to the basal ganglia caused by lesions and
disease, with the production of extra-pyramidal
dysfunction in experimental animals (Poirier and
Sourkes, 1965) and man (Ehringer and Hornykiewicz,
i960) has been shown to result in a reduction in the
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dopamine content of the bas&l ganglia. Although
dopamine-containing vesicles have not been isolated from
brain, as have noradrenaline-containing vesicles
(p. 176), dopamine has been detected from perfusates of
cat caudate nucleus following electrical stimulation of
the cortex and sub-cortex (McLennan, 1964). There is
therefore some evidence that dopamine acts as a neuro¬
transmitter in the basal ganglia. In other areas of
brain, such as the hypothalamus and midbrain, in which
the concentrations of dopamine are less than the
concentrations of noradrenaline (Bertler and Rosengren,
1959)» it is possible that dopamine functions solely as
a precursor of the latter amine.
Koradrenaline and dopamine appear to be metabolised
in the brain, as in the periphery, by nomoamine oxidase
and catechol-O-methyl-transferase. Both these enzymes
are widely distributed in brain (Bogdanski, Weissbach
and Udenfriend, 1957} Axelrod, Albers and Cleraente,
1959). In a study of the effect of various drugs on
the uptake and metabolism of H -noradrenaline introduced
into the lateral ventricle of the x'at, Glowinski and
Axelrod (1965) concluded that in the brain, as in the
periphery (Kopin, Hertting and Gordon, 1962), monoamine
oxidase is primarily responsible for the metabolism of
amines released intraneuronally and catechol-O-methyl-
transferase for the metabolism of amines released extra-
neuronally. Glowinski and Axelrod (1965) and Glowinski,
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Kopin and Axelrod (1965) also concluded that a major
5
part of the H -noradrenaline injected into the lateral
ventricle of the rat was taken up by the noradrenaline
storage sites in the neurons. A similar mechanism
for the removal of part of intravenously administered
adrenaline and noradrenaline by the peripheral tissues
of the mouse was previously demonstrated by Iversen and
Whitby (1962) and Whitby, Axelrod and Weil-ftalherbe
(1961).
The O-methylated metabolites of noradrenaline
and dopamine, normetanephrine and methoxydopamine, have
been demonstrated in brain tissue (Garlsson and
Lindquist, 1962; Garlsson and Waldeck, 1964). Di-
hydroxyphenylacetic acid and homovanillic acid, the
acid metabolites formed from dopamine, have also been
found to be present in brain (Rosengren, I960;
Sharman, 1963). Dihydroxymandelic acid and vanillin-
mandelic acid, the theoretical acid metabolites from
noradrenaline, have not been detected. This is
probably because the methods of estimation are not
sufficiently sensitive. It appears probable that the
aldehydes formed by the action of monoamine oxidase
on noradrenaline and normetanephrine are, in the main,
reduced to the corresponding alcohols rather than
oxidised to the acids. For example, Rutledge and
Jcnason (1967) found that on incubation with iP-
x
noradrenaline and H -dopamine, cortical slices from
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the rabbit formed aihydroxyphenylglycol and 3:methoxy»
^rhydroxyphenylglycol from noradrenaline and dihydroxy-
phenylacetic acid and homovanillic acid from dopamine.
A method of studying the effect of a drug on
brain catecholamines is to estimate the catecholamines,
their precursors and metabolites, in brain, before and
after administration of the drug. By comparing the
estimates obtained from the 'control' and 'treated'
animals, it should be possible to deduce whether the
drug affects amine storage, synthesis or metabolism
(Juorio and Vogt, 1965; Qlowinski and Baldessarini,
1966; Laverty and Sharmanp 1965^. in this section
of the thesis, an investigation of this nature was
carried out into the action of chlorpromazine on
catecholamine metabolism in dog brain, using the
technique described in the preceding section (I).
The effect of chlorpromazine on the levels of
homovanillic acid and dihydroxyphenylacetic acid in
the lateral ventricular C.S.P. of the dog was shown,
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in this department (Guldberg, 1967, p. 99), to be
dependent on the dose, the duration or time between
administration of drug and sampling of the G,S,F, and
to some extent, the individual animal. In most dogs,
5 mg/kg intravenous chlorpromazine produced increases
in the concentrations of homovanillic acid and di¬
hydroxyphenylacetic acid which were maximal at 4- and
2 hr., respectively, after administration of the drug.
Since the caudate nucleus froms a large part of the
wall of the lateral ventricle and since high concentra¬
tions of homovanillic acid and dihydroxyphenylacetie
acid have been found in this area in rabbits (Anden,
Roos and Werdinius, 1964-), it seemed probable that
the increase in the concentrations of homovanillic acid
and dihydroxyphenylacetic acid in the lateral ventri¬
cular C.S.F, was derived from an increase in the
concentrations of these acids in the caudate nucleus.
In order to test this hypothesis and to investigate
the mechanism of this increase, the concentrations of
dopamine and its acid and amine metabolites in the
caudate nucleus of toe dog 2 hr. after administration
of chlorpromazine were determined. If the rise in
dihydroxyphenylacetic acid in the ventricular C.S.P.
following chlorpromazine was due to the metabolism by
monoamine oxidase, of dopamine released from stores
in the caudate nucleus, the time of maximal action
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of chlorpromazine on the stores might be expected to
be about the same as the time for the concentration of
dihydroxyphenylacetic acid to reach its peak, in the
C.S.F. - i.e. two hr.• In the experiments the globus
pallidus was analysed in addition to the caudate
nucleus, in order to determine if chlorpromazine
affected similarly the dopamine metabolism in the two
different basal ganglia. The effect of chlorpromazine
on catecholamine metabolism was also investigated in
those areas of brain known to contain relatively high
concentrations of noradrenaline namely the hypothalamus,
midbrain and thalamus. Cortex was included as being
representative of those parts of the brain containing
low concentrations of catecholamines.
Similar experiments were also performed on dogs
killed 2 hr. after a three-fold larger dose of chlor¬
promazine, namely 15 rag/kg given intravenously. 1'his
dose was found (Guldberg, 196?* P» 108) to produce
very little effect on the levels of the acid metabolites
of dopamine in the C.S.J?, and it was of interest to
determine if it had an equally small effect on the
levels of the acids and of the amines in the brain
tissue. In this series of experiments, the hindbrain
was also investigated because chlorpromazine has been
postulated to act on the brain stem reticular formation
(Bradley and Key, 1959). Por technical reasons, the
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hindbrain was not included in the series of analyses
in the experiments with the lower dose of chlorpromazind•
185
METHODS
Dissection and Extraction of Brain Tissues
Male and female beagle dogs of about 10 kg body
weight and aged 1-2 years, with chronically implanted
guide-tubes to allow sampling of lateral ventricular
cerebrospinal fluid (C.S.F.) (Guldberg, 1967$ p. 57),
were used. For the period of the experiment the dogs
were Kept in a room with a thermostatically controlled
environmental temperature of 21°C, the rectal temperature
being measured from time to time with a clinical thermo¬
meter. The dogs were anaesthetised with intravenous
thiopentone sodium B.P. (Fentothal, Abbott Labs.). The
plane of anaesthesia, as Judged essentially by clinical
signs, was kept as uniform as possible from dog to dog.
Chlorpromazine (Largactil InJ. B.P., May and Baker)
was administered intravenously 5-10 min. after induct¬
ion of anaesthesia, to 4 dogs in a dose of 5 mg/kg and
to 4 dogs in a dose of 15 mg/kg, taking 5 min. to
inject the requisite amount. Eight dogs, for use as
controls, did not receive chlorpromasine. Experiments
on control and treated dogs were interspersed to mini¬
mise the effect of any technical differences between
experiments, on the comparisons of estimates obtained
for control and treated animals. The amount of anaes¬
thetic required to maintain anaesthesia in untreated
clogs was much more than that required to maintain
15„
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anaesthesia in the chlorpromazine-treated dogs. A
0.5 ral sample of lateral ventricular C.S,F, was with-
drawn just after induction of anaesthesia and before the
injection, if any, of chlorpromazine, as described by
Guldberg (1967, p. 57). Two further 0.5 ml samples
of lateral ventricular C.S.J?. were withdrawn at 1 hour
and 2 hours respectively, after induction of anaesthesia.
The animal was then killed, i.e. after 2 hours anaesthesl
by exsanguination from a femoral vein.
The top of the skull was cut out, using an
electric saw, to enable removal of the whole brain,
which was then halved sagittally. The following
areas, delineated as in Table IS , were dissected find
immediately wrapped in aluminium foil and frozen in
solid carbon dioxide (p. ): caudate nucleus, globus
pallidus, hypothalamus, midbrain, cortex, thalamus
and, in experiments on the effect of 15 rag/kg chlor¬
promazine, hindbrain. The length of time between
killing the animal and freezing these areas varied
from 20 - 60 rain.. The mean weight and standard
deviation of each area are given in Table IS . The
weights of the globus pallidus are meaned in two
groups, each consisting of 4 untreated dogs and 4 dogs
treated with 5 mg/kg or 15 mg/kg chlorpromazine.
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This was necessary because there was a significant
difference in the weights of this area between the
two groups of experiments, the dissections in the two
groups having been carried out by different workers.
There was no significant between-group difference in
the weights of the other areas, suggesting that the
delineations of the other brain areas, by the two
dissectors were the same.
The whole of each area removed was homogenised
in perchloric acid and centrifuged to give a perchloric
acid extract, as described on p. 95". If the weight
of tissue homogenised was more than 1,4 g, only a
portion of this extract, equivalent to about lg
tissue, was processed further, in order to prevent
overloading of the chromatogram with tissue extract.
Latterly, the weight of caudate nucleus was restricted
to about 0,5 g per sample because larger weights
contained such large amounts of dopamine that on
chromatography a wide acetyl-dopamine band was obtained
which obtruded into the neighbouring acetyl-metanephrine
and acetyl-methoxydopamine positions.
Two portions were taken of the caudate and
midbrain extracts after removal of protein by centri-
fugation (p.95") and a mixture of known amounts of the
amines and acids added to one portion from each of
these extracts, to determine the recoveries of the
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amines and acids through the whole procedure. 0.10 ml
of a mixture containing 0.5 ug dihydroxyphenylacetic
acid and 2 ug homovanillic acid in 0.01N hydrochloric
acid was added to portions of the caudate and midbrain
extracts. Different amounts of the amines contained
in 0.10 ml 0.01N hydrochloric acid were added to
these two extracts in order to determine if the
recovery of the amines through the procedure was
concentration dependent. Thus 0.20 ug noradrenaline,
0.10 ug or 0.20 ug adrenaline ad metanephrine, 1.00 ug
dopamine and 0.40 ug methoxydopamine were added to
the caudate sample and 1.00 ug noradrenaline, 0.40 ug
adrenaline and metanephrine and 0.20 ug dopamine and
methoxydopamine were added to the midbrain sample.
In some experiments, the amines and acids were added
to portions of the caudate and midbrain homogenates
before centrifugation to determine if the presence
of precipitated protein affected the amine and acid
recoveries.
Extraction of Acid Metabolites into Ethyl Acetate
After the foregoing volume adjustments and
preparation of recovery samples, the pH of the extract
was adjusted to 4 to precipitate perchlorate as on
p. % . The extract was then acidified to pH 1 - 2
arid shaken with ethyl acetate to remove the acid
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metabolites of the amines (p. 97 ). In order to
reduce the amount of amine which might be present in
the ethyl acetate extract as a result of mechanical
carry-over from the aqueous phase, the ethyl acetate
fraction was shaken for 5 min. with 2 ml 0.01N hydro¬
chloric acid which had been saturated with sodium
chloride, The two phases were separated by centri-
fugation at about 980 g for 5 min. and the aqueous
phase withdrawn. The fact that no adrenaline or
noradrenaline was detected in the ethyl acetate
fraction after shaking an acid solution of 200 mug
amounts of the amines with 1.5 vol. ethyl acetate
(p, 12-1 ), suggested that the amount of amine carried
over into ethyl acetate was very small compared with
the amount remaining in the aqueous phase. However,
even a very small degree of carry-over into ethyl
acetate from an extract of caudate nucleus, which
contains high concentrations of dopamine (Laverty and
Sharman, 1965)» could result in sufficient dopamine
passing from the ethyl acetate fraction into the
'tris' buffer, to interfere with the estimation of
dihydroxyphenylacetic acid. Interference could
occur because dopamine and dihydroxyphenylacetic acid
foran fluorophors with ethylenediamine which have the
same wavelength characteristics and the concentration
of dopamine in the caudate nucleus is considerably in
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excess of dihydroxyphenylacetic acid (Sherman, Poirier,
Murphy and Sourkes, 1967)# The ethyl acetate
extracts obtained from samples of dog brain were
therefore washed with acid, as described.
Since the percentage carry-over of adrenaline
and noradrenaline had been found to be low (p./2V),
the acid washes were discarded in the first group of
experiments, consisting of 4 control dogs and 4 dogs
which had received 5 mg/hg chlorpromasine• After
it had been found that a significant amount of
noradrenaline was removed into ethyl acetate from
acid extracts of hypothalamus (p. the acid wash
was added to the aqueous amine extract in the second
group of experiments of 4 control dogs and 4 dogs
treated with 15 mg/kg chlorpromazine. The acid
metabolites of the amines were back-extracted from
the ethyl acetate fraction into alkaline "tris' buffer
(p# 77 )• Separate portions of this buffer were used
for the estimation of hoiaovanillic acid and dihydroxy-
phenylacetic acid (Guldberg, 1967» P« 39)#
Estimation of the Amines
The amines were assayed as their acetylated
derivatives (p./0#-//7)» with the exception of normeta-
nephrine which could not be included because at the
time of these experiments, its method of assay had
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failed. Investigations into the reason for this
failure are riven on p. 132 . In order to limit the
number of assays and because the method of assay of
dopa described on p.n9 was not very sensitive, no
attempts were made to estimate dopa in dog brain.
A more sensitive method of dopa estimation was
subsequently developed (Appendix),
Estimation of Acetyl-methoxydopamine in Eluates
from Chromatograms of Extracts containing larree
Amounts of Acetyl-dopamine
Certain precautions, unnecessary when eluting
amounts of acetyl-dopamine of the order of 0.6 ug such
as were obtained on chromatographing extracts equi¬
valent to 1 g rat hrain were required for the
quantitative elution of the much greater amounts of
acetyl-dopamine (about 2 - 3 ug) obtained on chromato¬
graphing extracts of 0.3 S caudate nucleus. Investi¬
gation of the effect of extracts of brain grey matter
on the chromatography of acetyl-dopamine (p ,IS"0 ) had
indicated that, in the presence of such extracts, the
band width of 2 - 3 ug acetyl-dopamine on the chromato-
gram could be expected to be greater than the band
width of the visualised marker. Sections of the
chroraatograms from the dog brain extracts extending
from 0.5 cm below the lower limit of the acetyl-meta-
nephrine marker, to the half-way position in the space
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between the acetyl-dopamine and acetyl-methoxydopamine
visualised markers, were therefore eluted and assayed
for acetyl-dopamine. There was usually a 2 cm
separation betv/een these two markers (IPigure /S" ,
p. AfZ ). Hot'/ever, since with 0.8 - 2 ug amounts
of acetyl-dopamine, some was found to run up to 3 cm
beyond the farthest limit of the acetyl-dopamine
marker (p.A/-6), a significant amount of acetyl-
dopamine could be expected in the acetyl-methoxydopamirm
eluates from those chromatograins carrying extracts
derived from brain areas, such as caudate nucleus and
globus pallidus, which contain these high levels of
dopamine. The acety1-methoxydopamine eluates were
therefore assayed for acetyl-methcxydopamine and
acetyl-dopamine as follows:
A 1.00 ml portion of the eluate was put through
the acetyl-methoxydopamine assay technique (p. II0 ),
which assays both acetyl-methoxydopamine and acetyl-
dopamine (p.12.9 ). Standard amounts of acetyl-
dopamine (100 - 400 mug) were processed through the
acetyl-methoxydopamine assay in order to obtain a meas¬
ure, which varied slightly from run to rim (p./3d),
of the relative fluorescence intensities of these two
substances. A second eluate portion, 0.80 ml, v/as
assayed for acetyl-dopamine alone (p, ), by the
method given on p. \68 • With this information it
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was possible to calculate the contribution made by
acetyl-dopamine to the fluorescence reading obtained
by the acetyl-methoxydopamine assay, and hence, to
calculate the fluorescence due to acetyl-methoxydoparain3.
Investigations into the Transfer of Acetylated Amines
from round-bottomed .Flasks to Paper Chromatograms
Incomplete transfer of amines, from the round-
bottomed flask in which the dichloromethane was
evaporated, to the paper chromatogram (p. 99 ) was
anticipated as a possible source of amine loss. This
possibility was examined as follows. After applica¬
tion of the flask contents to the chromatogram, 3 ml
water were added to the flask and shaken vigorously
to effect solution of any acetylated amines adhering
to the flask wall. A 2.0 ml portion was treated with
athylenediamine/ammonium chloride as on p. 108 and the
relative fluorescence read at the wavelengths of
maximal fluorescence of acetyl-noradrenaline and
acetyl-dopamine (430/500 mp and 430/520 mp, respectively).
A fluorescence with the wavelength characteristics
of acetyl-noradrenaline, if the sample was derived
from an area containing predominantly noradrenaline
and with the wavelength characteristics of acetyl-
dopamine, if the sample was derived from an area
containing predominantly dopamine and equivalent to
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about 15% of the amount of amine recovered from the
chromatogram, was obtained from round-bottomed flasks
used in three preliminary experiments, in which the
wash-down technique with dichloromethane (p. 99 )
was omitted and the methanol was introduced into the
flask without being allowed to flow down the flask
wall.
Following these results, wash-down of the flask
wall with dichloromethane (p. 99 ) and solution in
methanol, of the residue obtained by evaporation of
the dichloromethane extract, using the precautions
given on p. 99 » were incorporated into the routine
experimental procedure. The efficiency of these
techniques in facilitating transfer of the amines
to the paper chromatogram was checked by testing the
round-bottomed flasks used in four experiments,
selected at random, for the presence of the amines
). The fluorescence readings obtained from
flasks which had contained extracts of globus pallidus,
midbrain, hypothalamus, thalamus and hindbrain were
found to be the same as the corresponding readings
from flasks which had contained extracts of cortex
and about 1.5 times the fluorescence readings of the
reagent blanks. It can be concluded that no amines
were present in these flasks and that transfer of the
amines in extracts of globus pallidus, midbrain,
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hypothalamus, thalamus and hindbrain, to the paper
chromatogram, was quantitative. A small but signifi¬
cant amount of fluorescence, showing maximal intensity
at wavelengths characteristic of the acetyl-dopamine
fluorophor and equivalent to 80 - 160 mug acetyl-
dopamine or + 4% (S.D.) of the acetyl-dopamine
recovered from the chromatogram, was found in flasks
which had contained extracts of caudate nucleus or
extracts of caudate nucleus to which dopamine had been
added (p. 19? ). Since this was a low and reasonably
constant percentage loss, it was ignored when calculat¬
ing the acetyl-dopamine concentration of tissue
samples.
Detection of partially Acet.ylated Amines
at the Origins of ChroHistograms of Extracts of Dog
Brain
In order to check for deposition at the origin of
a chromatogram, of any partially acetylated catechol¬
amines (|>*152) a band extending from 1 cm behind,
to 2 cm in front of, the line of application, was cut
from each chromatogram, eluted in 3 ml water and a
2.0 ml portion treated with ethylenediamine/ammonlum
chloride as on p.^6 .
The fluorescence produced from the origin
eluates from chromatograms of extracts of Gortex,
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thalamus, hindbrain, midbrain and hypothalamus did
not differ significantly from that produced from the
paper blank, implying that the acetylation and
chromatography procedures had not resulted in the
formation of detectable amounts of partially acetylated
catecholamines in these extracts.
A fluorescence showing maximal intensity at the
wavelengths characteristic of maximal fluorescence
of acetyl-dopamine (i.e. 4-3G/520 rap) and equivalent
to 2% + 2% (S.D.) of the acetyl-dopamine recovered
from the acetyl-dopamine position, was produced from
the origin eluates of chromatograms of 56 extracts
containing large amounts (i.e. more than 750 mjug)
of acetyl-dopamine. These extracts coraprised extracts
of caudate nucleus, caudate nucleus to which 1 pg
dopamine had been added (p.139 ) and globus pallidus.
The most probable reason for the presence of this
fairly uniform percentage of acetyl-dopamine at the
origin would appear to be that the acetylation procedure
gave rise to a small, but constant proportion of
incompletely acetyl&ted dopamine, probably H-acetyl-
dopamine (p./£^f- ). This incompletely acetylated
dopamine, since it accounted for only 2% + 2% (S.D.)
of the total acetyl-dopamine, was ignored when
calculating the acetyl-dopamine content of the
tissue extracts. Laverty and Sharman (1965) found
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0«5i& of the total acetyl-dopamine in an extract could
be recovered from the acetyl-noradrenaline position.
Since our chromatograms were developed for a longer
time than those of Laverty and Sherman, we obtained
complete separation of this incompletely acetylated
dopamine from acetyl-noradrenaline, on the few
occasions, always when gross de-acetylatlon was known
to have occurred (p./53 ), on which it was detected
on the chromatogram.
Presence of Aocfr.y3 --dopamine and -noradrenaline,
in the Acid Washes of Ethyl Acetate .Extracts of
Perchloric Acid Extracts of Caudate Nucleus and"
Hypo thaiaraus respectively
The estimates for noradrenaline in hypothalamus
and midbrain obtained in the first group of control
dogs were, like those obtained for noradrenaline in
rat brain using the same technique, about half the
corresponding estimates quoted in the literature
(Table 16 , p,ZOf , Table-2-2. , pEstimates
for noradrenaline in rat brain agreeing with those
reported in the literature were obtained in experiments
in which the acid extract of brain was not extracted
with ethyl acetate (p. ). These findings suggested
that, in the presence of an extract of brain tissue,
noradrenaline may be removed from an acid,salt-saturated.
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solution by ethyl acetate.
The ethyl acetate fraction was shaken for 4 min.
with 2 ml Q.G1H hydrochloric acid saturated with
sodium chloride and after centrifugation to separate
the layers, the aqueous phase was removed by pipette
and treated with ethylenediamine/ ammonium chloride
as on p. I°%,
A material fluorescing maximally at 430/920 mp
for the caudate nucleus acid wash and at 430/500 mp
for the hypothalamus and cortex acid washes was
present in these solutions. Since the acid and
alcohol metabolic derivatives of the catechol- and
methoxy-amines are unlikely to be back-extracted from
ethyl acetate into 0.1 vol. acid, dopamine and
noradrenaline are the only catechols which might be
present in the acid wash and which, on coupling with
ethylenediamine, would give rise to fluorophors showing
maximal fluorescence at 430/520 mp and 430/500 mp,
respectively. Using the cortex acid wash as the
blank, the acid washes of the ethyl acetate extracts
from three samples of caudate nucleus were found to
contain dopamine equivalent to 3%, 3% and 1% of the
dopamine present in these tissues. The acid washes
from three samples of hypothalamus were found to
contain noradrenaline equivalent to 32%, 30% and 25%
of the noradrenaline present in the respective
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hypothalami. The cortex acid wash was used as the
blank since in the cortical tissue extract the amount
of noradrenaline was found to be about & of that in
the hypothalamus tissue extract and the amount of
dopamine about ^"/20 of that in the caudate nucleus
tissue extract.
These results indicated that a significant
proportion of the tissue noradrenaline, but not
dopamine, was removed into ethyl acetate and could be
recovered from this ethyl acetate, by back-extraction
into acid solution. In the second group of dog
experiments, the acid wash from the ethyl acetate
fraction -was therefore added to the aqueous amine
extracts (p. I'll ) before the acetylation stage of the
procedure.
MBg 16.. P. 201
She concentrations of eateeftoiasixiee end their metabolites in discrete areas of the fersina of control dogs and of dogs treated with
chloi-proisaalne (CPS) 5 mgAg intravenously 2 hr, before killing#
Concentrations* given in j*g/g tissue (iftean ± standard deviation for estimates from four experiments unless otherwise indicated by number in
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Effect of Chlorpromazine on the Levels of the
Catecholamines and Their Metabolites in discrete
Areas of Pop; Brain
Estimates of noradrenaline, adrenaline, meta-
nephrine, dopamine, methoxydopamine, homovanillic
acid and dihydroxyphenylacetic acid in the caudate
nucleus, globus pallidus, hypothalamus, midbrain,
cortex and thalamus from 4 control dogs and from 4
dogs treated with intravenous chlorpromazine (5 mg/kg)
2 iir. before sacrifice are given in Table /6 .
Estimates of the same amines and acids in these six
areas of brain and also in the hindbrain, from 4
control dogs and 4 dogs treated with intravenous
chlorpromazine (15 mg/kg) 2 hr. before sacrifice are
given in Table '7 . The two groups of controls
were necessary because after the first 4 control
dogs and 4 dogs treated with 5 mg/kg chlorpromazine,
the technique was slightly modified and the dissections
performed by a different person (p./88). The mean
procedure recovery of homovanillic acid and of dihydro-
phenylacetic acid from twelve experiments was 99$ and
107$ t respectively. ho correction for recovery of the
homovanillic acid and dihydroxyphenylacetic acid
estimates was therefore necessary (Guldberg, personal
communication). The procedure recoveries of the
amines, howeve^r, varied widely, and did not appear
TABLE18
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to reflect the recoveries of the corresponding endo¬
genous amines (p. The amine estimates were
therefore not corrected for procedure recoveries.
The estimates for noradrenaline, dopamine,
methoxydopamine, homovanillic acid and dihydrox^phenyl-
acetic acid in each area from the brains of dogs which
had been treated with chlorpromazine were compared
with the corresponding estimates from the brains of
control dogs in the same group of experiments, using
the Student's 't-test' (.Table IS ). The concentra¬
tions of methoxydopamine in areas other than the
caudate nucleus and the globus pallidus were at or
below the limit of detection of the method. The
estimate of 0.38 pg/g for methoxydopamine in the
caudate nucleus in the first control group of experi¬
ments must be regarded with suspicion because at
the time of these experiments, it was not realised that
the ratio of the fluorescence intensities derived from
equimolar amounts of acetyl-methoxydopamine and acetyl-
dopamine using the acetyl-methoxydopaxaine method of
assay, could vary from run to run (p. 130 ).
Comparisons were therefore made using the estimate
of 0.61 pg/g, obtained in the second group of control
experiments. The hypothalamus was the only area in
which adrenaline was found. Neither dose of chlor¬
promazine affected the levels of hypothalamic adrena¬
line. Metanephrine reached just detectable levels
Z06
Figure 19
Fluorescence Spectra from the •Acetyl-dopamine* Eluate from
Chromatograms of Extracts of Dog Globus Pallidus and Cortex
and their corresponding Paper Blank, as compared with the
Fluorescence Spectra from authentic Acetyl-dopamine and the
Reagent Blank,
























Fluorescence Spectra from the 'Acetyl-methoxydopamine* Eluates
from Chromatograms of an Extract of Dog Globus P&llidus and its
corresponding Paper Blank, as compared with the Fluorescence
Spectra from authentic Acetyl-oethoxydopamine and the Keagent Blank*
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in the extracts of hypothalamus from 4- dogs which had
received 5 mg/kg chlorpromaaine but the concentrations
were not significantly different from the controls.
No metanephrine was found in any other area. No
dihydroxyphenylacetic acid was detected in extracts of
globus pallidus and hindbrain from dogs treated with
15 rag/kg chlorpromazine and from control dogs in the
same group of experiments (Table 17 ).
Fluorescence Characteristics of Nluatesjfrom Chromato-
:rams of Do? Brain Extracts
The 'acetyl-dopamine' and 'acetyl-methoxydopomine'
eluates from chromatograms of tissue extracts contain¬
ing measurable concentrations of dopamine and methoxy-
dopamine produced fluorophors which had the same
wavelength characteristics as the fluorophors from
authentic dopamine and methoxydopamine (Figures 19 and
2.0 ). As little as 20 mpg acetyl-dopamine and 25 mpg
acetyl-methoxydopamine produced a fluorescence which
was maximal ct 4-30/520 mp and was distinguishable from
the fluorescence from the paper blank, which was
maximal at 4-30 - 44-0/4-85 - 4-95 nip. The fact that
the fluorescence spectrum from the 'acetyl-dopamine'
eluate from a chromatogram of an extract of cortex
was the same as the spectrum from the corresponding
paper blank (Figure 19 ) demonstrates that the extract
209
Figure 21
Fluorescence Spectra from the 'Acetyl-noradrenalitfe * Eluatee
from Chroma tograins of an Extract of Dog Hypothalamus and its
corresponding Paper Blank, as compared with the Fluorescence
Spectra from authentic Acetyl-noradrenaline and the Reagent Blank.




of cortex contained no detectable acetyl-dopamine.
The 'acetyl-noradrenaline1 and •acetyl-adrenaline'
eluates from chro Histograms of extracta containing
measurable amounts of noradrenaline and adrenaline
gave rise to fluorophors which showed maximal fluor¬
escence at wavelengths characteristic of the fluorophors
from authentic acetyl-noradrenaline (Figure -2./ ) and
acetyl-adrenaline. Unfortunately, since the fluoro¬
phors from acetyl-noradrenaline and acetyl-adrenaline
fluoresced maximally at wavelengths (430/500 mp) close
to those of maximal fluorescence of the paper blank
(430 - 440/485 - 495 mp), it was not possible to
differentiate the fluorescence due to the blank
from that due to the acetylated amine. Extracts
of hypothalamus from 4 dogs treated with 5 mg/kg
chlorpromazine were the only extracts in which meta-
nephrine was detected. Since there was only about
10 - 20 mpg acetyl-metaaephrine in the portion of the
•acetyl-metanephrine' eluate taken for assay, no
fluorescence peak was obtained at the wavelengths of
maximal fluorescence of acetyl-metanephrine except
in one sample in which there was a slight fluorescence
peak at 520 mp, although there was no indication of an
excitation peak at 420 mp. Eluates from a chromato-
grara of an extract of caudate nucleus to which known
amounts of the amines had been added (p. 188) produced
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fluorophors which showed maximal intensity at wave-
lengths characteristic of the fluorophor of the
acetylated amine they were expected to contain.
Effect of ...luates from Chromstograms of Brain Extracts
from Dors which had received OhlorprcEiazine, on the
Sensitivities of Estimation of the Acetylo.ted .-.mines
Although quenching of the fluorescence of added
acetylated amines by eluates from chromatograms of
extracts of rat brain was negligible (p, 10? t III , /17 ),
it is possible that extracts of brains from dogs pre-
treated with chlorpromaaine might contain chiorpromazine
or a metabolite of chlorpromaaine which might affect
the fluorescence from the acetylated amines. The
fluorescence intensities from 1 ^ag and 100 mpg acetyl-
dopamine added to 1 ml portions of the 'acetyl-dopamine•
eluates from chromatograms of extracts of a caudate
nucleus and a midbrain, respectively, which had
originated from a dog treated with 15 mg/kg chlorproma-
zine, were the same as those derived from aqueous
standards of acetyl-dopamine, The fluorescence from
100 mjig acetyl-noradrenaline was similarly unaffected
by the presence of a 1 ml portion of the 'acetyl-
noradrenaline' eluates from chromatograras of two
extracts of midbrain from 2 dogs treated with 15 rng/kg
chlorpromazine. The fluorescence from 100 mjig acetyl-
methoxydopamine was unaltered by the presence of a 1 ml
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£>ortion of the 'acetyl-noradrenaline* eluates from
chroraafcograms of two extracts of midbrain from 2
dogs treated with 15 mg/kg chlorpromazine. The
fluorescence from 100 mug acetyl-methoxydopamine
was unaltered by the presence of a 1 ml portion of
the 'acetyl-raethoxydopamine * eluates from chromatograms
of extracts of caudate nucleus and globus pallidus
from a dog treated with 15 rag/kg chlorpromazine.
'Thus, if chlorpromazine or any of its metabolites were
present in the extract applied to the chromatogram,
they did not interfere with the fluorophor production
or measurement of the fluorescence from, acetyl-
noradrenaline , acetyl-dopamine or acetyl-methoxydopamin^
The following observations indicated that neither
chlorpromazine nor its metabolites contributed to the
'blank* fluorescence in assays of eluates from
chromatograms of extracts from chlorpromazine treated
dogs;
(i) The relative fluorescence from 'acetyl-noradrena¬
line' eluates from chromatograms of extracts of globus
pallidus was the same as that from the corresponding
paper blank irrespective of whether the extracts
originated from control or from chlorpromazine (15 mg/
kg) treated dogs. Ghlorpromazine or its metabolites
were therefore unlikely to contribute to the fluor¬
escence from 'acetyl-noradrenaline* eluates from
rasifi19
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chromatograms of extracts of other brain areas,
(ii) -The relative fluorescence from 'acetyl-dopamine1
eluates from extracts of cortex was the same as the
relative fluorescence from the paper blank, regardless
of whether or not the animals from which the extracts
originated had been treated with chlorpromazine.
Since there was no evidence that chlorpromazine
treatment of the dog resulted in the production of
chromatogram eluates which had 'blank' fluorescences
different from controls or which produced quenching
of the fluorescence from the acetylated amines, the
assay sensitivities of the acetylated amines in the
presence of eluates from chromatograms of extracts
from chlorpromazine treated dogs can be assumed to
be the same as those from control animals (Table 19 )•
Using the values for the sensitivity of assay
of each acetylated amine in the presence of a chroraato-
f IS~7
gram eluate (Table I-? , p.£/3) and the weights of each
area processed (Table /S~, the lowest detectable
concentration of each amine in each area was calculated
(Table 19 ). The limit of detection was taken as
equal to half the sensitivity (p.3/ ). Variations
in the lowest detectable concentrations of one amine
in different areas were due to differences in the
amounts of each area processed (Table /S*, p. /<?6 ).
Two estimates are given for the globus pallidus, since
T/J3LE2O



























the weights of this tissue in experimental groups
(1) and (2) were significantly different.
Effect on the Estimates of noradrenaline in different
Areas, of combining- the Acid Wash of the Ethyl .Acetate
Fraction with the Amine Fraction
The means of estimates for noradrenaline in the
hypothalamus, midbrain, cortex and thalamus were
32 - 50$ greater in 4- control dogs (experiments in
group 2) in which the acid wash from the ethyl acetate
fraction was combined with the aqueous amine fraction
(p. 1^/ ), than in 4 control dog experiments (in group
1) in which this acid v/ash was discarded (p.|9/ ).
The estimates for noradrenaline in the hypothalamus
and thalamus obtained from the control experiments in
group 2 were not, however, significantly different,
statistically, from the corresponding estimates
obtained from the control experiments in group 1,
because of the vd.de scatter of the individual estimates
for each area in both groups of experiments (Table / 7 ),
The estimates for noradrenaline in the midbrain and
cortex were signifdcarl'tdy greater in the control
oriments in (gpottp 2 than in group 1 (p<0.1 and
p<0.05, respectively). The mean of the estimates
for dopamine in the caudate nucleus, which contained
























































































































































































































whether or not the acid wash was included, suggesting
that no significant amount of dopamine was lost into
the ethyl acetate. Further evidence of this was
provided by the fact that there was no significant
difference in the dopamine values for each of the
other areas of the brain in the one control group,
as compared with the other control group, of experi¬
ments, with the possible exception of dopamine in the
hypothalamus, which at a 10$ level of significance
was greater in those samples in which the acid wash
was included. Thus it would appear that noradrenaline,
but not dopamine, was extro.eted from an acid extract
of brain tissue into ethyl acetate and then back-
extracted from the ethyl acetate into 0,01N hydro¬
chloric acid saturated with sodium chloride (p*Jf8 )*
Recoveries of the Catechol- and Methoxy-amines
through the Procedure
As was found with rat brain homogenates (p. 81 ),
recoveries of the amines added to perchloric acid
homogenates of caudate nucleus and midbrain in 4-
experiments (: . IB 8) were low and very variable
(Table J-! ). In contrast, the estimates for the
endogenous brain amines were much more consistent.
The protein precipitate must have been responsible
for some of this variability, since the recoveries
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of amines added to the supernatant, obtained by remov¬
ing the protein precipitate from the homogenate (p.188)1
although still low, had smaller scatters than the
recoveries of amines added to the homogenate (Table-2./ ),
Ho obvious difference was obtained between the
recoveries of amines added to homogenates and super¬
natant s from the caudate nucleus and the recoveries
added to homogenates and supernatants from the raid-
brain (Table -2_/ ). These results were obtained from
the first group of dog experiments, in which the acid
wash from the ethyl acetate was not included in the
a line o:c! recti (p, lV ).
The following experiments were designed to
determine the exact point of loss of the exogenous
amines. Known amounts of the amines (100 mjog - 1 pg)
in C.G1N hydrochloric acid were added, at different
stages in the procedure, to the portion of the per¬
chloric acid extract of caudate nucleus taken for
estimation of the recoveries (p»)8# ). In these
experiments, the perchloric acid extracts were
extracted with ethyl acetate and the acid washes from
the organic phases were added to the amine-containing
aqueous phases. The stages at which the exogenous
amines were added were as follows:
(1) to the extract immediately before the acetylation
procedure (p. 90 )»
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(2) to the acid extract immediately before extraction
with ethyl acetate (?. 97 )j
(3) to the extract at pH 4 immediately before
storage in the deep-freeze to aid precipitation of
potassium perchlorate (p. 9<o )»
(4) to the frozen supernatant of the centrifuged
perchloric acid homogen&te contained in a If? ml glass
stoppered test-tube. The extract was allowed to thaw*
almost but not completely, with occasional inversion
of the tube to mix in the added amines. The pH
was adjusted to 4, as described on p. 9<o , using
potassium hydroxide solutions at 4°C and intermittently
returning the test-tube to the solid carbon dioxide
to ensure its contents were maintained at about G°G,
as gauged by the continuous presence of a little ice
in the test-tube. The test-tube was then immediately
placed in the deep-freeze and processed as on p. *)<£>•
The results of these experiments prove that
variable loss of added amines occurred either* on
their addition to the perchloric acid extract or
during adjustment of the pH of this extract from 0.8
to 4, if these steps were performed at room temperature*
Amine loss could be prevented by adding the amines to
-
the frozen extract and carrying out the subsequent pH
adjustment at about 00.
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Homovanillic acid and dihydroxyphenylacetic acid
added to 0.4N perchloric acid extracts of caudate
nucleus and midbrain (p. 166) at room temperature,
were quantitatively recovered without chilling the




Extraction of Noradrenaline into Ethyl Acetate
from Acid Extracts of Brain Tissue
Addition of the acid wash of the ethyl acetate
extract to the aqueous amine extract (p. 11/ ) had the
effect of increasing the noradrenaline estimates in each
area of brain by about one third (p.2/6). This
proportionate increase is of the same order as the
proportion of noradrenaline found in the acid washes
of the ethyl acetate extracts of three hypothalamic
acid extracts (p. '?<? ) and is too great to be due solely
to mechanical carry-over of the amine from the aqueous,
into the ethyl acetate and then back into the aqueous,
phase. The amounts of dopamine, equivalent to about
of the dopamine present in the aqueous phase, which
were found in the acid washes from ethyl acetate extract^
of three acid extracts of caudate nucleus, were low
enough to be explained solely on the basis of a mechanical
carry-over. Under the extraction conditions employed
(p. ), noradrenaline, but not dopamine, would appear
to be transported into ethyl acetate, presumably attached
to some ethyl acetate-soluble substance, since noradren¬
aline is itself not extracted into ethyl acetate (p./2/ ).
Extraction of noradrenaline from acid solution
into ethereal solutions of 'tissue lipids', lecithin and
I
223
cephalin wan reported by von Euler (1946, 1947). The
noradrenaline could then be back-extracted from the ether
lipid into 5% sodium sulphate solution (von Euler, 1946,
1947). A similar mechanism may be responsible for
the removal into ethyl acetate of some of the noradrena¬
line in an acid (pH about 2) extract of dog brain and
for the subsequent back-extraction of this noradrenaline
from the ethyl acetate into a salt-saturated solution
of G.01H hydrochloric acid Lecithin and
cephalin are both present in dog brain (Biochemist's
Handbook, 1961, p. 644). No reports, however, could
be found in the literature regarding the ability of
ethyl acetate solutions of these or any other tissue
lipids, to remove noradrenaline from acid aqueous
extracts (p. // ). It is difficult to reconcile the
relatively high degree of extraction of noradrenaline
(equivalent to about 30$ of the total noradrenaline in
the aqueous phase) from brain extracts at pH 2 into
ethyl acetate, with the estimate of 5% quoted by
Norlander (1950) for the extraction of noradrenaline
into ethereal solutions containing 5$ lecithin from an
aqueous solution at pH 4. Reconciliation is especially
difficult since von Euler (1947) and Norlander (1950)
found the percentage of noradrenaline extracted was
reduced if the pH of the aqueous phase was less than 4.
These 'workers, hoivever, only investigated the degree of
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extraction of noradrenaline into lecithin-ether, from
solutions containing milligram amounts of noradrenaline;
it is possible that proportionately more noradrenaline
is extracted from solutions containing microgram or
milli-microgram amounts of noradrenaline. It is also
possible that the postulated noradrenaline-lipid complex
formed from brain tissue is stable at a lov/er pH than
the noradrenaline-lecithin complex and is more readily-
extracted into ethyl acetate than is the noradrenaline-
lecithin complex into ether.
Unfortunately, a second extraction with salt
saturated 0.Q1N hydrochloric acid of the ethyl acetate
fraction was never carried out. It is therefore not
possible to be certain that all the noradrenaline removed
into the ethyl acetate was recovered into a single
back-wash. The noradrenaline estimates obtained by
incorporating only a single back-wash into the amine
fraction may therefore be under-estimates.
A different person was responsible for the brain
dissections in the experiments of group 1 from that in
the experiments of group 2. It is possible that this
difference could have contributed to the increased levels
of noradrenaline found in the experiments of group 2,
in which tbe acid wash from the ethyl acetate fraction
was combined with the aqueous, amine fraction. There
is, unfortunately, no way of testing for the influence
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of dissectors on the amine estimates within the
experimental design used. It is, however, highly
unlikely that each area of brain dissected by one opera¬
tor would be so exactly different from the same area
dissected by the other operator as to cause a consistent
30% - 50% increase in the noradrenaline concentration
of each brain area.
Recovery of the Catechol- and flethoxy-amines through the
Procedure
No satisfactory explanation could be found for the
observation that catechol- and methoxy-amines added to
0.4N perchloric acid extracts of brain tissue were,
unlike the corresponding endogenous amines, subject
to extremely variable degrees of loss or destruction
during the extraction procedure. The results of the
control experiments indicated that the losses
might occur at two stages in the extraction procedure
as a result of (!) adsorption onto the protein precipi¬
tate which was subsequently discarded and (ii) destruct¬
ion in the acid supernatant or during the subsequent
adjustment of its pH from 0.8 to 4- (Table-2/, p.-2-'7).
Since 200 mug amounts of adrenaline and noradrenaline
were quantitatively recovered from pure solutions of
0.1N perchloric acid (p. it is unlikely that loss
of amines added to the 0.4-N perchloric acid brain extract
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was due to the perchloric acid itself, as suggested by
the work of Gunne (1963, p. 10 ), or to the subsequent
pH adjustment.
Anton and Sayre obtained 80% recovery of 0.2 ug
to 1.0 ug noradrenaline added to perchloric acid
homogenates of rat liver (1962) and 80% recovery of
0.2 ug to 2,0 ug dopamine added to 0.4-N perchloric acid
homogenates of dog brain (19&4), Gunne (1963) recover¬
ed 93%, 76% and 80% of 1,0 ug amounts of noradrenaline,
adrenaline and dopamine, respectively, added to
perchloric acid extracts of brain. Both Anton and
Sayre and Gunne stated that the temperature during
homogenisation was kept at 0°-4°Q but they did not
specify if this temperature was maintained during
addition of the amines and adjustment of the pH.
Without this knowledge, their results cannot be compared
with those given on p,Z20, in which it was discovered
that loss of amines added to the 0,4-N perchloric acid
extract was prevented if the extract was maintained at
about 0°C during addition of the amines and during the
subsequent pH adjustment. Since the replicate estimates
for rat brain amines (p. 174-) and for dog brain amines
(p. *0) were reasonably consistent despite varying
recoveries of exogenous amines, it would appear that
the endogenous amines must be protected in some way
from those influences causing the losses of the exogenous
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amines. This protection might be afforded by an
attachment to a protein or lipid (Barger, 1930; von
Euler, 194-7)* the combination being stable in, and not
precipitated by, the perchloric acid. It is difficult
to envisage the nature of such a complex since perchloric
acid is an efficient protein precipitant (Heuberg,
Strauss and Lipkin, 194-4-) and the resultant extract has
a relatively low pH, a condition under which any complex
is unlikely to be stable. There is a possibility,
albeit remote, that the endogenous amines under these
extraction conditions are present in some occluded state.
It would be of interest in this connection to know the
efficacy of perchloric acid in releasing catecholamines
from storage organelles in vitro.
Distribution of Catechol and hethoxy-amines
in Dog Brain
In Table 22, are listed the estimates, made by
various other workers and by the author, of the catechol--
and methoxy-amine concentrations in discrete areas of
dog brain. The quoted values for noradrenaline in the
present series are those from the second group of
experiments since they include some noradrenaline known
to have been lost in the experiments in group 1 (p..2.2-2),
Our values for noradrenaline in the midbrain, cortex
and thalamus agree fairly closely with the estimates
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quoted in the literature (Table-2Z.). Cur estimate
for noradrenaline in hindbrain is similar to that given
by Bertler and Rosengren (1959) for noradrenaline in
the medulla oblongata, which formed the major part of
our hindbrain section (Table /S~ , p./56). Cur
estimate for noradrenaline in the hypothalamus is,
however, lower than the estimates quoted by other
workers. It may be that 1-2 year old beagles have
less noradrenaline in their hypothalami than the dogs
(breed unspecified), used by other workers. Although,
as reported by Vogt (1954)» the noradrenaline estimates
for each area were found to vary widely from dog to
dog, the pattern of distribution within one dog remained
the same•
Adrenaline was found at a concentration less than
that reported by Vogt (1954) and Malhotra and Prasad
(1962) in the hypothaiamus, but in no other area of dog
brain. The fact that adrenaline equivalent to about
14% of the noradrenaline concentration was present in
all high noradrenaline-containing areas (Vogt, 1954)
suggests that adrenaline can be formed from noradrenaline
in brain. HcGeer and McGeer (1964) isolated H -adrena-
14
line and G -adrenaline from cat brain stem after inject-
5 14
ion of H -noradrenaline and G -tyrosine, respectively,
into the brain stems of anaesthetised cats, showing
that brain tissue has the capacity to synthesise
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adrenaline. Phenylethanolamine-K-methyl-transferase,
an enzyme capable of methylating noradrenaline to
produce adrenaline has been detected in 'minute amounts'
in rabbit midbrain (Axelrod, 1962) and in cat hypo¬
thalamus and caudate nucleus (McGeer and McGeer, 1964).
No estimates for metanephrine in brain could
be found in the literature although the detection of
radioactively labelled metanephrine in rat brain after
intra-ventricular administration of radioactively
labelled adrenaline (Snyder, Glowinski and Axelrod,
19&5) suggests that brain is capable of synthesising
metanephrine from adrenaline.
As reported by Bertler and Rosengren (1959)» the
distribution of dopamine in dog brain was found to be
quite different from that of noradrenaline. Our
estimate for dopamine in the caudate nucleus (5«5 ug/g)
agrees closely with Bertler and Rosengren's estimate
of 5»9 ug/g but both are lower than that found, by
Laverty and Shannon (196$). In both the caudate
nucleus and the globus pallidus the concentration of
dopamine was five to twenty times the concentration of
noradrenaline. 'Ihis high concentration of dopamine
in
relative to noradrenaline^/the basal ganglia of the dog
has been found in other species (p.\~lQ ), and is
suggestive of a transmitter function for dopamine in the
basal ganglia.
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The estimate obtained, for methoxydopamine in dog
caudate nucleus (0.61 ps/s) is the same order as
estimates found by Carlsson and Waldeck (1964) for
methoxydopamine in the caudate nuclei of pigs and
sheep (0.83 pg/g an<i 1*2 |ig/g, respectively). About
the same proportion of methoxydopamine to dopamine was
found in the globus pallidus as in the caudate nucleus,
implying a similar rate of metabolism of dopamine by
catechol-o-methyl-transferase in these two basal ganglia]
areas of dog brain.
Effect of Chlorpromazine on the Metabolism of the Catechc 1
amines in bog Brain
Effect of Ghlorpromazine on the Metabolism of Dopamine
in the Caudate Nucleus
The effect of chlorpromazine on dopamine metabolism
will be discussed using the estimates obtained from
the caudate nucleus, because chlorpromazine produced
statistically significant changes in the concentrations
of dopamine and its metabolites in this area. Although
chlorpromazine also altered the concentrations of
dopamine and its metabolites in other areas, these
alterations were, with certain exceptions, not statisti¬
cally significant (p >0,10).
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Effect of chlorpromazine on the distribution of
dihyoroxyphenylacetic acid and liomovanillic acid
between the caudate nucleus and lateral ventricular
. The increase in the concentrations of dihydroxy-'
phenylacetic acid and homovanlllic acid in the caudate
nucleus produced by 5 nig/kg chlorpromazine was
pivoportionately the same as the increase in the concen¬
trations of these acid metabolites in the lateral
ventricular C.S.F. produced by this same dose of chlor¬
promazine (Guldberg, personal communication). This is
evidence in favour of the hypothesis (p. 182) that the
levels of dihydroxyphenylacetic acid and homovanillic
acid found in the lateral ventricular G.S.J?. reflect
those in the caudate nucleus. The ratios of the
brain.acid levels to the C.S.E. acid levels were unalter¬
ed by treatment of the dog with 5 mg/kg or 15 mg/kg
chlorpromazine, indicating that such doses of the drug
did not affect the transfer of the acid metabolites from
the caudate nucleus into the C,S,F,,
Effect of 5 nig/kF-: chloi'promazine on the metabolism
of dopamine in the caudate nucleus. Administration
of 5 mg/kg chlorpromazine increased the concentrations
of the acid metabolites of dopamine, decreased the
methoxydopamine and had no effect on the dopamine
concentration. . With the exception of the alteration
in methoxydopamine, all these actions of chlorpromazine
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had been demonstrated previously in the corpus stratum
of the rabbit (Anden, Rcos and Werdinius, 1964). The
rise in the levels of the acid metabolites cannot be
explained by a release of dopamine from its storage
sites onto monoamine oxidase, which is believed to
account for the metabolism of amines released intra-
neuronally (Glowinski and Axelrod, 1965)> because there
was no concomitant reduction in the dopamine concentra¬
tion. Two possible explanations for these effects of
chlorpromazine remain namely:
(i) stimulation of dopamine turnover;
(ii) inhibition of acid egress from the caudate nucleus.
(i) Stimulation of dopamine turnover. An increase in
dopamine synthesis could cause an increase in the levels
of dihydroxyphenylacetic acid and homovanillic acid.
A rise in the dopamine level need not necessarily result
from such an increased synthesis since the dopamine
stores may be already saturated. Since there is no
way of distinguishing 'stored' from 'free' dopamine,
it is impossible to tell if the dopamine stores under
normal conditions are saturated or not. Other possible
explanations for the unchanged dopamine levels are
that there is an inhibition of uptake into and release
of dopamine from, storage sites or that there is an
activation of mitochondrial monoamine oxidase, so that
newly synthesised dopamine is metabolised by monoamine
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oxidase instead of being stored. There is in vitro
evidence that chlorpromazine, at a concentration that
might be expected in brain following a 5 mg/kg dose
(de Jaramillo and Guth, 1963) inhibits uptake of dopa¬
mine by rabbit and bovine adrenal medullary granules
(Carlsson, HiHarp and Waldeck, 1962) and inhibits
release of adrenaline from rabbit adrenal medullary
granules (Weil-Malherbe and Posner, 1963). It is
not, however, known if dopamine exists in the brain in
membrane limited organelles (p. 1?9). The possible
activation of mitochondrial monoamine oxidase by low
concentrations of chlorpromazine was suggested by
Guldberg (1967, p. 112), but has not been examined
experimentally.
(li) Inhibition of acid egress from the caudate nucleus.
We found that 5 rag/kg chlorpromazine did not affect
the transfer of homovanillic acid or dihydroxyphenyl-
acetic acid from the brain tissue into the 0«8*V« (p.23/
It is, however, possible that chlorpromazine blocks
transport of these acids from the brain and from the
C.S.P. into the blood. Anden, Roos and verdinius
(1964) and Sharman (1967) have also obtained evidence
that chlorpromazine may have such an inhibitory action.
A method of investigating such a mode of action would
be to estimate homovanillic acid in the lateral ventri¬
cular C.S.f.and cisternal C.S.F., before and after
?7A
administration of chlorpromazine. Since homovanillic
acid has been shown to be actively removed from the
C.S.P. at some point between the lateral ventricle and
the cisterna (Guldberg, Ashcroft and Crawford, 1966),
any effect of chlorpromazine on active transport would
be reflected in an alteration of the ratio of the
concentrations of the acids in the lateral ventricular
and cisternal C*S.F,
Although, in view of the increase in the noradrena¬
line levels in other areas, a stimulation of catechol¬
amine synthesis would appear to be the more likely
explanation for the action of 5 ®g/kg chlorpromazine
leading to an increase in the acid metabolites, it is
not possible, on the present evidence, to exclude an
inhibitory action on the egress of the acid metabolites
from brain.
The marked fall in the levels of methoxydopamine
after 5 mg/kg chlorpromazine is unlikely to be due to
inhibition of catechol-O-methyl-transferase since this
inhibition would also result in a decrease in the levels
of homovanillic acid, A reduction in methoxydopamine
could be brought about by an Inhibition of extraneuronal
release of dopamine or by the facilitated conversion of
methoxydopamine to homovanillic acid. As already
stated (p.kL33 )» low doses of chlorpromazine may inhibit
uptake of dopamine into and release of dopamine from,
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its storage sites and such doses may activate mito¬
chondrial monoamine oxidase.
The mechanism of a chlorpromazine induced increase
in catecholamine synthesis is a matter for speculation.
Activation of tyrosine hydroxylase has been demonstrated
in the brains of rats following intraperitoneal admin¬
istration of 10 nig/kg chlorpromazine (Burkard, Gey and
Pletscher, 1967) but it is not known if this is a direct
or an indirect action. Garlsson and Lindquist (1963)
and anden, Hogs and Werdinius (1964-) suggested that
chlorpromazine acts as an adrenergic blocking agent in
the brain, as in the periphery (Courvoisier, Pcurnel,
Ducrot, Kolsky and Koetschet, 1953) and that block of
central adrenergic receptors resulted in an increased
release of catecholamines from the nerve endings, which
in turn stimulated catecholamine synthesis. Oarlsson
and Lindquist (1963). using mice pre-treated vd.th a
monoamine oxidase inhibitor, found that 5 rag/kg chlor-
promazine gave a rise in the concentrations of normeta-
nephrine and methoxydopamine in brain, without affecting
the levels of noradrenaline and dopamine. These
findings are in accord with the hypothesis that chlor¬
promazine increases dopamine turnover but do not necess¬
arily imply, as Garlsson and Lindquist inferred, that
chlorpromazine stimulates this turnover by blocking
adrenergic receptors. Anden et al. (1964-) deduced,
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since Garlsson and Lindquist (1963) had found that the
levels of normetanephrine but not those of methoxy-
dopamine, were increased by another ©C-adrenergic
blocking agent namely phenoxybenzamine, that chlor-
proraazine stimulated dopamine synthesis in the corpus
striatum as a consequence of blocking receptors which
"were not of the c^-type". Our results with a higher
dose of chlcrpromazine (15 mg/kg) make it unlikely
that chlorpromazine stimulates synthesis as a result of
receptor block. Presumably 15 mg/kg chlorpromazine
could be expected to give a more intense block of the
catecholamine receptors and effect an even greater
release of dopamine and stimulation of dopamine synthe¬
sis, than would be effected by 5 mg/kg. The fact
that 15 mg/kg had no effect on the concentrations of
the acid metabolites suggests that this dose of chlor¬
promazine does not increase catecholamine synthesis.
Stimulation of synthesis by 15 mg/kg chlorpromazine
to the point of exhaustion of the substrate is unlikely,
in view of the relatively high concentration in the
brain of the catecholamine precursor, tyi'osine (Tallan,
Moore and Stein, 195*0.
affect of 15 gig/kg chlorpromazine on the metabolism of
dopamine in the caudate nucleus. 15 mg/kg chlor¬
promazine brought about a reduction in the levels of
dopamine and methoxydopamine but did not alter those
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of the acid metabolites of dopamine. Laverty and
Sharman (1965) also found a reduction in the dopamine
content of cat caudate nucleus, 4- hr. after the sub¬
cutaneous administration of 10 mg/kg chlorpromazine.
Release of catecholamines from bovine (Carlsson and
Eillarp, 1-961) and rabbit (Weil-Malherbe and Posner,
1963) adrenal medullary granules in vitro has been
demonstrated with concentrations of chlorpromazine
greater than those required to inhibit catecholamine
uptake and release (p.Z?>5 These facts suggest
that 'high1 doses of chlorpromazine may release brain
dopamine from its storage sites. As a consequence
of the reduction in stored dopamine, less is available
for release upon nervous stimulation and the concentra¬
tion of methoxydopamine therefore falls. The fact
that reserpine, which decreases the levels of noradrena¬
line and dopamine in brain (Bertler, 1961) also lowers
the concentrations of normstanephrine and methoxydopamin^
in brain (Mggendal, 1969a), suggests that a reduction
in the methoxyamines may be a consequence of a reduction
in stored catecholamines.
In order to explain the unchanged levels of
dihydroxyphenylacetic acid and homovanillic acid
occurring simultaneously with release of dopamine, it
is necessary to make one or other of the following
postulates regarding the action of 15 rag/kg chlorpromaziii
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(i) facilitation of the egress of the dopamine acid
metabolites from brain;
(ii) metabolism, by a different pathway, of the
dopamine released by chlorpromazine;
(iii) decrease in dopamine synthesis*
It should be possible to investigate (i) in the same
way as was suggested to investigate the hypothesis that
5 mg/kg chlorpromazine inhibited acid egress (p.235 )•
(ii) Inhibition of aldehyde dehydrogenase by chlorproroa-
aine with the consequent formation of the alcohols,
instead of the acids, from the 3J4:dihydroxyphenylaceta-
Idehyde formed from dopamine by the action of monoamine
oxidase, may take place, (iii) A decrease in dopamine
synthesis would follow if the drug diminished uptake
of the precursor amino acid, tyrosine* La^tha and
Toth (1965) found that 50 mg/kg chlorpromazine inhibited
uptake of amino acids by mouse brain in vivo*
Effect of Chlorpromazine on the Catecholamines and their
Metabolites in Areas other than the Caudate Nucleus
Chlorpromazine (5 mg/kg) had no significant effect
on the levels of dopamine and its metabolites in the
globus pallidus. This lack of significance could be
due to the wide scatter in the estimates, which may be
a reflection of the difficulty in dissecting this area
reproducibly. However, the fact that 15 mg/kg chlor¬
promazine significantly lowered the dopamine concentration
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(p <0.10) suggest© that, at least at the high dose,
chlorpromazine affected dopamine metabolism in the
globus pallidas in the same way as it affected dopamine
metabolism in another basal ganglia, the caudate nucleus.
The noradrenaline concentrations in those areas
found to contain more noradrenaline that dopamine,
namely the hypothalamus, thalamus, midbrain and hind-
brain, were all increased by the low and also by the
high dose except in the case of the midbrain. However,
only in the thalamus were the increases significant
(p<0.01). Since no estimates were obtained for the
metabolites of noradrenaline, it was impossible to say
if these increased levels of noradrenaline were due to
a decrease in noradrenaline release or to an increase
in noradrenaline synthesis. However, the fact that
the dopamine concentrations in the hypothalamus and
thalamus were increased by 5 mg/kg chlorpromasine
suggests, as has been postulated to occur in the caudate
nucleus, that this dose of chlorpromaaine stimulates
catecholamine synthesis. Whereas in the caudate
nucleus this stimulation resulted in increases in the
metabolism of dopamine to its acid metabolites, in the
noradrenaline-containing areas the increased synthesis
of dopamine was channelled into production of more
noradrenaline in the noradrenaline storage granules
(Kirschner, 1359) and the levels of dlhydroxyphenylacetio
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acid and homovanillic acid were not significantly
altered. The fact that the noradrenaline concentration^
were increased by 15 mgAg chlorpromazine indicate^
that this dose may also Increase noradrenaline synthesis
There was no specific effect of ehlorpromazine
(15 mgAs) on the levels of the amines and their metabo¬
lites in the hindbrain which could be correlated with
the observation of Bradley and Key (1959) that chlor¬
promazine increased the threshold for arousal produced
by stimulation of the brain stem reticular formation.
The thalamus is of particular interest since, alone
among the areas which contained more noradrenaline than
dopamine, the increases in noradrenaline concentration
produced by both doses of chlor. roraazine were highly
significant (, <0.01), The concentration of dopamine
in the thalamus was also significantly increased
(p <0,G2) by 5 &g/kg chlorproraazine. This could imply
that the thalamus is very susceptible to the stimulation
of catecholamine synthesis induced by chlorpromazine.
$© information on the rate of turnover of catecholamines
in the thalamus could be found in the literature.
An increase in the noradrenaline concentration
was observed in the hypothalamus and midbrain after
treatment with both doses of chlorpromazine. Malhotra
and Prasad (1962) have also reported increases in the
noradrenaline concentrations in these areas after
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5 mg/kg ehlorprom'azine. Ihe increases observed by
them were, however, much greater than those found by
us. fhey did not investigate the effect of Vj mg/kg
but reported that 10 mg/kg produced a fall in the
noradrenaline concentrations. fhe following are
possible reasons for the discrepancies between their
results and our results:(i) they used chloroform as
an anaesthetic whereas w# used thiopentonej (ii) they
did not control the body temperature of the dogs during
treatment vdth chlorpromazine; (iii) they probably
did not us© the same breed of dogs as was used by us.
£o conclude, it would, appear that the fundamental
action of chlorpromazine in brain is to stimulate
catecholamine synthesis. Other, apparently dose
dependent, actions operate to alter the metabolic
pattern of the amines and their metabolites in the





The aim was to develop a method whereby the
catecholamines, their precursors and metabolites could
be estimated in the same brain sample. Since the
acid metabolites could be removed from a brain extract
by extraction into an organic solvent and subsequently
estimated, the main problem centred on devising a
technique which would allow the estimation of the
catecholamines, methoxyaraines and dopa present in the
brain extract after removal of the acid metabolites.
Two techniques were devised and have been discussed.
The first depended on the separation of the amines and
dopa by paper chromatography in. phenol:hydrochloric
acid prior to estimation. This method proved unsatis¬
factory and was superceded by a more satisfactory
method, in which the amines and dopa were separated
and estimated as their acetyl derivatives.
The ohcnol; ,y'cf. . -ic acid method. Hat brain was
homogenised in perchloric acid and perchloric
acid removed as its insoluble potassium salt.
The extract was chromatographed on paper, first
in an acidified saturated sodium chloride solution
to separate the catecholamine group from the indolic
substances.
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After removal of that portion of the ehromatogram
bearing the indoles, chromatography was continued
in phenol:hydrochloric acid. The three methoxy
amines were separated from one another and from the
catechol compounds. Noradrenaline was not well
separated from dopa* these substances were therefore
eluted together and estimated by a differential
fluoriroetric method. For a similar reason,
adrenaline and dopamine were eluted together and
estimated by a differential method.
Oonnlstent estimates were obtained for noradrenaline
in rat brain but the estimates for rat brain dopamine
and normetanephrine were unexpectedly high.
The method proved unsatisfactory in practice for the
following reasons:
(i) The presence of phenol in the chromatogram
eluates complicated the assays.
(ii) It was suspected that some other substance was
included in the dopamine estimates.
(iii) The assay method for dopamine was insufficiently
sensitive.
(iv) There was on occasion incomplete chromatographic
separation of norraetanephrino and adrenaline,
necessitating estimations in two separate
portions of eluate, thus decreasing the
sensitivity of the determination.
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reparation and estimation of tlie amines as their
acet.ylated derivatives* The technique outlined below
was rigorously tested in pure solution before its
application to the estimation of the amines and their
metabolites in extracts of rat brain was investigated.
The brain tissue was homogenised in perchloric
acid and the perchloric acid removed as the potassium
salt from the supernatant.
The acid metabolites of the amines were extracted
from the acidified extract into ethyl acetate,
back~extracted into "tris* buffer and aliquots
taken for the fluorimetric estimation of homovanillic
acid and dlhydroxyphenylacetic acid.
After extraction with ethyl acetate, the acid
aqueous extract was acetylated and the acetylated
derivatives of the amines extracted into dichloro-
methane.
The aqueous remaining after extraction with
dichloromethane was acidified and the acetylated
derivatives of the amino acids extracted into
ethyl acetate. The acetyl-dopa in this extract
was estimated by the ethylenediamine fluorimetric
method.
The dlchloroiaethane extract containing the acetylated
amines was chromatographed on paper in the organic
phase of toluene ; ethyl acetate : methanol : water
» 10 : 1 { 5 s 5.
The acetylated amines were eluted and assayed
fluorimetrically.
?A5
Acetyl-noradrenaline, acetyl-adrenaline and acetyl-
dopamine were estimated after condensation with
ethylenediamine. Acetyl-metanephrine and acetyl-
normetanephrine were estimated after acid hydrolysis
by the tri-hydroxyindole procedure.
A new method, based on coupling with ethylene!!amine
was developed for the estimation of acetyl-rnethoxy-
dopamine (and methoxydopamine).
The sensitivities of assay for the different
acetylated amines in pure solution ranged from
10 mpg to 4-5 m\ig.
This technique gave consistent estimates for
noradrenaline, dopamine and methoxydopamine in rat
brain. Adrenaline and normstanephrine were below the
level of detection of the method. The recoveries of
the amines added to perchloric acid extracts of brain
tissue were not satisfactory. The reasons for this
have been investigated.
The analytical method was applied to a study of
the effects of chlorproinaglne (01J) at two dose levels
5 rag/kg and 15 mgAs, intravenously, on the catechol¬
amine metabolism in various areas of the brains of
beagle dogs. Two hours after drug administration,
the following changes were observed.
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Dopaminet 5 mg/kg CPE produced no change in the levels
in the caudate nucleus, globus pallidas and
midbrain and increased the levels in the
hypothalamus (p<Q«10) and in the thalamus
(p<0.02).
15 mgAg CPE gave a reduction in the levels
in the caudate nucleus and globus pallidus
(p<0.10). The concentrations in the
hypothalamus, midbrain, thalamus and hind-
brain were unchanged.
Homovan- 5 mgAg CPZ increased the levels of both
illic acid acp^B caudate nucleus (p<0.05) and
had no effect on the acid concentrations




15 mg/Icg CPZ produced no change in the
acid concentrations in any area.
Methoxy- 5 ®gAg and 15 mgAg CPZ reduced the
dopamine; concentration in the caudate nucleus
(p <0.05) and had no significant effect
on the concentration in the globus pallidus.
Nor- The concentrations in the hypothalamus,
adrenalines midbrain, thalamus and hindbrain were
increased by 5 mgAg and 15 mgAg CPZ.
However, only in the case of the thalamus
(p<C,01) were these increases significant.
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It was concluded that the actions of chlorpromazine
on catecholamine synthesis and metabolism in the brain
of the dog are dose dependent.
In the lower dose of 5 mg/kg» chlorpromazine
was postulated to have the following actions;-
(1) to increase catecholamine synthesis;
(2) to inhibit the egress of the acid metabolites of
dopamine from the brain tissue;
(3) to activate mitochondrial monoamine oxidase or
to inhibit extraneuronal release of dopamine.
At the higher dose level of 15 mg/kg, chlorproma¬
zine was postulated to act as follows:
(1) to release dopamine from its storage sites;
(2) to alter the metabolic pathway of dopamine or
to potentiate egress of the acid metabolites
of dopamine from the brain tissue;
(3) to increase catecholamine synthesis in those
areas of brain containing higher concentrations
of noradrenaline than of dopamine.
IThe fundamental action of chlorpromazine in





The low sensitivity of the estimation of acetyl-
dopa in the presence of brain extracts (p. 160 ) was due
to the following factors:
(i) a high 'blank' fluorescence, originating from
the residue from evaporation of the 20 - 30 ml ethyl
acetate used to extract the acetylated acid (p•/££ ),
(ii) the quenching of acetyl-dopa fluorescence by the
tissue extracts (p. 160 )t
(iii) the low intensity of the fluorescence derived
from acetyl-dopa, as was indicated by the fact that
the sensitivity of estimation of acetyl-dopa in pure
solution was only 40 mjig (Table $ , p.
Using the following technique, quenching by
tissue extracts was eliminated and the fluorescence from
a tissue extract to which no dopa had been added was
reduced from 5 times to 3 times, that from the reagent
blank. This resulted in a sensitivity of estimation
of acetyl-dopa in the presence of a tissue extract,
of 120 mug, as compared with 400 mug using the method
described in Section I (p, ).
The acetyl-dopa was extracted into ethyl acetate
from the acidified aqueous solution after removal of the
acetylated amines (p.//2 ). To the ethyl acetate
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(20 - 30 ml) was added 2.5 ml 0.111 pH 8.3 borate buffer
together with solid sodium bicarbonate (0.75 g per
0.5 ffil acetic anhydride added during the acetylation
procedure). This amount of sodium bicarbonate was
required to neutralise the acetic acid contained in the
ethyl acetate (p. /// ). Vigorous stirring for 15 -
20 min. was essential to ensure that reaction of the
acetic acid with the sodium bicarbonate went to
completion. Borate buffer was used because there
was an indication that it slightly potentiated the
fluorescence from acetyl-dopa. To 1.0 ml of this
borate extract was added 100 rope acetyl-dopa as an
internal standard, another 1,0 ml portion being used
as the sample. The fluorescence was developed as on
p. H? • A mean recovery of ?Q% + 16jfe (s.D.) was
obtained from 0.5 pg dopa added to extracts from six
different areas of dog brain Just before the acetylation
procedure. The high ♦blank* fluorescence ( » )
was probably due to the high concentration in the
extract solution, of sodium acetate resulting from the
neutralisation of the acetic acid (about 1 ml 10M)
present in the ethyl acetate. Acetyl-tyrosine, which
might be present in the acetyl-dopa extract, would not
contribute to the ♦blank' fluorescence because it did
not react with ethylenediamine.
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On further investigation, dichloromethane was
found to extract acetyl-dopa from acid solution with
the same efficiency as ethyl acetate* However, as
was found with the ethyl acetate extracts derived
from brain tissue, evaporation of the dichloromethane
extracts to dryness and estimation of acetyl-dopa in
the residues gave high blanks and about 50$> quenching
of the fluorescence from added acetyl-dopa. Although
dichloromethane took up very much less of the acetic
acid, formed by interaction of hydrochloric acid with
the sodium acetate (p./^) formed during the acetylation
procedure, than did ethyl acetate, sufficient was
removed into a 20 rol dichloromethane extract to prevent
back-extraction of acetyl-dcpa into 2.5 ml 0.1M
pH 8.3 borate buffer. However, less sodium bicarbon¬
ate would be required to neutralise the acid contained
in the dichloromethane extract with a resulting
decrease in the amount of sodium acetate, compared
with that from ethyl acetate extracts, in the aqueous
phase for analysis and hence a possible lowering of
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